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CHAPTER I
INTRODUCTION
CALCITONIN
HISTORICAL

DEVELOPMEN~

Calcium is among the best regulated ionic constituents of extracellular fluid in mammals.

Many vital processes, including mus-

cular contraction, neuromuscular excitability, membrane permeability,
blood clot formation, and the activity of a number of enzyme systems
are critically dependent on the level of ionic calcium.

At blood

calcium levels below 4 to 5 mg/100 ml, some mammalian forms enter
into tetanic convulsions, often resulting in death, while blood calcium levels of 12 to 13 mg/100 ml in most mammals often results in
cardiac disturbances and renal calcification which may also prove
fatal.

Therefore, the precise regulation of blood calcium concen-

tration within a narrow range is of vital importance in maintaining
mineral haemostasis and hence normal physiological and metabolic
function of all mammalian forms.
The regulation of blood calcium level requires

a~

internal.

balance between calcium mobilization from the skeleton and calcium
deposition in new and maturing bone.

The latter process depends on

the rate of ne\; bone deposition and on the concentrations of ionic
Calcium and phosphate in blood.

Diminished levels of either calcium

or phosphate will interfere with this process resulting in rickets

-1-

-2-

or osteomalacia and defective mineral depositidn on bone matrix.
The precise regulation of plasma calcium, especially in young mam-

mals, is dependent on the metabolic interaction of two hormones,
parathyroid hormone (PTH) and calcitonin (CT), both of which influence calcium mobilization from bone, by as yet, undetermined mechanisms.
The first calcium-regulating hormone to be discovered was the
parathyroid hormone which is secreted by the parathyroid glands.
In 1880, Sandstrom, a Swedish anatomist, presented a detailed description of these minute endocrine glands which have an intimate
association with the thyroid glands of many mammalian species.

How-

ever, he was unaware of their physiological role in maintaining
mineral homeostasis of mammals.

Gley (1891) was the first investi-

gator to recognize the physiological importance of the parathyroid
glands, since their unintentional removal during tota.l thyroidectomy
in dogs often resulted in tetanic convulsions and ultimate death of
.the animals.

However, their important role in calcium metabolism

was determined by Maccallum and Voegtlin (1909), who demonstrated
that parathyroidectomy resulted in a precipitous fall in plasma calcium, associated with tetany and convulsions.
be alleviated by calcium administration.

These symptoms could

Collip (1925) successfully

prepared an acid extract of parathyroid tissue which proved to be
biologically potent since it elevated plasma calcium levels in normal dogs and alleviated the hypocalcemia and tetany in parathyroidectomized dogs.
Rasmussen and Craig (1959) and Aurbach (1959), working independently, announced almost simultaneously, the isolation of essentially

-3PTH by phenol extraction of bovine parathyroid glands and counpure .
tercurrent dis~ribution of the extracteJ material. Rasmussen and
Craig, utilizing ultracentrifugation and dialysis, estimated that
the molecular weight of their purified extract was on the order of
7,000 ± 1,500.
Niall~

al. (1970) determined the complete amino acid sequence

of the bovine PTH molecule, consisting of 84·amino acids and having

a molecular weight of 9,500.

Studies by Potts

established that the amino-terminal

~

al. (1968) have

JO residues of the 84 amino

acid molecule are an absolute requisite for full biological activity.

This has recently been verified by Potts et al.(1971) who

have synthesized biologically active fragments of bovine P'I'H comprising the J4 amino acid sequence from the amino terminus of the
molecule.

The synthetic J4 amino acid peptide exhibited all of the

- specific properties of the native molecule which included stimulation of adenyl cyclase in both bone and kidney cells, elevation of
blood calcium in rats and dogs, and increased excretion of cyclic

AMP and phosphate in rats.
In contrast to the slow progression of parathyroid hormone research, encompassing a 63 year period since Maccallum and Voegtlin
(1909) elucidated the role of the parathyroid glands in calcium
metabolism, the progression of calcitonin research has been extremely rapid since the proposal of Copp et al. (1961) of a hormone involved in regulating the "tone" of calcium in body fluids.

The

series of experiments which led to the identification, isolation,
structural analysis, synthesis and characterization of the physiological role of calcitonin have all been successfully accomplished

Within the last 11 years.

-4Prior to the discovery of calcitonin, the precision of calcium
~omeostasis,

the maintainence of blood calcium concentration in a

narrow range, was thought to depend entirely on the parathyroid
glands and the interaction of PTH with the calcium reservoir in the
skeleton. McLean and Urist (1955) and McLean (1957) had proposed a
simple negative feedback system in which a fall in plasma calcium
prompted the parathyroid glands to secrete additional amounts of

pTH, which consequently increased bone resorption and the release
of calcium from the skeleton.

McLean (1957) proposed that there was

no positive means by which the organism could respond to hypercal-

·cemia, the only control being that of parathyroid hormone secretion.
The first definitive study which clearly demonstrated the inadequacy
of this concept was performed by

Sanderson~

al. (1960).

These

investigators demonstrated that in thyroparathyroidectomized dogs
there was an inability to adequately respond to either an acute
calcium load or calcium deprivation.

The hypocalcemia which resul-

ted could readily be attributed to removal of the parathyroid glands;
however, the impaired recovery of these animals from the effects of
calcium infusions could not be readily explained by the prevailing
concept of calcium regulation.

Sanderson et

realize the import of these findings.

~~·

(1960) did not

It remained for Copp and co-

workers to evaluate the effects on systemic blood calQium of acute
stimulation or suppression of parathyroid glandular activity.

In a

series of classic experiments, Copp and Davidson (1961) and Copp
~ ~l.

(1961,

~962)

evaluated

parathyro~d

gland activity by noting

the effects of acute calcium load or c~lcium deprivation on blood
Calcium levels.

Regional perfusion of the dog thyroid-parathyroid

-5gland complex was performed by successive 2 hour perfusion periods
with blood containing higher (+2 mg/100 ml) or lower (-2 mg/100 ml)
calcium concentrations than normal levels.

Hypocalcemic perfusion

of the gland complex resulted in hypercalcemia through the action
of increased PTH secretion, an anticipated result; however, the
hypocalcemia which developed more rapidly after hypercalcemic perfusion of the isolated thyroid-parathyroid gland complex as compared to the hypocalcemia which resulted after total thyroparathyroidectomy could not be accounted for by simple suppression of PTH
secretion.

Therefore, Copp and coworkers proposed the existence

of a humoral factor which exerted a positive control on hypercalcemia.

Copp and Henze (1964) proposed that the source of this

hypocalcemic factor was the parathyroid glands, and that it be
called calcitonin because it was exerting a positive role in regulating the level or "tone" of calcium in plasma and extracellular
fluids.
Copp and coworkers' proposal of the existence of a hypocalcemic hormone which played a significant role in calcium homeostasis proved to be correct; however, their proposal that calcitonin
originated from the parathyroid gland proved to be incorrect.
Hirsch, Gauthier, and Munson (1963) made a second and highly
significant observation.

These investigators noted that parathy-

roidectomy by the Erdheim cautery technique, which involves hot
wire cauterization of adjacent thyroid tissue in the rat, resulted
in a much more rapid and profound hypocalcemia than simple surgical
Parathyroidectomy.

Thus, the postulation by Hirsch et al. (1963),

that the cautery procedure released into the circulation a potent
hypocalcemic substance stored in the thyroid glands, proved to be

-6correct.

Hirsch~

al. (1964) were able to demonstrate that injec-

tion of as little as 0,1 mg of an acidic extract of rat thyroid
gland into recipient intact rats prompted a marked hypocalcemia.
Hirsch and coworkers assigned the name, thyrocalcitonin, to their
thyroid extract in order to distinguish the gland of origin, although their extract was possibly identical to the factor studied by
Copp and his associates.

Since their isolatfon of a hypocalcemic

hormone from the thyroid glands, this hormone has been referred to
by both names, calcitonin and thyrocalcitonin.

However, the name,

calcitonin, is gaining more acceptance since potent hypocalcemic
extracts have recently been isolated from non-thyroid sources such
as the ultimobranchial glands of both mammalian and non-mammalian
forms thereby ruling out the thyroid gland as the exclusive source
for this hormone.
The first definitive experiments confirming the ability of the
thyroid gland to protect against hypercalcemia and ruling out the
parathyroid gland as an important factor were supplied by Talmage
et al. (1964, 1965).

These investigators used rats with functional

parathyroid gland transplants, thereby allowing them to determine
the effects of acute calcium load in thyroidectomized as well as
parathyroidectomized animals.

Talmage et al. (1965) determined

that rats with intact thyroids could respond adequately to calcium
load while thyroidectomized animals could not.

Moreover, parathy-

roidectomy did not significantly alter this response.
Foster et al. (1964) demonstrated that hypercalcemic perfu8ion
of isolated external parathyroid glands of the goat which had all
thyroid tissue removed did not result in any hypocalcemic effect.

-7However, hypercalcemic perfusion of the thyroid lobe with its contained internal parathyroid resulted in a 15% decrease in systemic
plasma calcium indicating that· the thyroid was essential for a hypocaicemic effect. Confirmatory evidence for the release of a hypocalcemic factor from the thyroid glands in response to hypercalcemic
perfusion was presented by Care (1965).

Care examined serial sec-

tions of perfused pig thyroid tissue and demonstrated that it contained no parathyroid tissue which could affect the response to
hypercalcemic perfusion.

CELL OF ORIGIN
With the unequivocal demonstration by Care (1965) that the
thyroid gland was the gland of origin of calcitonin, it was then
possible to investigate the cell of origin of this hypoca.lce:r.'d.c
hormone.

--

Munson et al. (1966) presented evidence which
ruled out
.

the possibility that calcitonin was synthesized and released from
the thyroid follicular cells.

These investigators demonstrated that

thyroid-stimulating hormone (TSH), essential for thyroxine and triiodothyronine production of the follicular cells, did not alter the
calcitonin content of the thyroid glands.
Attention was therefore focused on the "light 0 , cell or parafollicular cell, a cell type of the thyroid which previously had no
function assigned to it.

This cell type had been referred to as the

"light" cell by Stux et al. (1961) because it stained poorly witu
Periodic acid-Schiff reagent.
in l9Jl.

These cells were examined by Nonidez

He described the cells in the thyroid glands of dogs as

-8arising in the follicular epithelium, later migrating into the
.interfollicular spaces, and remaining around the periphery of the
follicle; hence, the term "parafollicular" cells.

Nonidez noted

the presence of argyrophile granules within these cells and proposed that "the granules represented the antecedent of an endocrine
secretion poured directly into the vessels."
Wissig (1962) presented the first report of the electron microscopy of the parafollicular cells of the rat thyroid.

He indi-

cated that. these cells had a high content of spherical vesicles
which were contained within their cytoplasm.

These subcellular

structures measured between 1500 and 2000 ~ in diameter and some
contained electron-dense material which appeared as discrete granules.

Pearse (1966) demonstrated that these cells were primarily

epifollicular (oriented towards blood vessels rather than the follicular lumen) in pigs while in man these cells appear to be both
epifollicular and parafollicular.

He therefore referred to these

·cells as "C" cells to indicate their possible role in calcitonin
secretion.

The name, "C" cell, avoided reference to the staining

qualities of the cells and to their precise localization.

For this

reason, the new name, "C" cell, could be applied to all species and
to organs and tissues other than the thyroid.
There are three lines of experimental evidence' that, combined,
conclusively identify the "C" cells as the source of calcitonin.
First, these cells were sensitive to small changes in serum calcium
levels.

Foster et al. (1964) had demonstrated that the "C" cells

responded to high calcium concentrations by discharging their electron dense vesicular content.

Similarly, Matsuzawa and Kurosu~i

-9(l 6?) demonstrated that during hypercalcemic stimulation of the

9

rat with calcium chloride, there was a decrease in secretory granule number reaching a minimum at 4 hours after injection.

Secondly,

an immunofluorescent-antibody technique developed by Bussolati and
Pearse (1967) based on antiserum obtained from guinea pigs injected
with highly purified porcine CT, indicated that CT in the pig thyroid was present in cells which were morphologically indistinguishable from the "C" cells.

Thirdly, a preferential uptake of 5-hy-

droxytryptophan (5-HTP) by mouse thyroid "C" cells was described by
Ritzen et al. (1965) while Larsen et al. (1966) noted that the biogenic amine precursor, L-dihydroxyphenylalanine (1-DOPA) was stored
selectively by these cells.

By utilizing specific staining tech-

niques, these compounds would exhibit their characteristic fluorescence in the "C" cells.

Pearse and Carvalheiro (1967) took advan-

tage of this unexplained amine concentrating mechanism of the "C"
cells to determine the embryological origin of these cells.

Since

both 1-DOPA and 5-HTP cross the placenta freely, these compounds
were injected into pregnant mice and rats and the initial appearance
of fluorescent "C" cells in the embryos was monitored.

Pearse and

Carvalheiro (1967) first noticed fluorescence on the 12th day in
the fourth pharyngeal pouch and the ultimobranchial body of 14-day
old rat embryos.

The fluorescent "C" cells,

compri~in~

the ultimo-

branchial body, finally fused with the thyroid gland and assumed
their characteristic distribution within the thyroid.
Final proc f of the ultimobranchiaJ. origin of CT was obtained
by Copp, Cockcroft, and Kueh, in studies on the hypocalcemic effect
of extracts of these glands in chickens and turkeys (Copp, Cockcroft,

-10-

and Kueh. 1967a), and in dogfish shark (Copp, Cockroft, and Kueh,
6?b), in amphibia {bullfrog) and reptiles (Copp and Parkes, 1968),
19
and in fish (salmon) (O'Dor et al., 1969). In addition, Copp and
coworkers demonstrated that CT was absent from the thyroids of birds
which had potent ultimobranchial CT.

In all of these species, the

ultimobranchial gland was separate and distinct from the thyroid.
Subsequent work with the isolation and characterization of the biologically active material from the ultimobranchial glands of salmon
(O'Dor et al., 1969b), has established that the ultimobranchial
glands contain CT that has many similarities to mammalian CT.

More-

over, the salmon hormone exhibited 25 times the biological activity
of the most potent mammalian extracts.

BIOLOGICAI, ASSAY AND RADIOIMMUNOASSAY

Biological

Ass~y

Determination of the amino acid sequence and chemical synthesis of CT necessitated the development of purification procedures
leading to the isolation of the hormone in pure form.

Hence, it

was essential that a reliable biological assay for CT be developed
in order to assess extent of purification at each stage of the isolation procedure.

The rat and the mouse proved to be ideal test

animals for assaying the hypocalcemic activity of CT preparations
(Hirsch et al., i964; Kumar et al., 1965).

Most researchers

today utilize the rat assay of Hirsch et al. (1964), or a modification of this method.

The assay of Hirsch et al. (1964) was

-11based on the decline in plasma calcium 1 or 1~5 hours after intravenous or subcutaneous injection of rat thyroid extracts into lOJ to
150 gram rats.
In 1966, the Division of Biological Standards of the National
Institute of Medical Research, Mill Hill, London, England, established an international reference standard which was termed "Thyroid
Calcitonin Research Standard A."

This was a crude but stable acid

extract of porcine thyroid glands prepared in accordance with the
salt fractionation procedure of Baghdiantz et al. (1964).
The Medical Research Council unit (MRC Unit) was defined as
the calcium lowering activity contained in four ampoules (40 mg or
10 mg/ampoule) which was equivalent to 250 µg protein/mg and 0.25
MRC units per ampoule.

Approximately 0.01 MRC unit of this material

given intravenously in the biological assay procedure of Kumar et al.

(1965), in which blood calcium is determined 50 minutes after injection of test solution in rats, produced a 10 percent fall in plasma
calcium.

In 1967, Research Standard A was superseded by Research

Standard B, a more highly purified, but less stable preparation of
porcine CT furnished by Dr. Robert Schleuter of Armour Pharmaceutical Company, Kankakee, Illinois to the Medical Research Council.
This preparation was standardized against Research Standard A by
international collaborative assays (Parsons and Reynolds, 1968)
'

-

that established the ratio of specific biological activity of A to
B to be equal to 1 to 900.
units/mg.

Standard B had a potency of 22 MRC

-12~ioimrnunoassa.y

Deftos et al. (1968) and Lee et al. (1969) developed a highly
sensitive and specific radioimmunoassay for porcine CT whereby as
little as 15 to 20 µµg of porcine hormone could be detected reproducibly.

Their studies with rabbits indicated that CT circulated

in the blood of the normal animal, that secretion of the hormone
increased 15-fold in response to induced hypercalcemia (CaC1 2 load),
and that the disappearance of CT in the blood was rapid. The halflife of secreted CT was estimated to be 5 to 15 minutes.

Deftos

and coworkers were also able to demonstrate CT in normal and malignant human thyroid tissue.

This meant that normal human CT, which

could not be detected by biological assay except in patients with
thyroid carcinoma, could now be detected routinely by the highly
sensitive radioimmunoassay procedure.

CHEMIST'RY

Hirsch et

~1.·

(1963) prepared the first potent extracts of cal-

citonin from rat thyroid

glands~

The injection of extract from as

little as one-third of a rat thyroid gland resulted in a marked
hypocalcemia in recipient normal and thyroidectomized rats one hour
after injection.

However, Hirsch and coworkers

se~ec~ed

hog rather

than rat thyroid extract for purification procedures due to the
availability and abundance of material, even though the biological
activity of ho~ CT preparations was less than rat CT extracts.

~lso,

contamination with parathyroid tissue was not of concern since the
Parathyroid glands of the ltog a.re embedded at sites remote from the

-13thyroid gland and in the thymus gland.

Hirsch~~·

(1964) accom-

_plishe d a ten-fold purification of the starting acid extracts of
hog thyroids by centrifuging this material at 100,000 x g for 24
hours. The supernatant was hypocalcemic in intact rats. A subsequent two-step purification procedure consisting of fractionation
on Sephadex G-50, and Sephadex G-25 resulted in a total ·500-fold purification of calcitonin from the starting extract.
An effective alternative method for partial purification of
porcine CT, utilizing dried, defatted thyroid tissue which subse--f!ue.ntly underwent salt fractionation ( 2-J M NaCl) and gel fil tration on Sephadex G-100 columns was reported by Baghdiantz et al.
(1964).
Baghdiantz et al. (1964), Hirsch et al. (1964), and Tashjian
and Warnock (1967) also demonstrated the peptide nature and the
concomitant loss of biological activity of their relatively impure
- CT preparations.

These hypocalcemic preparations were readily in-

.activated by incubating them with a variety of proteolytic enzymes
such as trypsin and pepsin.
Further purification of porcine material was accomplished by
Tenenhouse et ..§1.. (1965) who successfully applied a method for tre
partial purification of bovine PTH.

Hog thyroid glands were de-

hydrated and defatted by successive extractions with acetone and
Chloroform.

The resulting powder was treated with 8 M urea - 0.2 N

HCl - O.l M cysteine at 4° C for one hour, followed by solvent and
Salt fractionation, precipitation of tlbactive material with triChloroacetic acid (TCA), and recovery of this precipitate as a
lyophilized powder.

This TCA powder was passed through a column of

-14sep h

adeX G-75 and yielded a preparation which Tenenhouse et al.

(l 65) considered to be homogeneous after fractionation by starch

9

This hypocalcemic preparation was given the
ge l electrophoresis.
name, TA.~ peptide, since Tenenhouse, Arnaud, and Rassmussen (1965)
devised the isolation procedure for its preparation.

These inves-

tigators determined the molecular weight of the TAR peptide, which
they presumed to be pure CT, to be 8700 on the basis of amino acid
composition.

Munson et al. (1966 and 1968) repeated the work of

Tenenhouse et al. (1965) and demonstrated that more retarded eluates
fro~

Sephadex columns yielded CT preparations having up to 10 times

the biological activity of the TAR peptide.

Munson and coworkers

clearly demonstrated that the TAR peptide could be further fractionated into 5 bands on highly sensitive analytical polyacrylamide
gels thereby furnishing conclusive evidence that the TAR peptide was
still a heterogeneous preparation.

Potts et al. (1967) and Munson

-- -

et al. (1968) utilized preparative polyacrylamide gel electrophoresis to obtain a porcine CT preparation which represented a 50,000fold purification of the starting acetone-chloroform dried extract.
Potts et al. (1967) determined the molecular weight of their most
purified porcine CT extract to be

4,ooo as calculated from their

estimate of the amino acid composition.

This value was in rather

close agreement with the value of 5,000 to 6,000 as ' determined
by
.
the sucrose density centrifugation procedure of O'Riordan et al.

(1966) and the Sephadex G-100 gel filtration experiments of Mcintyre
tl

fil_.

(1965) in which a molecular weigtt of less than J,000 was

assigned to their CT preparations.

The first correct report of the

amino acid composition of porcine CT was presented by Putter et al.
(1967).

-15Based on the findings of

Mcintyre~

al. (1965), O'Riordan

t al. (1966) and Potts et al. (1967), all of whom had extracted
~and isolated CT by different techniques, the molecular weight of
the hormone was variously estimated at 3,000 to

6,ooo.

Final proof

of isolation of essentially pure CT necessitated the determination
of the entire amino acid sequence, chemical synthesis of a peptide
with the proposed structure, and
peptide had the
occurring CT.

hypoc~lcemic

demonst~ation

that the synthetic

activity of the isolated, naturally

All of these extremely important projects were suc-

cessfully accomplished by a number of research groups in 1968.
The complete amino acid sequence of pure porcine calcitonin
was reported by Potts et al. (1968).

It was determined through the

use of sequential degradation by the phenylisothiocyanate procedure,
digestion with exopeptidases, and isolation and analysis of peptide
subfragments resulting from cleavage of the polypeptide by trypsin,
pepsin, chymotrypsin, papain, cyanogen bromide, and limited hydrolysis in dilute acid and concentrated acid.

Neher et al. (1968)

simultaneously arrived at the identical amino acid sequence for porcine CT and Bell et al. (1968) arrived at the same sequence finding
the weight-average molecular weight of porcine CT to be 3700, which
was in excellent agreement with the value of 3604 as required by the
amino acid sequence of the molecule.

Distinctive structural fea-

tures of the 32 amino acid molecule are that the proportion of
charged amino acids is low, the carboxyl-terminal amino acid is prolinamide, and ~here is a 1-7 intrachain disulfide bridge, providing
a 2J-membered ring at the amino terminus.

Brewer

£1

al. (1968)

demons~rated that pure porcine CT did not contain more than 0.02%

-16iodine, indicating the distinct difference between this molecule
and the iodinated thyroid hormones. Ri·~tel et §.1_. ( 1968) and
Guttmann

.§! al. (1968) confirmed the sequence determination of por-

cine CT by chemical synthesis of a polypeptide which possessed the
same specific biological activity as the isolated, naturally occurring hormone.
Utilizing gel filtration and ion-exchange chromatographic
methods, Brewer et al. (1970) isolated bovine CT and determined its
amino acid sequence while Potts et al. (1970), utilizing similar
techniques, determined the amino acid composition of ovine CT.
_Sauer et al. (1970) succeeded in determining the amino acid sequence
of ovine CT which is depicted in Figure 1.

The specific biological

activity of the bovine and ovine calcitonin when compared to the
porcine molecule was found to be closely similar, ranging from 50120 Medical Research Council Units/mg.

The amino acid composition

-of these three calci tonin differed by only a few residues.

Neher et al. (1968) isolated and determined the complete amino
acid sequence of human CT from extracts of a single medullary carcinoma of the thyroid.

This tumor exhibited an overabundance of

"C" cells when compared to normal human thyroid tissue.

The human

CT molecule also consisted of 32 amino acids; however, 18 of the J2
amino acid residues differed from the

corresponding_po~itions

occupied in the porcine CT molecule.

Riniker et al. (1968) pre-

sented evidence that human tumor CT existed in two forms.

The

first, termed CT "M", consisted of 32 amino acids, while the seccnd,
CT "D", proved to be an antiparallel dimer of CT "M".

The dimer

could be converted into the monomer by treatment with base.

Riniker
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1
7
8
9
10
11
12
CVS CVS VAL L EU SER ALA TVR
2 SER

13
TRP 14
LVS lS
ASP
LEU16
ASN17
ASN18
TVR19
HIS20

THR6

SER 5
3ASN
LEU
4

ARO 21
TVlt 22
SER23
GLV24
MET25
Gl V26
PHE27
GLV PRO GLU THR PRO
28
29
30
31
32

OVINE

Figure 1.

C

~o

-.NH2

CALCI TONIN

The amino acid sequence of ovine calcitonin

(Sauer et al. 1970).
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..

and

Co workers

activity.

proposed that the dimer exhibited full biological

However, no dimer of porcine1 bovine, or ovine CT has

The concept of a biologically active dimer of
bee n identified.
(1970) presented evidence which
human CT was revised when Mcintyre
suggested the dimer was without activity until its gradual conversion into an active monomer by incubation for one hour with bovine
plasma albumin.
Copp §..1 al. (1967) had demonstrated the ultimobranchial origin
of CT in several submammalian vertebrate species and he and his
ass~ciates

(O'Dor et al., 1969) successfully isolated CT.in homo-

geneous form from salmon.

These extracts were extremely potent in

mammalian bioassay systems.

Niall

~%1•

(1969) achieved final pur-

ification of salmon ultimobranchial CT in quantities sufficient to
permit sequential determination of the molecule by use of the Edman
degradation method.

The salmon molecule possesses, in common with

other calcitonins, a 32-amino acid peptide chain terminating in
-prolinamide and a 1-7 intrachain disulfide bridge.

Keutmann et al.

(1970) detected two chemically different forms of salmon CT termed
CT I and II.

The major isohormonal form, CT I, had the )2 amino

acid sequence determined by Niall et al. (1969), while the minor
component, CT II, exhibited similar biological potency to the major
peptide having a specific activity in rabbit of 2409

lf~C

units per

mg as compared to 2700 MRC units for the major component, or 10
times the potency of the most active mammalian preparations.
The amino acid sequence of CT molecules from 5 different species, (porcine, bovine, ovine, human, and salmon), is now known and
is depicted in Figure 2.

Each of the five calci tonin molecules con-
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PORCINE CALCITONIN

s-----------------------s
I

I

H N-CYS-SER-ASN-LEU-SF..R-THR-CYS-VAL-LEU-SER-ALA-TYR-TRY-ARG 14
2
2
3 -r;- 5 --e;- 7
8 9 10 11 12 lJ ASN 15

-r-

LEU 16

~SN 17
A~N 18
O"-PRO-THR-GLU-PRO-GLY-PHE-GLY-MET-GLY-SER-PHE-ARG-HIS-PBE 19
NH(°--s2

Jl

JO

29 ~

27

26

25

24

23

22

21

20

BOVINE CALCITONIN

s-----------------------s
I

I

tt 2 N-CYS-SER-ASN-!&1l.-SER-THR-CYS-VAL-!&Q-SER-ALA-TYR-TRY-L;s 14
ASP 15
I
LEU 16
ASN 17

o

I

ASN 18
"PRO-THR-GLU-PRO-GLY-PHE-GLY-MET-GLY-SER-PHE-ARG-HIS-TYR 19

NH~""'J2

31

JO

29

~

27

26

25

24

23

22

21

20

OVINE CALCITONIN

s-----------------------s
I

I

H N-CYS-SER-ASN-LEU-SER-THR-CYS-VAL-LEU-SER-ALA-TYR-TRY-LYS 14
2
2
--e;- -:r- 8
10 11 12 lJ ASP 15

-r-

~~~

~

I

LEU 16
I
ASN 17
I
O
ASN 18
"PRO-THR-GLU-PRO-GLY-PHE-GLY-MET-GLY-SER-TYR-ARG-HIS-TYR 19
NH~ 32 Jl JO 29 -ZS 27 26 25 24 23 22 21 20

Figure 2.
(Potts

.£1

The complete amino acid sequence of porcine
al. 1968), bovine (Brewer et al. 1970), ovine

(Sauer et al. 1970), human (Neher et al. 1968), and salmon
(Niall et al. 1969) calcitonin.
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Figure 2, continued

-

HUMAN CALCITONIN

s-----------------------s
I

I

H N-CYS-GLY-,ASN-LEU-SER-THR-.Ql.§.-MET-LEU-GLY-THR-TYR-THR-GLN 14
2 --r- 2
3 -i;- 5 ~ 7 8 9 10 11 12 13 ASP 15
I

PHE 16
ASN 17
• 18
LYS
___ O......_PR 0-ALA-GLY-V AL-GLY-ILE-ALA-THR-GLN-PR 0-PHE-THR-HI S-PBE 19

NH~~

Jl

JO

29

28

27

26

25

24

23

22

21

20

SALMON CALCITONIN

s-----------------------s
I

H

I

N-CYS-SER-ASN-LEU-SER-THR-CYS-VAL-LEU-GLY-LYS-LEU-SER-GLN 14
2
2 ~ -i;- ~5~ ~
8 ~ 10 11 12 13 GLU 15

--rr-

-r-

I

LEU 16
I
HIS
17
I
LYS 18

o..........

I

/'"PRO-THR-GLY-SER-GLY-THR-ASN-THR-ARG-PRO-TYR-THR-GLN-LEU 19

NH 2

32

Jl

JO

29

28

27

26

25

24

2J

22

21

20

I

I.I
i

-21·sts of a J2 amino acid chain exhibiting a 1-7 amino terminal dis1
sulfide bridge and a carboxyl terminal prolinamide. Only nine
acids occupy identical sequence positions in the five calci-arnino
tonin molecules depicted in Figure 2. Seven of these nine occur in
the amino terminal disulfide loop region occupying positions one,
three, four, five, six, seven and nine.

The carboxyl-terminal pro-

linamide at position J2 and the glycine, at position 28, are the
two remaining constant positions.
In the porcine, bovine, and ovine calcitonins, a marked similarity in sequence occurs in the positions between 10 and 27; how_ever, a noticeable difference exists between these three calcitonins
when compared to human and salmon calcitonin which also differ from
each other considerably.

Habener et al. (1971) have suggested the

increased potency of the salmon CT as compared to porcine CT may be
due to an increased resistance to metabolic destruction.

These in-

---v-estigators were able to demonstrate that a progressive decrease in
lmmunoassayable activity of porcine CT occurred after in vitro incubation of the preparation in dog plasma while salmon CT remained
completely stable.

Salmon CT differs from porcine CT in 19 of J2

residues, and in 11 positions it contains amino acids not found in
any other CT.

These structural differences might well be involved

in a lesser inactivation of the molecule in the extravascular compartrnent, vascular bed, or one or more organs, and thereby result
in greater stability of the salmon CT molecule.
Sieber et al. (1969) evaluated the biological activity of a
variety of synthetic peptide fragments of porcine CT.

Their studies

indica.ted that fragments of the molecule, the peptide sequence 1-9
from the amino terwinal of the molecule, which includes the disulfide
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bridge, or the peptide sequence l0-32, and a number of other peptide
-yariants such as the residues 1-10 joirn'd to residues 20-32, exhibited no or little biological activity.

Deleting even one or two

amino residues from the carboxyl-terminal end of the porcine molecule while retaining the carboxyl terminal prolinamide, resulted in

almost complete loss of biological activity.
Fragments of many other peptide hormones exhibit full or partial biological activity.

For example, the peptide sequence, l

through 29, of PTH exhibits full biological activity.

However, the

entire J2 amino acid chain together with the carboxyl terminal
amide must remain intact or a dramatic decrease of hypocalcemic
activity of the CT molecule occurs.
Although small variations in the length of the CT molecule drastically decrease biological activity, considerable amino acid substitution or modification within the 32 amino acid chain have little
···influence on biological activity, as shown by Potts et .§1.. (1971).

SITES AND MODE OF ACTION
The principal, physiologically important action of calcitonin
is the inhibition of bone resorption thereby producing its characteristic hypocalcemic and hypophosphatemic effects. ' Considerable
.
evidence has been presented which indicates that calcitonin inhibits
PTH-induced bone resorption both in vi..YQ and in vi.:tf:Q..
The hypocalcemic effect of calci tonin is the primary attrib: .te
1

Which resulted in its discovery in rat thyroid glands by Hirsch et al.

(1963); however, Kenny (1964) and Hirsch et al. (1964) soon discov-

-23that injections of porcin~ CT preparations into rats also reere d
suited in a significant hypophosphatemir. response. The decreases
.

in

plasraa calcium and phosphate usually occurred over the same time

interval and exhibited similar dose-response relationships.

The

hypophosphatemic effect of CT is now attributed to the primary action of CT in inhibiting bone resorption since hypocalcemia induced
by CT probably results in a compensatory increase in PTH secretion.
The increased PTH levels would then lead to decre.ased reabsorption
of phosphate by the kidney and hence a hypophosphatemic response.

·In-vivo
- investigations

relying on administration of radioactive

bone-seeking iostopes have been utilized to evaluate the mechanism
of action of CT on bone.

In order to interpret data from these

types of experiments, one would have to accept the concept that there
are both stable pools of calcium in bone, which are PTH-sensitive,
and labile, or readily exchangeable, pools of bone calcium.

Twenty-

-four hours after the administration of 45ca, the isotope is interchanged to a great extent with the labile pools of bone calcium.
Consequently, the specific activity of the radioisotope in the blood
declines rapidly in the first 24 hours since there is little reab4
sorption of 5ca during this time interval. However, two weeks after
injection of 45ca, when all bone pools are labeled, alterations in

PTH levels change the 45ca concentration in blood proportionately
to changes in tot2l serum calcium, thereby resulting in no change in
specific activity of serum calcium.

Milhaud and Moukhtar (1966)

injected a single tracer dose of 45ca (50 pCi) intravenously into
rats two hours after the first of a series of injections of calcitonin which produced a low plasma calcium level for three days.

The

-24in their study, were fasted and any calcium absorption from
rats
the gut was negligible. Their studies suggest.ed that the dilution
of the radioactive calcium pool by unlabeled calcium could only be
bone catabolism since they found that following injection of
due to
the hormone, there was the expected hypocalcemic response; however,
the specific radioactivity in the blood remained constant.

There-

fore, Milhaud and Moukhtar (1966) proposed that the action of CT
was on the stable or slowly exchangeable pool of bone rather than
the labile pool which would have exhibited a drastic decline in specific activity as well as the hypocalcemic response.
Johnston and Deiss (1966) noted the effect of CT injections on
the levels of radioactive calcium in rats whose bones were labeled
with 4 5ca either three hours or two weeks before CT injection. CT
produced a significant decrease in labeled as well as unlabeled calcium (no change in specific activity) in serum of rats which had
4
received 40 µCi of 5ca prior to hormone injection. However, in
three-hour labeled rats (receiving 10 µCi) in which stable bone was
not labeled, serum calcium also decreased but there was an increase

in serum calcium specific activity.

Their experiments indicated

that CT causes inhibition of the metabolically active bone resorption.
Klein et al. (1967) studied the effect of porc·ine. CT in rats
by utilizing a peritoneal lavage technique which employs a calcium-

ana phosphate-free rinse.

4 5ca and 32 p were administered to rats

either three weeks or 18 hours before peritoneal lavage. The remov45 ca andJ2p administered 18 hours prior to peritoneal lavage
al of
of normal and parathyroidectomized rats was decreased by CT as was

-25tha t
1110val

th!'ee

of total calcium and phosphate; however, CT decreased the reof the isotopes from bone to a greater degree in rats labeled
weeks prior to lavage.

In concurrence with other investiga-

their results indicated that the labile calcium in bone as
tors,
well as the stable calcium was affected by CT, but to a lesser degree. o'Riordan and Aurbach (1968) presented evidence that CT
caused no detectable change in the disappearance of radioactive cal-

cium from rats injected with

45ca 2.5 hours earlier although serum

calcium levels fell precipitously and there was an interruption in
the normal decline in specific activity.

Their data implied that

CT had inhibited further dilution of radioactive calcium in the circulation with unlabeled calcium by blocking the mobilization of calcium from bone.
The most direct evidence indicating an effect of CT on bone

in vivo was that presented by Macintyre ,fil al. ( 1967).

These inves-

-- -tigators demonstrated that CT infusion caused a net retention (+5%)
of calcium in the isolated perfused tibia of the cat.

This reten-

tion was associated with a small increase in acidity of the outflowing venous blood, possibly indicative of the formation of a
calcium phosphate salt with release of hydrogen ion.

lnYiY.Q.

In other

experiments, the rate of urinary excretion of hydroxyproline,

a major component of collagen and hence, of the bone . matrix,
has
.
been utilized as an indicator of the rate of matrix breakdown~ and
indirectly, of bona resorption.

In line with this concept, Harris

and Sjoerdsma ( 1966) demonstrated that prnH injection into rats wh2.ch
had received isotopically labeled L-proline four to twelve weeks

earlier, increased the urinary hydroxyproline output, indicating
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des t

tha t

ruction of mature collagen.

Martin et al. (1966) demonstrated

infusion of 20 µg per hour of CT dramatically decreased the ex-

·on of hydroxyproline in intact rats after a three hour period.
ere tl
Similarly, Rasr.1ussen et al. (1967) have demonstrated that CT, administered in conjunction with PTH, could inhibit the rise in urinary
hydroxyproline in thyroparathyroidectomized rats.

The effects of

CT administration on extracellular levels (serum and lavage fluid)
of hydroxyproline in rats were examined by Klein and Talmage (1968)
following peritoneal lavage, parathyroidectomy, nephrectomy, and
calcium-restricted diet.

These investigators noted that CT markedly

reduced hydroxyproline levels in all instances, being especially
efficacious in reducing the total amounts of hydroxyproline and calcium removal during an 8-hour lavage period with a calcium and phosphate free rinse.

The foregoing in vivo experiments provided sub-

stantial evidence that CT administration resulted in inhibition of
all phases of bone resorption.
In vitro experiments have been of two kindsa

those in which the

effect of CT has been studied on cultured bone and those in
which changes in an isolated, perfused limb have been investigated.
Alipoulious et al. (1966) produced resorption in cultured calvariae
from five day old mice by the daily addition of 0.5 units of PTH to
the in vitro culture system over a seven day period.

The PTH-in-

duced resorption of cultured bones had previously been well established by Gaillard (1965).

However, these inves~igators noted that

CT added to tissue cultures of calvariae could counteract, in a doserelated manner, the resorption of bone stimulated by daily PTH
additions.

Similarly, Friedman and Raisz (1965) and Friedman et al.

-27(l 68) noted the effectiveness of CT in inhibiting PTH-induced bone

9

resorption of radii and ulnae obtained from 19-day fetal rats whose
4
mothers had been injected with 5ca on the 17th day of gestation.
The inhibition of bone resorption was independent of the action of
PTH since CT could also be shown to inhibit spontaneous resorption
which occurred in control bone cultures in the absence of PTH.

The

inhibitory effect of CT on bone resorption could not be overcome by
increased. PTH doses.

However, the inhibition in tissue culture

appeared to be of limited duration.

Friedman et al. (1968) and

Wener et al. (1972) demonstrated that after a period of J6 to 48
hours of treatment with both PTH and CT, the cellular transformation
and the elevated

45ca release, characteristic of PTH-induced bone

resorption in tissue culture, reappeared despite the addition of
fresh CT in maximal or supra-maximal doses.

However, fresh addi-

tions of CT to culture media after several days without CT resulted
once again in active inhibition of resorption.

Wener and coworkers

demonstrated that the initiation and magnitude of this "escape"
phenomenon was proportional to the intensity of stimulation of bone
resorption.

Concentrations of PTH which produced submaximal stim-

ulation of bone resorption either delayed the onset of "escape" or
resulted in uincomplete" escape.

Further, these investigators

showed that a 24 hour pre-incubation of bones with PTH could result
in a prolonged resorptive response which they termed "induction."
This inductive response occurred even though the_bones were washed
and transferred to fresh media without PTH and with or without CT.
Low concentrations of calcium or phosphate in the culture medium
impaired "induction" and also impaired or delayed "escape."

The
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of the "escape" and ''induction" phenomena are unknown,
mechanisms
it is likely that both depend upon changes in nuclear transbu t
.
cription which leads to an increase in the activity and number of
bone r esorbing cells. Brand and Raisz (1972) carried out bone culture studies which indicated that PTH stimulates the release of both
previously incorporated 45ca from the mineral and JH-hydroxyproline
from the matrix of fetal rat bone.

Moreover, their studies suggest

that mineral breakdown must precede matrix breakdown, since the 45ca
label was lost earlier and at a more rapid rate than 3H-hydroxyproliDe.

The addition of 2 or 3 mM phosphate to the incubation medium

provided sustained inhibition of PTH-induced resorption of matrix as
well as mineral.

However, CT addition

promp~ed

inhibition of min-

eral resorption which was short-lived and which was not effective
in preventing the release of 3H-hydroxyproline.

These investigators

proposed that the ineffectiveness of CT in blocking matrix resorption was attributable to the inability of the hormone to block release of collagenases into the culture medium after PTH exposure.
Thus, Brand and Raisz proposed that CT has no direct effect on the
activity or synthesis of PTH-induced collagenolytic enzymes, but
was effective in blocking resorption of calcium from bone mineral.
The preceding in vitro experiments indicate that bones undergoing PTH-induced resorption are more responsive t9 aqditions of CT.
However, Munson et al. ( 1966) and Gudmundsson et .?J_. ( 1966) clearly
indicated that CT does not act by direct inhibition of PTH, since
its unique hypocalcemic response could be demonstrated in parathyroidectomized rats which remained normocalcemic by feeding of a
high calcium diet.
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in vitro bone
--

culture experiments of Raisz and Niemann

(l 6?) and Reynolds and Dingle (1968) indicate that the effective-

9

ness of CT in inhibiting PTH-induoed bone resorption may be sufficiently rapid to account for the hypocalcemic effect in vivo.

Raisz and Nieman's in vitro culture system consisted of paired radii
and ulnae from 19-day old rat fetuses which had been prelabeled with

45ca on the seventeenth day of gestation.

Their studies indicated

that CT addition to the culture medium could effectively inhibit
release of 4 5ca from PTH-stimulated bones within three hours.
Reynolds and Dingle labeled calvariae of two day old mice with

45ca

and removed the labeled calvariae for tissue culture six days after
birth.

The PTH-induced resorption of these calvariae could be sig-

nificantly suppressed by CT within JO minutes after the addition of
the hormone.
Nisbet and Nordin (1967), utilizing an in vitro bone culture
system consisting of calvariae from 5-day old mice, demonstrated
that these PTH-treated calvariae released more citrate while CT and
PTH addition reduced the levels of citrate and of calcium in the
medium.

These investigators noted that the PTH induced inhibition
of metabolism of 1, 5- 14c-citrate was not affected by CT. It was

possible that CT was exerting its inhibitory effect on citrate accumulation in the medium by blocking a step in glucose metabolism
before citrate.

Even though this possibility existed, a popular

concept of the primary action of PTH was thought to be that of increasing the citrate concentration at the bone/blood interface and
that a rise in citrate concentration was the initial event in PTHinctuced mobilization of calcium from bone.

However, this concept

-30of th.e ·contrasting metabolic actions of PTH and CT when closely

·ned, was not tenable since Firsche~ et al. (1959) had demonexam 1
- ~trated that a rise in citrate concentration in intact dogs after
PTH-induced resorption was accompanied by a ·concomitant rise in
lactate concentration.

It is riow clear that changes in citrate and

lactate do not precede mobilization of calcium from bone, but may
well be secondary to changes in calcium concentration.
Reynolds (1968) induced resorption of near term (19-day) mouse
calvariae, grown in vitro, by using vitamin A (22 international units
of retinol/ml of medium) and PTH.

Vitamin A and PTH treatment for

two days induced resorption of calvariae with the appearance of
numerous multinucleated osteoclasts.

Moreover, most recognizable

osteocytes disappeared, and a transformation of osteoblasts into a
fibroblastic form occurred when CT was added to the culture media
with vitamin A or PTH; bone resorption was suppressed since, histological sections showed a decline in the number of multinucleated osteoclasts.

However, CT did not prevent the PTH and vitamin

A-induced loss of osteocytes, or the transformation of osteoblasts.
These investigators therefore proposed that CT primarily inhibited

in vitro resorption of calvariae by altering the number of multinucleated osteoclasts.
In contrast to the work of Reynolds (1968),

th~

in

vivo work

of Belanger and Rasmussen (1968) demonstrated that CT inhibited
bone resorption (PTH-induced bone resorption was thought to occur
through a process termed ttosteocytic osteolysis" by Belanger in
1965) in thyroparathyroidectomized rats infused with PTH and CT for

l4 to 16 hours.

These investigators noted changes in the cellular

-Jlcture of osteocytes and chemical changes in the matrix immestru
diatelY adjacent to the lacunae containing osteocytes within four
hOU r

s of increased PTH activity or after long term treatment with

iow calcium diets, hypervitaminosis D, pregnancy, or parathyroid
tumor.

Histochemical studies revealed that osteocytes released

alkaline phosphatase and lysosomal proteases.

Similarly, there was

a reduction in mineral and matrix content around the osteocyte as
well as an increase in stainable mucopolysaccharide.

The lacunae

became enlarged with irregular borders, indicating increased resorptive activity.

However, CT-treated rats showed a reversal of some

of these processes since there were fewer enlarged lacunae and the
matrix was more dense.
In further in vitro experiments with rat calvaria, Reynolds
~al.

(1968) demonstrat~d that vitamin A, in a manner similar to

that of PTH, increased release of lysosomal enzymes.

This release

was not blocked by CT even though vitamin A-induced resorption (increased multinucleated osteoclastic activity) was halted.

These

investigators proposed that CT acted by inhibiting the release of
bone mineral from resorbing bone and preventing the breakdown of
mature

collag~n.

However, the hormone was not thought to affect the

turnover of other matrix components (hexosamine and hydroxyproline)
from immature collagen of embryonic bones which are degraded by the
release of PTH and vitamin A-induced lysosomal enzymes.
On the other hand, there was abundant evidence based on tissue
Culture studies of Gaillard and Goldhaber and peritoneal lavage exPeriments of Talmage and coworkers that implicated the osteoclast
in mediation of PTH-induced bone resorption.

Gaillard (1965) had

-32that administration of PTH to cultured mouse radii resulted
.shown
in decreased osteoblastic activity in bcne shafts and increased
· bers of multinuclear osteoclasts in areas of active bone resorpnum
Goldhaber (1965), utilizing the calvaria of 5-day old mice,
, -·· -··tion.
demonstrated the appearance of numerous giant vacuolated osteoclasts
( 40 _50 µ in diameter) which developed and accumulated in areas of

rapid resorption 24 hours after PTH or vitamin D-treatment.
The peritoneal lavage studies of Talmage (1967) and Park and
Talmage (1968) confirmed the stimulation of osteoclast production
following PTH-treatment.

However, their experiments indicate that

.-these effects on osteoclasts do not correlate in time or location

with the rapid mobilization of calcium from bone due to PTH-treatment since stimulation of osteoclast

productio~

six to eight hours after PTH administration.

did not occur until

These investigators

proposed that both mechanisms of bone resorption, osteocytic and
osteoclastic, are physiologically important.

Park and Talmage pro-

posed that osteocytic osteolysis may be the principal mechanism for
rapid mobilization of calcium from bone in response to PTH-treatment and the osteocytes are the bone cells which are responsive to
CT-treatment.

The

act~on

of PTH on osteocytes did not appear to

require increased RNA synthesis as a prerequisite for hormone action.

These investigators propose that the osteoclqst _plays a prom-

inent role in the normal remodeling of bone and the chronic, or
longer term effects of continued PTH-induced bone resorption.

The

Production of i~creased numbers of osteoclasts may proceed throush
Changes

in

RNA

0 steoclasts.

synthesis in mesenchyme cells, the progenitors of

-JJAlthough the gastrointestinal tract has an important influence
on the extent of absorption of dietary calcium, and to some extent,
the levels of calcium excretion, it is not critical in mediating
the hypocalcernic effect of CT.

Aliapoulious et~· (1965) and

Munson tl al. (1966) have clearly demonstrated that CT was effective in lowering blood calcium levels of rats even after removal
of the entire gastrointestinal tract.

Additional evidence point-

ing to the lack of CT involvement in modulating calcium absorption
was presented by Robinson et al. (1968) who demonstrated that CT
had no influence on calcium absorption from isolated gut loops of
rats.

The other organ system which is important in calcium metab-

olism, the kidney, was also shown by Munson~ al. (1966) and
Gudmundsson et al. (1966) not to be essential in mediating the
action of CT.

These investigators showed that CT was effective in

lowering blood calcium levels of rats when given immediately after
nephrectomy, indicating the fall in plasma calcium was not due to
increased renal excretion of calcium.

MECHANISM OF ACTION
Currently, there exists no convincing data suggesting an explanation of the biochemical mode of action of CT in inhibiting
PTH-induced bone resorption as mediated either by the osteocyte
or the osteoclast bone cells in YiY.Q or in vitro.

However, it has

been clarified that the hormone's hypocalcemic effect is not dependent upon direct inhibition of PTH.

This view was well documented

by the studies of Tashjian (1965) and Robinson et al. (1967) who
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ted that CT was fully active in surgically parathyroidec-

tomized rats.

It is unlikely that CT administration affects procein

synthesis, or the formation of new RNA since the action of the

hor~

mone is unaffected by prior administration of actinomycin D to rats
as demonstrated by Tashjian (1965) and Gudmundsson et al. (1966).
Tashjian's work indicated an unaltered hypocalcemic response in
rats which had been injected with actinomycin D, J, 8, or 11 hours
prior to CT administration.

The hypocalcemic effect could be ob-

served at 8 to 12 hours after actinomycin D injection when endogenous or exogenous PTH proved completely ineffective.

Moreover, the

action of CT is not dependent on vitamin D, since the hormone exerts
its hypocalcemic and hypophosphatemic effect in vitamin D-deficient
rats as shown by Morii and DeLuca (1967).
Chase and Aurbach (1967 and 1968) and Chase et al. (1969)
presented experimental evidence that suggested that cyclic J', 5'adenosine monophosphate (cyclic AMP) was a mediator in the mechanism
of action of PTH on the kidney and bone in vitro,

PTH stimulated

adenyl cyclase, the enzyme which converts ATP to cyclic AMP, in rat
renal cortex preparations within 15 seconds after in vi..1£2. hormone
addition.

In line with Chase and Aurbach's work, Wells and Lloyd

(1967 and 1968) have advanced the hypothesis that CT exerts its
characteristic hypocalcemic and hypophosphatemic effec~ by altering
the activity of the enzyme, phosphodiesterase, which degrades cyclic

AMP.

Their hypothesis was based on indirect evidence derived from

Utilizing the fharmacologic agents, imi~azole, isoproterenol, and
theophylline.

According to their hypothesis, agents which activate

Phosphodiesterase should have a hypocalcemic action similar to that

-35of CT·

Wells and Lloyd (1968) found that injection of imidazole,

which stimulates phosphodiesterase activity, led to hypocalcemia in
intact, parathyroidectomized or thyroparathyroidectomized rats,
thereby mimicking the action of CT.

On the other hand, administra-

tion of large doses of theophylline, (Wells and Lloyd, 1967) which
was thought to act by diminishing the degradation of cyclic AMP,
and isoproterenol (Wells and Lloyd, 1968) which enhances adenyl
cyclase and consequently, cyclic AMP synthesis, should affect serum
calcium levels in a similar fashion to PTH.

These investigators

found that the two agents were effective in blocking the hypocalcemic effect of exogenous or endogenous CT in intact and parathyroidectomized rats.

Based on these observations, Wells and Lloyd hy-

pothesized that the rate of mobilization of calcium from bone and,
secondarily, the level of blood calcium, are related to variations
·in the level of cyclic AMP within bone cells.

The hypercalcemic

effect of parathyroid hormone was thought to depend on its ability
to elevate bone cell cyclic AMP by enhancing bone adenyl cyclase
activity while the hypocalcemic effect of CT might be due to the
ability of this agent to lower cyclic AMP levels by activating phosphodiesterase activity.
Wells and Lloyd's hypothesis is no longer tenable, since Care
~al.

(1971) have demonstrated that a diacylated derivative of

cyclic AMP, dibutyryl cyclic AMP, stimulated CT secretion in vivo
in pigs, and that this stimulatory effect was shared by theophylline,
a recognized inhibitor of endogenous degradation of cyclic AMP.

In

addition, Chase and Aurbach (1970) and Murad et al. (1970) found
that porcine CT caused small increases (about two-fold) in concen-

-J6tration of cyclic AMP in bone and in kidney homogenates in vitro
(Murad et al., 1970).

These investigators demonstrated that there

was little or no effect of dose, whereas PTH showed a log-dose response in this system over a ten to twenty-fold range of cyclic AMP
concentration.

Moreover, Chase and Aurbach demonstrated that CT

did not activate adenyl cyclase or affect phosphodiesterase levels
in this tissue.

Therefore, it would be difficult to conceive that

the action of both PTH and CT, recognized as physiological antagonists, could be mediated through increased cyclic AMP concentrations
in the same cell.

The foregoing experimental observations tend to

indicate that whatever the mechanism of action of CT on bone, it
most likely does not occur at the level of cyclic AMP effects, but
rather antagonizes the action of PTH by another, as yet, undetected
subcellular mechanism.

The observations of Wells and Lloyd could

thus be explained simply as another example of the overall physiological antagonism of PTH and CT in maintaining mineral homeostasis.
Another set of biochemical observations in which CT has been
implicated are the effects of PTH and CT in, respectively, inl\ibiting and stimulating the activity of bone pyrophosphatase (P-Pase).
Fleisch et al. {1966) have proposed that inorganic pyrophosphate
(PPi), an anhydrodimer of orthophosphate, might be one of the physiological regulators of calcification.

These investigators proposed

that calcium phosphate deposition can occur only after the destruction of pyrophosphate by pyrophosphatase {alkaline phosphatase), an
enzyme present in large concentration in calcifying tissues.

Fleisch

ana coworkers demonstrated that addition of PPi inhibited the calcification of chick femurs in tissue culture, an observation which

-37might be explained as a blockage of crystal growth centers by adsorption of PPi onco apatite crystals at the site of calcification.
Their studies indicated that pyrophosphate-coated crystals dissolved
more slowly.

The physiological importance of this observation was

uncertain; however, it is possible that CT might diminish PTH-induced bone resorption through a mechanism of increasing ·the protective PPi layer.
Orimo et al. (1971) demonstrated that CT caused a significant
and rapid

~ncrease

in alkaline phosphatase activity of rat tibia

within 15 minutes after injection.

The increased alkaline phospha-

tase level preceded the development of a significant hypocalcemia.
PTH injection into thyroparathyroidectomized rats significantly decreased the alkaline phosphatase activity of tibia within six hours.
These investigators have suggested that CT activates alkaline phosphatase which consequently degrades PPi and subsequently may facilitate bone mineralization or accretion.

Bone resorption may occur

.through PTH-induced activation of acid phosphatase.

Their experi-

ments utilizing physiological concentrations of PTH and CT suggested
that the various pyrophosphatases were directly involved in the mechanism of action of CT and PTH.
Rasmussen and Tenenhouse (1967) and Tenenhouse and Rasmussen

(1968) have utilized an in vitro system consisting -0f Ehrlich ascites tumor cells.

This would allow them to study a homogeneous cell

population incubated in a chemically defined medium, which would be
responsive to CT and PTH in an easily detectable fashion, and the
hormonal response might be likened in some way to the in vi V....Q. action
Of these two hormones.

These investigators harvested the tumor cells

-J8. and incubated them with CT and PTH.

The response was either re-

45

Ca from dead, prelabeled mouse bone, or P-Pase activity.
. the presence of 10 -4 M Ca++ , increased
.
parathyroid hormone, in
the

JD 011 a1

of

elease of 45 Ca from the bone, increased cyclic AMP concentration
r
in the tumor cells, and inhibited the activity of P-Pase which was
released into the medium (Rasmussen and Tenenhouse, 1967).

--

s~imulated

CT

pyrophosphatase activity in the absence of PTH and re-

-

moved the blocking effect of PTH on P-Pase.

However, Tenenhouse

and Rasmussen (1968) demonstrated that CT did not inhibit the PTHindµced increase in cyclic AMP within these cells.
Although a number of interesting hypotheses explaining the biochemical basis of action of both CT and PTH in regulating mineral
homeostasis have been advanced in recent years, none have been sufficiently well-documented to date, and this still remains an area
of intensive research.

CONTROL OF SECRETION

As implied by the previously cited results of Copp et aJ..

(1962), Kumar et al. (1963), Foster et al. (1964), Talmage

~t

al.

(1965), and Care (1965), the rate of secretion of calcitonin is
regulated by the calcium concentration of the blood.flowing through
the thyroid gland, rising as the calcium level increases and falling
as it decreases.
Care et al. (1968) examined the relationship between CT secretion rate and plasma calcium concentration in pigs in an endeavor
to clarify the control mechanism of CT secretion as related to blood

-39calcium.

Pig thyroid glands, which have no embedded parathyroid

tissue, were surgically isolated and perfused with blood, the calcium concentration of which varied between 5 to 11 mEq/l.

The thy-

roid venous effluent from these perfused pig thyroids was assayed
for.hypocalcemic activity and CT content by intravenous injection
into 5 to 6 week old rats.

These investigators demonstrated that

there was a high correlation between plasma calcium concentration
in the thyroid venous plasma and the rate of CT secretion since a
linear

rel~tionship

existed between these two parameters over the

range of 6-10 mEq Ca/l.

It was determined that no significant change

in CT secretion occurred over a 3-fold range of blood flow rates
through the perfused thyroid, from which Care and coworkers concluded that the CT released by the 'C' cell of the thyroid was directly controlled by the ambient plasma calcium concentration and not
by

the rate, degree, or direction of calcium flux in the plasma.

However, these investigators were unable to detect CT secretion at
·normocalcemic levels, below 6 mEq/l,

whic~

they attributed to the

limitations of their bioassay technique rather than to the absence
of CT in normocalcemic blood.

The evidence of Care and coworkers

supported a direct proportional control of plasma calcium.
Klein and Talmage (1968) and Minkin and Talmage (1968) carried
out a number of experiments in rats utilizing the peritoneal lavage
technique which supported the concept that CT was continuously secreted throughout the normal range of plasma calcium levels (9 to 11
mg/100 ml).

In their studies, all the l'ats were parathyroidectomized and half of these were thyroidectomized, and received 85sr
and/or 45ca one or two weeks before experimental use.

The lavage
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dure utilizing a lavage fluid of 12 mg% calcium, allowed cal-

. m transfer into the hypocalcemic rats and gradually raised the

ClU

.

starting plasma calcium values of 7.0 mg% to the normocalcemic range
of 1 0 mg%. Although only slight differences in both plasma calcium
and total transfer of calcium out of lavage fluid were observed between the parathyroidectomized and thyroparathyroidectomized rats,
a marked difference developed in the amount of radioisotope transferred to lavage fluid.

Rats with functional thyroids transferred

2 5% less radioactivity into lavage fluid than thyroparathyroidec-

· tomized rats.

These investigators interpreted this to mean that CT

secretion was prompted by calcium challenge (12 mgi; lavage fluid)
and that CT was secreted and was effective in preventing removal of
the stable pool c45ca and 8 5sr) of bone mineral, even at normal plasma calcium levels.
Although Care et al. (1968) had suggested that CT was secreted
at normocalcemic ranges and the experimental evidence of Klein and
Talmage (1968) and Minkin and Talmage (1968) allowed such an interpretation, no direct experimental evidence was available which would
indicate that CT was continuously secreted in the regulation of normal blood calcium concentrations.

The subsequent development of the

radioimmunoassay technique by Deftos et al. (1968) and Lee et .§1._.
-(1969) made possible the confirmation that the hormone is secreted
continuously under normal physiological concentrations of blood calcium.

Calcitonin concentration in rabbits was measured both in the

Peripheral circulation and thyroid effluent blood by Deftos et al.
(1968).

The concentration of· CT found in thyroid effluent blood in

unstimulated rabbits was 10 mµg/ml while that in the peripheral cir-
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cuiation was 0.14 mµg/ml.

These investigators detected rapid

changes in CT concentration following hypercalcemic challenge.
peripheral blood concentratipns of the hormone were elevated three
to fifteen-fold shortly after

infusion~

of calcium chloride. How-

ever, no CT was detected in the blood of thyroidectomized rabbits,
before, during, or after the calcium challenge.

Recent studies by

cooper et al. (1971) utilizing a radioimmunoassay for porcine CT
clearly demonstrated that there was a rapid response in CT secretion rate, when hypercalcemia was induced by calcium chloride infusion.

Hormone concentrations rose dramatically from basal lev-

els of 10-20 mµg/ml in thyroid venous effluent plasma to as much
as 2000-3000 mpg/ml when blood calcium was elevated to 15 mg/100
ml.

When hypercalcemia was eliminated by administration of EDTA,

a rapid decline of CT occurred in thyroid venous blood and hormone
was essentially undetectable as calcium fell ·to 8 mg/lOOml.
Radde et al. (1970) carried out experiments to determine if
varying concentrations of divalent cations (Ca++ and Mg++) would
stimulate the release of CT from fresh pig thyroid slices in a KrebsRinger bicarbonate buffer incubation medium.

These investigators

demonstrated that the levels of CT in the incubation media rose with
increasing calcium levels in the media.

A 20 to 25% increase in

calcium concentration was necessary to produce enhanced CT release
into the incubation media indicating that the effect of calcium ion
was direct.

Increasing magnesium concentrations also stimulated in-

creased CT release, but this did not occur until magnesium levels
had been raised to double the normal value (to 3.0 meq/l), a situation which probably never occurs under normal circumstances; more-
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yer, by measuring the residual biological activity in incubated

thyroid slices, these investigators confirmed that increasing calcium concentrations increased both synthesis and release of CT.
Gittes et al. (1968) assayed thyroid glands of rats, subjected
to either prolonged hypocalcemia or hypercalcemia for CT content
and demonstrated that levels of CT within the glands were consistent with the experimentally achieved levels of blood calcium.
systemic hypercalcemia induced in intact rats by intraperitoneal injections of calcium chloride reduced the CT content of the thyroid
glands to 35% of the content in normocalcemic controls as early as
two hours after the onset of hypercalcemia.

However, recovery to

normal CT levels in the gland occurred within sixteen hours after
cessation of a two hour hypercalcemia.

In parathyroidectomized rats

fed a normal diet, a chronic hypocalcemia occurred with concomitant
12-fold accumulation of CT over normal levels within 14 weeks.

Rats

which received parathyroid homografts returned to normocalcemic
ranges, although the CT content of the glands was not markedly reduced.

Gittes and coworkers concluded that systemic hypercalcemia

was the stimulus for rapid release of CT; however, the rate of CT
biosynthesis was not sufficiently increased to maintain an elevated
rate of secretion.

During chronic hypocalcemia, minimal amounts of

stored CT are secreted, although hormone biosynthesis

re~ains

un-

altered and consequently more CT was stored in the glands.
The studies of Deftos et al. ( 1968), -Lee et al. ( 1969), and

--

Cooper et al. (1971) confirmed the observations of Care et al. (1968)

--

that the rate of CT secretion was directly related to the degree of
hypercalcemia.

Moreover, these studies demonstrated that CT was

-4 Jinuously secreted and that the rate of hormone secretion was
con t
under ~irectly proportional control of blood calcium even in the
normocalcemic range.
It is currently well-established that blood calcium concentration is under reciprocal control of PTH and CT.

Hypercalcemia stim-

ulates CT secretion and inhibits PTH secretion; this change leads
to a reduction in the rate of bone resorption and a consequent decline in blood calcium concentration.

Conversely, hypocalcemia in-

hibits CT secretion and stimulates PTH secretion; the resultant increase in bone resorption provides sufficient calcium from skeletal
mineral deposits to restore blood calcium concentration toward normal levels.

METABOLISM AND DURATION OF ACTION
Scant information exists concerning the metabolic fate of calci tonin.

Deftos et al. (1968) injected a rabbit with a potent ex-

tract of porcine CT (90 MRC units) and monitored the disappearance
of the hormone from the peripheral circulation utilizing their radioimmunoassay technique.

Although CT concentrations were as high

as 500 mU/ml ten minutes after hormone injection, the levels dropped
precipitously to

o.6

mU/ml after one hour.

On the basis of this

observation and from the decline of endogenous CT which occurred in
rabbits after the cessation of calcium chloride infusion, these inVestigators proposed that the circulating half-life of the hormone
Was approximately 10 to JO minutes.

Foster et al. (1972) demon-

strated that the rate of clearance of CT from blood was extremely
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rapid.

These investigators have established by use of radio-

immunoassay that human CT injected into dogs disappeared rapidly
having an initial half-life of three minutes which was followed by
a second, more prolonged half-life of 40 minutes.

Injectior:2 into

dogs of calcitonin labeled with lJlI demonstrated that the hormone
was mainly concentrated by the liver and kidney.

Although both of

these organs concentrated radioiodinated human CT, Foster and coworkers demonstrated that nephrectomized dogs exhibited higher
levels of circulating hormone and that the initial disappeara.nce of
the hormone was prolonged.

Similarly, arterio-venous differences

across the dog kidney following infusion of human CT indicat?d that
nearly one-third of the infused hormone was removed whereas only
minor amounts were removed following liver infusion.

Although these

studies indicated that the circulating half-life of CT was of short
duration (J to JO minutes) and that the kidney played a role in hormone degradations, no studies have been carried out or hypotheses
advanced which endeavor to explain the rather long duration of the
hormone's hypocalcemic effect.

ROLE IN CLINICAL DISORDERS OF CALCIUM METABOLISM
Since it has been thoroughly established that calcitonin inhibits bone resorption both in vitro and in vivo and thereby lowers
blood calcium concentrations, the hormone might be efficacious in
the treatment of both hypercalcemic conditions and diseases involving increased bone resorption.

-4SA number of experimenters have successfully lowered blood calcium levels with CT in hypercalcemic patients.

Foster et al. (1966)

were the first investigators to utilize porcine CT as a therapeutic
agent in the treatment of three patients with hypercalcemia as a
result of metastic carcinoma of bone.

Calcitonin injection at a

dose level of 1 to 22 MRC units, resulted in a marked reduction in
serum calcium levels for periods up to 18 hours, although serum
calcium values never quite reached normal levels.

Haas and

nambacher (1968) observed remissions of hypercalcemia in 12 patients
with hyperparathyroidism which were injected with porcine calcitonin.
Milhaud (1968) demonstrated that children with hypercalcemia resulting from hypersensitivity to vitamin D or vitamin D intoxification
responded well to injections of O.l MRC units calcitonin by an enhanced and prolonged hypocalcemia which was manifested one hour
after hormone injection.
The syndromes, hypervitaminosis D, hyperparathyroidism, and
metastic carcinoma of bone, all involve extensive resorption of bone
and.should therefore prove amenable to the therapeutic use of calcitonin.
A number of investigators have also attempted to investigate
the effects of CT injection in preventing bone resorption in several
types of experimentally-induced osteoporosis.

Foster et al. (1968)

Produced experimental osteoporosis in rats by subcutaneous injections of 2500 international units of vitamin A three times a week.
It was found that 100 mU of CT administered over a four-week period
not only prevented vitamin A-induced resorption, but also retarded
some of the general systemic effects produced by vitamin A.

Experi-

-46al conditions similar to osteoporosis were produced in rats by
111en t
pujita £.! .01.• (1968) ty feeding the animals low calcium diets and
b treatment with corticosteroids.
y

..

Tibia of rats treated with the

corticosteroid, prednisolone, were decreased in thickness and were
less resistant to bending stress than control rats or animals which
bad

r~ceived

and

low calcium diet.

CT injections concurrent with corticosteroid treatment
However, the possibility that CT might prove

to be effective in treating human osteoporosis, especially the postmenopausal variety, remains uncertain.
Considerable therapeutic success has been achieved in patients
with generalized Paget's disease.

This is a syndrome which is char-

acterized by a rapid rate of bone turnover without hypercalcemia,
increased urinary hydroxyproline excretion, and elevated serum alkaline phosphatase.

Bijvoet et

~l.

(1968) noted a marked decline in

plasma calcium, phosphate, and hydroxyproline of patients with generalized Paget's disease subsequent to injections of small doses of
porcine CT.

It was likely that CT administration was efficacious

in retarding the rate of bone turnover.

' PHYSIOLOGICAL ROLE

Despite all that has been learned about calcitonin. since its
postulated existence by Copp et al. (1962), and discovery in the
thyroid by Hirsch et

~l.

(1963), its physiological role in the main-

tenance of vertebrate mineral homeostasis remains uncertain.

In

response to an adequate stimulus, PTH-induced hypercalcemia, CT is
secreted by the thyroid gland into the general circulation where
the hormone markedly retards bone resorption as evidenced by the

-47rapid decline in blood calcium levels.

However, calcitonin may also

plaY a key role in combatting hypercalcemia of dietary origin, although it is well known that starvation or calcium deficiency are
Jl'lore

C ommonplace,

Cooper

~1

natural occurrences than calcium excess.

al. (1970) showed that endogenous CT could adequately

protect rats against a hypercalcemic challenge which did not evoke
a detectable rise in blood calcium in animals with intact thyroid
glands.

This was demonstrated by injecting sufficient PTH to ele-

vate the serum calcium levels of thyroparathyroidectomized rats
about J mg/100 ml whereas sham-operated rats which had been given
identical doses of PTH exhibited normal blood calcium ranges.
~ver,

How-

thyroidectomizing half of the sham-operated rats within three

hours after PTH administration prompted a persistent hypercalcemia
which was no longer opposed by the action of endogenous CT.

Munson

and Grey (1970) demonstrated that thyroidectomized and thyroparathyroidectomized rats became transiently hypercalcemic (60 to 90 minutes) after a gavage of 10 mg of calcium chloride whereas sham-operated rats exhibited unaltered blood calcium concentrations.

More-

over, these investigators noted that feeding as little as three mg
of calcium chloride by stomach tube markedly increased serum calcium
levels after thyroidectomy.

In an attempt to simulate natural con-

ditions, fasted thyroidectomized rats were permitted to eat food
containing a normal concentration of calcium (1%) over a 90-minute
Period, and it was demonstrated that very similar results occurred.
These observations of Munson and Grey provided the first direct physiological data which indicated that CT was functioning at normocalcemic ranges to protect rats against hypercalcemia.

Thyroidec-
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tomized (calcitonin deficient) rats were unable to cope with hypercaicemia of naturally occurring dietary origin, this deficiency state
being directly attributable to the loss of this hypocalcemic hormone.
However, it was possible that the importance of CT in combatting
hypercalcemia may be confined to the actual time of food consumption
or immediately thereafter.
In order to fully substantiate the concept that CT is a hormone
which exerts a tonic effect at normal blood calcium concentrations,

it would be necessary to demonstrate spontaneous hypercalcemia in
thyroidectomized animals since parathyroidectomy has been shown to
result in spontaneous hypocalcemia.

However, such an effect has not

yet been demonstrated, and no initial hypercalcemic signal which
would stimulate calcitonin release has been detected.

However,

Cooper and coworkers (1970) carried out an experiment which provided
direct evidence that such a signal actually occurred.

These inves-

tigators demonstrated that elevation in serum calcium of sham-operated rats could not be detected three hours after injection of 85
units of PTH; although, at this time interval, thyroidectomized rats
which had received an identical dose of PTH were markedly hypercalcemic.

Moreover, thyroidectomy of sham-operated (PTH-treated)

rats three hours after PTH injection, while they were still normocalcemic resulted in elevation of serum calcium similar to rats
Which had been thyroidectomized at time zero.

These results were

further indirect proof that the presence of the thyroid gland
(endogenous CT secretion) had prevented a rise over the first three
hours in serum calcium due to PTH injection.
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some experimental evidence exists that indicates CT may also
influence the rate of mineral accretion.

Foster

~ ..§1..

(1966)

demonstrated that CT increased the metaphyseal area of trabecular
bone in vertebra of growing rats and diminished the number of osteoclasts.
over

Since the metaphyseal area of all bones exhibit rapid turn-

rat~s,

these investigators proposed that this is the area of

bone which may serve as a ready source of calcium.

Therefore, CT

may prevent cortical mineral loss during periods of calcium deficiency by augmenting metaphyseal bone reserve.
Although the action of CT does not depend on the presence of
the kidney, Bijvoet et al. (1971) have presented evidence that infusions of synthetic human CT into humans resulted in a transient
increase in the urinary excretion of sodium.

This was attributed

to a decrease of fractional reabsorptiqn from the proximal kidney
tubules.

These investigators suggest that CT.in physiological con-

centrations exerts a natriuretic effect sufficient to influence
volume homeostasis (decreases expanded extracellular volumes) in
man, an effect that endogenous CT may also bring about.
Investigations attempting to determine the exact physiological
role of CT are still being actively pursued.

However, evidence is

accumulating that suggests calcitonin is continuously being secreted
and exerting a tonic or fine control in maintaining normal blood
calcium levels in healthy animals and keeping PTH-induced bone resorption at minimal levels. ·It is likely that CT has a more significant role in vertebrate mineral homeostasis in young, rapidly
growing animals, during pregnancy, lactation, bone-healing processes,
and periods of starvation or limited calcium intake.

-50STATEMENT OF THE PROBLEM

----

A number of in vitro biosynthetic studies, some of which

~ave

employed subcellular fractionation procedures, have provided "/8.linfor~ation

uable

about the physiological role of a number of hor-

mones.
Brown and Ulvedal (1960) prepared subcellular fractions from
the anterior pituitary lobe of pigs by differential ultracentrifugation.

The hormones of the anterior pituitary were shown by these

investigators to be present in separate subcellular fractions; LH
and STH, in the secretory granules; TSH, in the mitochondria; and
ACTH, in the microsomes and supernatant; and FSH, in several fractions.

Similarly, Hamilton and Cohn (1969) were able to

demor~strate

hypercalc.emic activity in the 100, 000 x g particulate fractio:r; from
bovine parathyroid tissue.

Fractions obtained by differential cen-

trifugation of pig thyroid homogenates (Bauer and Teitelbaum, 1966)
and rat thyroid homogenates (Cooper and Tashjian, 1966) were assayed
for the hypocalcemic activity of calcitonin.

Most of the recovered

activity appeared in 100,000 x g particulate fraction which also
contained numerous secretory granules when examined by electron microscopy.
An insight into the mechanism of in vivo synthesis and release
of a number of hormones has been achieved by utilizing in vitL.Q. biosynthetic media containing either slices or homogenates of

e~~ocrine

glands and monitoring biosynthesis and release of the hormones by
biological assay.

Takabatake and Sachs (1964) accomplished

i;1

vitro

biosynthesis of vasopressin in hypothalamic tissue, and Adiga et al.

(1965), using various labeled amino acids, demonstrated the i~ vitro

-51biosynthesis of ACTH in anterior pituitary tissue.

Studies of

aamilton and Cohn (1969) and Hamilton~ ..§:1• (1971) demonstrated
1the

in

vitro incorporation

o~

several labeled amino acids into para-

thyroid hormone isolated from bovine parathyroid glands.

Incorpor-

ation of the tracer amino acids was found to vary inversely with the
concentration of calcium in the medium suggesting that the tissue
retained the physiological regulatory mechanism which is characteristic of the function of the gland in .YJ.vo.

When the concentration

of calcium was lowered, there was an increase in radioactive PTH
isolated from the tissue and the incubation medium.

The identity of

the newly synthesized radioactive species with PTH was established
by

chromatography, polyacrylamide gel electrophoresis, and rat bio-

assay.

Sorgente (1969) utilized an in vitro biosynthetic medium

containing sheep thyroid slices to establish the role of varying
calcium and magnesium ion concentrations on the synthesis and release of calcitonin.

The incorporation of glycine-C-14 into ovine

calcitonin was directly related to the calcium concentration of the
incubation medium.

High calcium concentration stimulated both syn-

thesis and release of calcitonin while varying the magnesium concentration was without effect in the calcitonin regulatory mechanism.
The experimental work to be reported in this investigation
concerns a study of the hypocalcemic activity of cytoplasmic particulate fractions obtained from ovine thyroid glands in an effort
to determine more precisely its localization and to define the role
of calcium ion on its biosynthesis.

Such a study will be useful in

the further analysis of factors affecting the biosynthesis and secretion of this hypocalcemic hormone.

A differential centrifugation

-52procedure will be utilized to obtain mitochondrial, nuclear, and
microsomal subcellular fractions from the thyroid slices.
slices have been incubated
taininr, glycine-C-14.

i~

These

vitro in a biosynthetic medium con-

The subcellular fractions will be assayed

for hypocalcemic activity in rats and the influence of low, physiological, and high calcium concentrations on the biosynthesis of
the hormone in theseihree fractions will be determined.

Standard

and subcellular calcitonin preparations will be fractionated into
their protein components by polyacrylamide gel electrophoresis.
This will be done to establish the identity of the hypocalcemic
subcellular fraction with calcitonin preparations of known potency
and to determine the homogeneity of these preparations at each
stage of hormone purification.

An isoelectric focusing procedure

will be utilized to determine the isoelectric point of subcellular
and standard calcitonin preparations, thereby providing a physical
constant which may serve to further characterize this hormone.
Moreover, the highly sensitive resolving power of this technique
will be employed to obtain milligram quantities of purified subcellular preparations exhibiting hypocalcemic activity.

CHAPTER II
MATERIALS AND METHODS

-

GENERAL EXPERIMENTAL PROCEDURE
The first part of this investigation consisted of determining

the hypocalcemic activity of particulate fractions of ovine thyroid
glands and the influence of low, physiological and high calcium concentrations on the biosynthesis of the hormone in mitochondrial,
nuclear, and microsomal subcellular fractions obtained from sheep
thyroid slices utilizing the in yij;ro biosynthetic medium, described
by Sorgente (1969).

Sheep thyroid glands were obtained fresh from

the slaughter-house 10 to 20 minutes after the animals were killed.
The glands with all adhering tissue were placed in ice-cold KrebsRinger bicarbonate buffer (pH 7.4) containing glucose (320 mg/100 ml)
and all the amino acids of calcitonin (20 mg/liter) with the exception of the tracer amino acid, glycine-C-14 (UL), which was added
during the incubation period.

The glands were brought to the labor-

atory and dissected free from fat, connective tissue, and possible
contaminating parathyroid tissue.

Thyroid slices ranging in thick-

ness from 0.5 to 1.0 mm were prepared with a Stadie-Riggs tissue
slicer.

Two grams of slices were transferred to each of a series of

50 ml Erlenmeyer flasks containing 10 ml of the Krebs-Ringer bicarbonate buffer.

To each flask, 2.5 µCi of the tracer amino acid, gly-

cine-C-14 (UL) (International Chemical and Nuclear Corp., Irvine, Calif.,
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I

-54s.A• 80 me/mm), was added, gland slices were incubated for 4 hrs at
o

J7

c

in biosynthetic media containing low calcium (4.8 mg/100 ml),

.

physiological calcium (11.5 mg/100 ml), and high calcium (26.o mg

/lOO ml) concentrations.

The incubation period was terminated by

placing the Erlenmeyer flasks containing the gland slices into an
ice bath after which the gland slices were minced and thoroughly
homogenized.
A standard procedure of differential centrifugation was then
utilized to obtain mitochondrial, nuclear, and microsomal subcellu1ar fractions from thyroid slices obtained from the incubation media
containing low, physiological, and high concentrations of calcium.
The subcellular preparations were inspected for homogeneity by phase
contrast and electron microscopy.

In some instances, the three

lyophilized fractions were assayed for hypocalcemic activity in rats
without further purification.

However, in the majority of experi-

ments, the lyophilized mitochondrial, nuclear, and microsomal preparations were further purified by passage through a column of
Sephadex G-100 before assaying for biological activity.

The sub-

cellular fractions were then assayed for hypocalcemic activity in
lJO to 160 gm male Holtzman rats which had been fasted for 18 hours.
Radioactivity and protein content of mitochondrial, nuclear,
and microsomal preparations were determined at each stage of the
purification.

The hypocalcemic activity of a particular fraction

was estimated by determining spectrophotometrically the change in
serum calcium level before, and 50 minutes after, the injection of
aliquots of each of the subcellular fractions into rats.

Radioacti-

vity was measured by the use of a Beckman LS 250 Liquid Scintilla-

-55tion Spectrometer and total protein was determined by a modification
f the Lowry method.

o

.

The difference between the hypocalcemic ac-

tiYitY of subcellular fractions obtained from media containing high
and 1ow calcium concentrations and fractions obtained from the medium containing a physiological calcium concentration was used as
an index of calcitonin biosynthesis.
In the second part of this investigation, the microsomal fraction which had consistently demonstrated hypocalcemic activity was
-~ssayed

for homogeneity by polyacrylamide gel electrophoresis.

Microsomal calcitonin preparations were inspected for homogeneity
in polyacrylamide gels after passage through Sephadex G-100 and G-50
.~olumns.

A standard calcitonin preparation of known potency was

electrophoretically fractionated along with the microsomal preparations to establish the identity of the microsomal preparation.

The

standard calcitonin preparation had a potency of 88 Medical Research
.C2uncil Units and was fractionated along with the microsomal fraction into their component protein bands in anionic polyacrylamide
gels under identical conditions of milliamperage per gel column
(2.5 ma), electrophoretic separation time (1 hour and 20 minutes),
and gel concentration (7.5%).
Finally, an isoelectric focusing procedure utilizing an LKB

·8100 Electrofocusing Column (LKB Instruments, Inc., Rockville,
Maryland) was employed to characterize microsomal calcitonin preparations, by determining their isoelectric points.

The highly sensi-

tive resolving power of· this technique which is based on the ampho~eric nature of protein molecules was employed to obtain milligram

quantities of the component protein bands of microsomal subcellular
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preparations.

The resolved protein bands were then assayed for

radioactivity and hypocalcemic activity utilizing a rat bioassay.
All chemicals utilized in this investigation were of analytical reagent grade.

PREPARATION OF INCUBATION MEDIA
Krebs-Ringer bicarbonate buffer with modifications of the
calcium ion concentration served as the incubation medium for
ovine thyroid slices.

The composition of Krebs-Ringer bicarbonate

buffer at a physiological calcium ion concentration (11.5 mg ca++)

/100 ml) is represented below:

100 part(s)

0.90%

(0.154 M)

"

(0.0047 M)*

(0.110 M)

CaC1 2

If

(0.0025 M)*

2.11

(0.154 M)

3.82

"

KH2P04 II
MgSO4 ·7H20

1.30

If

"

1.15

"

3

"
"
"

1.22

1
21

If

(0.1180 M)*

KCl

4

1

NaCl solution

*Final concentration

NaHC0 3

(0.0012 M)*
II

If

Ionic strength

(0.0012 M)*
(0.0248 M)*

= 0.16

(ca++= 11. 5 mg/100 ml)

-57TWenty milligrams of each of the amino acids of calcitonin
eicept the glycine-C-14 (UL) and J.2 grams of glucose were added

to each liter of freshly prepared buffer.

A 95% oxygen-5% carbon

dioxide mixture was bubbled into the medium for 15 minutes and the
pH was adjusted to 7.4 before it was used for the incubation.
The calcium ion concentration of the above mentioned KrebsBinger bicarbonate buffer was altered to prepare- incubation media
Y"'Containing low calcium (4.8 mg Ca++/100 ml) and high calcium
-(26.0 mg Ca++;100 ml) concentrations.

The composition of media is

Tepresented as followss

Low-calcium medium
100

part(s)

4
· 1.4
1
1
21

0.090%

(0.154 M)

NaCl solution

(0.1180 M)*

KCl

Co. 0047 M)*

..

1.15

..

"

1.22

( 0.110 M}

CaC1 2

2.11

(0.154 M}

KH 2Po 4

..

..
..

3.82
l.JO

*Final concentration

..
..

"

..

(0.0012

"

(0.0012 !!1)*

MgS0 4 •7H 2 0

NaHCOJ

"

= 4.8

(0.0012 .M)*
(0.0248 M)*

"

Ionic strength
(Ca++

MJ*

= 0.16

mg/100 ml}
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100 part( s)

4
8
1

1
21

..
..

"
"
"

medium
0.90%

(0.154 M)

NaCl solution

(0.1180 M)*

KCl

( o. 0047 fil)*
( o. 0062 .fil)*

1.15

..

1.22

( 0.110 _M)

CaC1 2

2.11

(0.154 .r:J.)

KH 2 Po 4

3.82

"

...

l.JO

..

(0.0012 fil)*

ff

MgS0 4 •7H 2 0

"

(Ca++

Co. 0012 M)_*
(0.0248 fil)*

NaHCOJ

Ionic strength

*Final concentration

TISSUE PREPARATION AND

ff

= 26.o

= 0.17

mg/100 ml)

INCUBATION

Ovine thyroid glands were obtained fresh from the slaughterhouse, usually 10 to 20 minutes after the sheep were killed.

The

glands with all adhering tissues were placed in cold Krebs-Ringer
bicarbonate buffer (pH 7.4) containing J20 mg glucose/100 ml, and
20 mg/L of all the amino acids of calcitonin.

The glands were

brought to the laboratory where they were dissected free from fat,
connective tissue, and possible contaminating parathyroid tissue.
In sheep, one of the two pairs of parathyroid glands is located
near the posterior extremity on the deep surface of the lobes of
the thyroid.

The whole· thyroid glands were then sliced in the cold

into slices approximately 0.5-1.0 mm in thickness with a StadieRiggs tissue slicer.

The time interval between killing of the

-59sheep and incubation of about 100 grams of thyroid slices was
usually three hours.

Approximately two grams of slices were placed

in each of a series of 50 ml Erlenmeyer flasks.

Each flask con-

tained 10 ml of Krebs-Ringer bicarbonate buffer and 2.5 µCi of the
labeled glycine.

Air served as the gas phase and all incubations

were carried out in a hood for 4 hours at 37° C in a shaker water
bath.

The incubation period was terminated by placing the Erlen-

meyer flasks containing the thyroid slices into an ice bath.
To determine the effect of low, physiological, and high calcium
-~on

concentration on altering the hypocalcemic response (a reflec-

tion of the synthesis of calcitonin) of the mitochondrial, nuclear,
and microsomal preparations, the incubations were carried out in
buffer containing low calcium (4.8 mg Ca++/100 ml), physiological
calcium (11.5 mg ca++/100 ml), and high calcium (26.0 mg Ca++;
After the 4 hour incubation period, the

100 ml) concentrations.

thyroid slices were thoroughly homogenized and mitochondrial, nuclear, and microsomal subcellular fractions were obtained by differential centrifugation.

ISOLATION SUBCELLULAR FRACTIONS
After the 4 hr incubation period, the ovine thyroid slices
were minced with scissors.

Mitochondrial, nuclear, and microsomal

subcellular fractions were obtained by utilizing a fractionation
scheme described by Mahler and Cordes (1966) in their text,
Biological Chemistry.

A 25% thyroid homogenate was prepared by
I

Placing 5 gm of minced thyroid tissue in 15 ml of "homogenizing
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medium" (0.32 M sucrose, containing 0.02 M Tris, pH 7.6, and 3 x
1o-3 M MgC1 2 ) in a glass Duall homogenizer.

Five slow, up and

down pestle movements were us_ed to break up the fibrous tissue
which is dispersed throughout the thyroid gland.

This crude homog-

enate was then filtered through 2 layers of cheesecloth to remove
the remnants of the fibrous tissue.

The filtrate was then trans-

ferred to a Kontes Teflon homogenizer for a more thorough homogenization (15 slow, up and down pestle movements) to completely disrupt cell walls.

Each 12.5 ml of homogenized thyroid preparation

was diluted to a final volume of 20 ml by adding 7.5 ml of "diluting medium" (0.25 M sucrose containing 0.02 M Tris, pH 7.6, and 3

x 10-3 M MgC1 2 ).

Twenty milliliters of homogenizing medium was

then layered underneath this preparation.

The entire volume was

centrifuged for 10 minutes at 700 x g at 4° C in an International
Model PR-2 Centrifuge (International Equipment, Company, Needham Hts.,
Massachusetts).

Two fractions were obtaineds

(1) a supernatant

fraction, containing mitochondrial and microsomal material, and (2)
a residue, termed the crude nuclear preparation.

The residue was

resuspended in 13 ml of a solution of 2.4 M sucrose containing 1.0

mM MgC1 2 •

The crude nuclear preparation was centrifuged for 1 hr

at 50,000 x g at 4° C in a Spinco Model L Ultracentrifuge (Beckman
Instruments Incorporated, Palo Alto, California).
were obtaineds - (1)

Two fractions

the supernatant which was discarded, and

a residue, termed the purified nuclei.

(2)

The purified nuclear prepa-

ration was then taken up in 1 ml of diluting medium.

This prepara-

tion was checked for homogeneity by phase contrast and electron microscopy.

The electron microscopy was performed by Dr. John U. Balis

Associate Professor of Pathology, Loyola University, Medical Center.

-61Twenty milliliters of 0.1 M formic acid was added to the suspension
and the entire preparation was lyophilized.
The supernatant fraction containing mitochondrial and microsomal material was thoroughly mixed and centrifuged for 10 minutes
at 7,000 x g at 4° C in the International Centrifuge resulting in
a residue, termed the crude mitochondrial preparation, and a supernatant, containing crude microsomal material.

The crude mitochon-

drial preparation was taken up in 10 ml of diluting medium and centrifuged for 10 minutes at 24,000 x g at 4° C in the International
Centrifuge.

The residue from this centrifugation was termed the

purified mitochondrial preparation and the identity of this preparation was established by examining an aliquot by phase contrast
and electron microscopy.

This fraction was prepared for lyophiliza-

tion in a manner identical to the nuclear preparation.

The super-

natant, containing crude microsomes, was added to the 7,000 x g
supernatant.

This combined material was then centrifuged for 100

minutes at 105,000 x g at 4° C in the Spinco Ultracentrifuge.
supernatant was discarded.

The

The residue, termed the crude micro-

somal preparation, comprised of free ribosomes and smooth and rough
endoplasmic reticulum, and dense granules, was suspended in one ml
of diluting medium.

The identity of this subcellular fraction was

checked by electron microscopy.

The remainder of the crude micro-

somal preparation was added to 20 ml of 0.1 M formic acid and lyoPhilized.

A diagram of the.scheme for the subcellular fractionation

is shown in Figure

J.

Electron micrographs of the microsomal and

mitochondrial fractions are shown in Figure 4 and in Figure 5, while
a phase contrast photograph of the nuclear fraction is presented
in Figure 6.

_Subcellular

Fractionation

Scheme

°/o

25
Thyroid homogenate C1 part tissue, 3 parts
homogenizing medium). Prepared in a Duall homogenizer. 5 up and down pestle movements.

I
I .

Teflon homogenizer -15 pestle movements & filtered.

Diluted each 12.5 ml of homogenized tissue to a final
volume of 20 ml using the diluting medium.

I

Layered 20ml of homogenizing medium underneath
this preparation.

I

Centrifuged for 10 minutes at 700 - g at 4

Residue

I

°'I

f\)

° C.

Supernatant

Figure 3. Fractionation scheme utilized to obtain
mitochondrial, nuclear, & microsomal fractions from
incubated ovlne thyroid gland slices.

,Figure 3, continued
r -______________.._______________-a

Residue (crude nuclei) resuspended
to a volume ol 13 ml in 2.4 M sucrose.
Centrifuged .60 minutes al 50,000·g

-

I

I

Residue
(purified nuclei)

Supernatant - centri tuged tor
10 minutes at 7,~oo- g

I

Supernatant
{Discard)
Supernatant
Centrifuged 100
minutes at 105,000-g
Residue (crude mitochondria)
Taken· up in 10 ml ol diluting
/
medium. centrifuged tor 10
/
minutes at 24,000-g
l>I

I

I

Res'idue
(purified mitochondria)

I
Supernatant

I

-tit'
I

I

°'

\...0
I

I

Residue
(crude m icrosomes)

Supernatant
(Discard)
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Figure 4.

Electron micrograph of the thyroid microsomal frac-

tion (105 ,000xg) containing smooth and rough endoplasmic reticulum, free ribosomes, and dense granules.

Very little contamin-

ation from the mitochondrial fraction was observed (x39,SOO).
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Figure 5.

Electron micrograph of a crude mito-

chondrial fraction (7,000xg) exhibiting some microsomal contamination.

Purified thyroid mitochond-

rial fractions (24,000xg) were assayed for hypocalcemic activity.
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Figure 6.

Phase contrast photograph of a puri-

fied thyroid nuclear fraction (50,000xg).
little contamination was observed (xSSO).

Very

-67In some instances, the mitochondrial, nuclear, and microsomal
prepar~tions

were assayed for hypocalcemic activity in rats without

further purification.

Two milligrams of the respective subcellular

ftactions were dissolved in 250 µl of deionized water and injected
intravenously into rats.

Subcellular fractions were purified by

dissolving the lyophilized preparations in 0.1

Mformic

acid

(18 mg/ml) and applying the dissolved material to a 2.5 x 60 cm
column of Sephadex G-100 (Pharmacia Fine Chemicals, Inc., Picataway,
New Jersey) and eluting with the same solvent.

The transmission of

the effluent was monitored with a Uvicord Absorptiometer and Recorder (LKB Instruments, Inc., Rockville, Maryland) and 50 drop
fractions (approximately 4 ml per fraction) were collected on a
unifrac Fraction Collector (Savant Instruments Inc., Hicksville,
New York).

The fractions representing the elution peak, usually

-numbering 6 to 7 were pooled and lyophilized in 0.1 M formic acid
as were the 10 to 12 fractions beyond the elution peak.

In every

instance, lyophilized material could be recovered only from the
}>ooled fractions representing the elution peak.

These purified

subcellular fractions were assayed for radioactivity, protein content, and hypocalcemic activity.

In some instances, microsomal

preparations which had already been passed through a Sephadex G-100
column were purified further by passage through a 2.5 x 45 cm column (at a concentration of 2.5 mg/ml) of Sephadex G-50 Superfine
and eluted with O.l M formic acid.

The microsomal fractions ob-

tained from the elution· peak (usually numbering 4 to 5) were then
lyophilized.

Lyophilized microsomal material from the elution

Peaks of both Sephadex G-100 and G-50 columns were assayed for homo-

-68geneity by polyacrylamide gel electrophoresis.

The identity of

ea ch of these microsomal preparations was established ty fractionating a standard ca.lcitonin preparation under identical conditions

in polyacrylamide gels.

-

SOLUTIONS

109.6 gm of sucrose (C 12 H22 o ), o.61 gm of
11
and 1.7 gm of Trizma-HCl (Tris (hydroxymethyl) amino-

HPmogenizing Mediums

MgC1 2 •6 H2 o,

methane hydrochloride) and 1.4 gm of Trisma-Base (Tris (hydroxymethyl) aminomethane) were dissolved in one liter of deionized
~ater.

A pH of 7.6 was attained by slight adjustments of either

the Trisma-Base or Trisma-HCl concentrations.

_,Diluting Mediums 85.6 gm of sucrose, o.61 gm of MgC1 •6 H o, 1.7 gm
2
2
of Trizma-HCl, and 1.4 gm of Trizma-Base were dissolved in one
liter of deionized water.

822 gm of sucrose and 0.2 gm of MgC1 •6 H o
2
2
were dissolved in one liter of deionized water.

2.4 M Sucrose Solution:
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OF SERUM CAI,CIUM

Serum calcium was determined with the use of the HPE Calcium
oetermination KIT, commercially available from the American Monitor
Corporation, Indianapolis, Indiana.

The technique is a modifica-

tion of Burr's (1969) automated method of serum calcium detection.
/·fhe Monitor HPE Calcium Determination utilizes a dye, di(o-hydroxyphenylimine)-ethane in methyl alcohol.
complex with calcium at pH 12.
by

This dye forms a colored

Specificity for calcium is maintained

a combination of dye-specificity and pH.

The dye binds-prefer-

entially to calcium, forming a red-colored complex which is spectrophotometrically determined at 545 nm.
~-

Polyvinylpyrrollidone is

utilized in this method to catalyze the complexing of phosphate by
molybdate, thus eliminating occasional low results caused by the
formation of a phosphate-calcium complex.
are obtained by complexing all calcium.

Individual serum blanks
Calcium and phosphate com-

plexes are quickly dissociated at an acid pH.

The dissociated phos-

phate is removed by a catalyzed reaction with molybdate.
·alkaline pH is then established.

A strongly

The phosphate remains complexed

with rnolybdate and calcium reacts with the dye causing a change
from a pale yellow to an intense red-colored complex.
Blood samples (400 µl) were collected in microcentrifuge tubes
by

tail bleeding.(cutting off

anesthetized rats.

t inch of the tip of the tail) of

Blood was obtained from each rat before and 50

minutes after the injection of aliquots of the three subcellular
fractions.

The blood was allowed to clot for JO minutes before the

sample was centrifuged for 4 minutes in a Beckman Spinco Microfuge
resulting in approximately 200 ul of serum.

Fifty rnicroliters of

-70serum collected from each rat before and SO minutes after the injection of aliquots of the test material was utilized for the
determination of serum calcium levels.
The calcium determination is carried out by the addition of
1 ml of molybdic acid reagent to a plastic tube (glass tubes often
1each out calcium and interfere with this sensitive assay) containing molybdate and polyvinylpyrrolidone.

This tube is termed

the ''Reagent Blank" and the same amount of acid reagent is added
to a second tube termed the "Test."

One then adds SO pl of rat

serum to the "Test" tube followed by a thorough mixing.

This is

followed by the addition of 2 ml of 0.2 N NaOH to both the "Reagent Blank" and the "Test" tubes followed by mixing of the contents.

Two milliliters of 0.0002 M di(o-hydroxyphenylimine)ethane

are then added to both the "Reagent Blank" and the "Test" tubes
and both are mixed

once again.

After waiting two minutes, one

determines the absorbance of the "Test tube and the "Reagent
Blank" at S4S nm with a Beckman DU Spectrophotometer.

Readings

are performed within S minutes of completion of the procedure since
color stability decreases significantly after 10 minutes.

Calculations
Absorbance of Unknown
Serum Calcium (mgi'o) -

Absorbance of 10.0 mg%
Calcium Standard

X

Concentration
of the
Standard (10.0 mg%)
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Protein was determined by utilizing the method of Lowry (1951)
as modified by Oyama and Eagle (1956).

There are two distinct

steps which lead to the final color with proteins

(1) a reaction

with copper in alkali, and (2) a reduction of the phosphomolybdicphosphotungstic acid reagent by the copper-treated protein.

One

milliliter of reagent "C" was placed in each of a series of 10 x

75 mm test tubes.

Two hundred microliters of sample was added to

the sample tubes and 200 pl of deionized water was added to each
blank tube.

The contents of each tube were immediately mixed on a

vortex mixer and allowed to stand for 10 minutes.

Then O.l ml of

Folin-Ciocalteu (Hartman-Leddon Company, Philadelphia, Pa.) reagent

was added to each tube and the samples were thoroughly mixed again.
The reaction mixtures were allowed to stand undisturbed for a minimum of JO minutes while color development of the reaction was completed.

The transmittance of blank and sample solutions was deter-

mined with a Beckman DU spectrophotometer at a wavelength setting
of 750 nm.

A standard curve was prepared following this procedure

using bovine serum albumin as the standard.

The calibration curve

data are indicated in Table! and the standard curve is shown in
Figure 7.

Q.alcula ti ons
The percent transmittance values are converted to absorbance
and the density of the reagent blank is subtracted from that of
Unknown and standard preparations to obtain the absorbance of each
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TABLE I

STANDARD CURVE DATA FOR PROTEIN DETERMINATION

Albumin (µg)

Number of
Determinations

Absorbance
750 nm

5

'6

0.0932

10

6

0.1435

20

5

0.2434

JO

6

0.3229

40

5

0.3975

50

6

o.4690
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-74o! these preparations.

The concentration of the unknown (pg protein/

ml of unknown sample) is calculated using the formulas

pg of protein/
ml of unknown
sample

Absorbance
= Absorbance

of Unknown
(concentration of
of Standard x Standard in µg) x

5

Solutions

of Na2 co , 4 gm of NaOH and 200 mg of KNaC H o
3
4 4 6
•4 H2 0 were dissolved in one liter of deionized water.

!eagent A:

20

gm

5 gm of Cuso 4 •5 H2 o
deionized water.

Reagent Ba

Folin-Ciocalteu Reagents

were dissolved in one liter of

Folin-Ciocalteu Reagent was obtained from

Hartman-Leddon Company and diluted with deionized water in the
ratio of 5 parts of the phenol reagent to 7 parts of deionized water
as recommended by Oyama and Eagle (1956).

~agent Ca

Fifty parts of reagent A and one part of reagent B

were mixed fresh just prior to use.

-

-

-------

-

-75MEASUREMENT OF RADIOACTIVITY

~

A Beckman LS-250 Liquid Scintillation Spectro8eter was utilized

for all measurements of radioactivity.

Samples were counted in 22

ml low potassium-40 content glass vials with tin-foil lined plastic
screw caps.

Ten milliliters of scintillation fluid was added to

each vial.

The scintillation fluid mixture was prepared fresh on

the day of use by dissolving
of scintillation grade.

4.o

gm

of PPO in 1 liter of toluene

Twenty milliliters of Bio-Solv solubilizer

BBS-J (Beckman Instruments, Fullerton, California) was then added
to each 100 ml of this fluid.

An appropriate amount of sample was

then added to the 10 ml of scintillation fluid in each vial and the
sample was counted three times, each time for 10 minutes.
The Automatic Quench Compensation function (AQC) of the Beckman instrument was utilized, the gain was set at 500 and the external standard Isoset was set at 0.766.
counting error ranged from J to 7%•

The 2 sigma statistical
Radioactivity was expressed

as disintegrations per minute {dpm) per mg of protein.

Quenching

was not a problem in the measurement of the radioactivity of the
samples.

This conclusion was based upon an evaluation of a quench

correction curve of a plot relating

% efficiency versus external

standard ratio, for a series of counting vials prepared by adding
various amounts of protein (2 to 10 mgs) isolated from the mitochondrial fraction of thyroid homogenates, in 1 ml of O.l

B formic

acid, to 10 mls of the toluene-based fluor containing 0.025 microcuries of 14c-glycine. · No quenching effect was found.

-76~TION

OF BIOLOGICAL ACTIVITY

Male Holtzman rats (Holtzman Company, Madison, Wisconsin) in
the weight range of 110 to 120 grams were kept in the animal rooms
and

fed a standard rat diet until they reached a weight of lJO to

i60 grams.

The animals were fasted 18 hours prior to their use for

determination of hypocalcemic activity of standard calcitonin preparations and of mitochondrial, nuclear, and microsomal subcellular
preparations.

The rats were anesthetized with sodium pentobarbital

which was injected intraperitoneally at a dose of 5 mg per 100 gm
of body weight.

At this dose level, the rats remained anesthetized

for approximately one hour and a half.

At zero time, a tail-blood

i inch of the tip of the
The femoral vein of the rat was exposed and 2000 pg of

sample was collected after cutting off
rat's tail.

the desired subcellular preparation dissolved in 250 pl of deionized
water was injected into the vein over a JO second period using a
250 pl Hamilton syringe.

clips.

The incision was then closed with wound

A second blood sample was collected into a microcentrifuge

tube by snipping off an additional portion of the tail fifty minutes after the injection of the test material.

Kumar et al. (1965)

noted that the maximal hypocalcemic response after intravenous injection of calcitonin preparations occurred JO to 60 minutes after
injection.

They therefore selected 50 minutes as the standard

Collection time for the second blood sample.

I
.:1

1.

The blood was allowed to clot for

! hour.

It was then centri-

fuged in a Beckman Spinco Microfuge for 5 minutes to separate the
serum.

Serum calcium level (mg/100 ml) was determined for both the

time zero and fifty minute samples.

Hypocalcemic activity was

-77.,ipresse d as the change in serum calcium between time 0 and 50
·nutes per 10 pg of protein of the test materials.
1111
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pQLYACRYI.AMIDE GEL ELECTROPHORESIS OF MICROSOMAL AND STANDARD

----

CALCI'I'ONIN PREPARATIONS

----

Standard calcitonin preparations having a potency of 88 MR.C

units and microsomal preparations which had been passed through a
sephadex G-100 or through both a G-100 and G-50 columns were subjected to polyacrylamide gel electrophoresis utilizing a Canalco
.-·Model 66 Disc Electrophoresis Unit (Canal Industrial Corp., Rockville, Maryland).

This was done to establish the identity of the

hypocalcemic microsomal fraction with a calcitonin preparation of
known potency.

Microsomal and standard calcitonin preparations

were fractionated into their component protein bands in anionic
polyacrylamide gelso

In some instances, calcitonin standard pre-

parations were fractionated in cationic gels and under identical
conditions of milliamperage per gel column (2.5 ma), electrophoretic
separation time (1 hour and 20 minutes), and gel concentration (7.5%).
Electrophoresis was performed in small gel columns consisting
of three sections (Figure 8 ) ;
termed the sample gel, into

( 1) a large-pore anticonvection gel,

which the ionic mixture (microsomal and

standard calcitonin preparations) was introduced; (2) a large-pore
gel, termed the spacer

~r

stacking gel, which has an identical chem-

ical composition to that of the sample gel and in which the sample

Was electrophoretically concentrated; (3) a small-pore gel, termed
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Disc electrophoresis is performed in glass columns filled

with polyacrylamide gel consisting of a sample, stacking, and separation
gel.

A power supply, electrolyte compartments, and electrodes complete

the arrangement.

""

00

-79running or separation gel, in which the sample was separated
the
eiectrophoretically and by molecular sieving. The gel column was
-positioned between two buffer chambers and an electrical field was
applied across the gels.

Each component migrated as a band with

characteristic electrophoretic migration rate depending on its size
and net charge t>
Williams and Reisfeld (1964-65) have designated the necessary
ionic constituents of a zonal polyacrylamide gei setup as the trailing ion (usually glycine or a weak acid or base),
(usu~lly

~he

leading ion

chloride ion), and the buffer counterion (Trizma-Base).

The trailing ion (the correct term is trailing ion constituent, which
-!'efers to a weak ion forming species regardless of whether or not
it is actually ionized) is in two electrode compartments; the lead-

ing ion is in the sample, spacer, and running gels; and the sample
is in the sample gel.

The buffer is in both the upper and lower

electrode compartments as well as throughout the entire gel.

A

marked pH variation occurs at the boundary of the spacer gel and
separation gel.
As the electrophoretic run commences (Figure 9 ) , the sample
"migrates electrophoretically from the sample gel into the stacking
gel.

In the stacking gel, two things happen to the migrating ionic

species.

First, the constituent ions of the sample are segregated

from one another and stacked into contiguous zones.

Their stacking

alignment is dependent on the order of their relative electrophoretic mobilities.

The entire sample is sandwiched between the trail-

anq leading ions.

Second, a concentration step for all these segre-

~ted

stacks occurs.

The thickness of these concentrated zones of
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Figure 9.

In polyacrylamide gel electrophoresis, the sample is first

electrophoretically stacked.

Once the components of this stacked zone

have passed the pH discontinuity, they are separated electrophoretically and by molecular sieving.

-81the various ionic species present in the stacks is independent of
the initial concentrations in the mixture, but is entirely dependent upon the leading ion concentration.

Therefore, sample mixtures

which were initially very dilute in the sample gel can be readily
stacked and concentrated in the stacking gel by varying the concentration of the leading ion whose movement in the gel sets up an
electrical gradient.

No molecular sieving effect is thought to

occur in the sample and stacking gels.

These are the two gel areas

where electrophoretic effects predominate.
The concentrated sample ions in the stacking gel then migrate
into the separation gel.

At the stacking gel/separation gel inter-

iace a new set of conditions prevail.

There is a discontinuity in

pH between the gels and a change in pore size.

As the leading ion/

trailing ion boundary passes the pH discontinuity of the stacking
gel/separation gel interface, the previously observable schlieren
··boundary (boundary of leading ion/trailing ion) breaks up.

It is

at this stacking gel/separation gel interface that the mobility of
the trailing ion now surpasses even that of the fastest sample
ionic species.

The trailing ion species which formerly had trailed

the sample species in the stacking gel now continuously overtakes
and passes through the sample species.

This leading ion/trailing

ion boundary migrates down the separation gel leaving behind a rather uniform voltage gradient in which the sample ionic species now
resolve into a number of characteristic boundaries.

This is due to

the combined effects of the electrophoretic voltage gradient and
the molecular sieving effect of the separation gel.

The molecular

sieving effect has been shown to depend upon the concentration of

-82-

monomer used in the polymerization of the separation gel.

Chrambach

a.nd Ro.dbard ( 1971) have shown that the synthetic polymer, polyacryl-

amide, can be made to provide an effective median pore radius of

o.5

to 3 nm by simply adjusting the total acrylamide concentration

(3 to JO% w/v), and the concentration of the cross-linking agent
(1 to 25% w/v) of the total monomer concentration in the polymerization reaction.

The structural formula of acrylamide, the cross-

linking reagent, initiators of the polymerization reaction, and the

I
I

~

I

cross-linked polymer (polyacrylamide) are shown in Figure 10.

STANDARD PROCEDURE--ANIONIC GEL SYSTEMS

Stock Solutions
Stock solutions (Table II) were prepared using deionized water
and were filtered and stored in brown glass bottles or bottles
wrapped in foil in the refrigerator.

Most of these stock solutions

had a shelf-life of up to three months.
Working Solutions
Working solutions (TableI7I) were prepared fresh from the stock
solutions on the day they were to be used.

However, the persulfate

solution, when kept stored in the refrigerator, was usable for a
Period of a week.
I'

'1'
'I

I

00

w
I

+
Figure 10.

LIGHT

After Chrambach and Rodbard, Science (1971) 172 No. 3982.

The polymerization reaction of acrylamide.

The structures of acryla-

mide, N,N'-methylenebisacrylamide and of a representative segment of
cross-linked polyacrylamide are shown.

Initiators shown are per-

sulfate, riboflavin, and N,N,N' ,N'-tetramethylethylenediamine.

-84TABLE II
ANIONIC GEL STOCK SOLUTIONS

Separation Gel

Sample and Stacking Gels

(Small-pore gel)

(Large-pore gels)

(A)*

( B)

l 1! HCl

approx. 48
36.3

TRIZMA-BASE

water

1 N HCl

gm

TRIZMA-BASE

5.98

TEMED

o.46 ml

o.46 ml

TEMED

100

to

ml

water

(pH 6. 7)

(C)

(D)

30.0

gm

Acrylamide

BIS

o.8

gm

BIS

Potassium Ferricyamide

o.015gm

to

100

ml

water

( E)

Ammonium Persulfate
water

*
**

to

(pH 8.9)

Acrylamide**

water

approx. ·48

ml

to

to

100

gm

ml

10.0

gm

2.5

gm

100

ml

( F)

0.14 gm
. 100

ml

- o.oo4gm

Riboflavin
water

to

100

pH adjusted by titrating with 1 N HCl.

Acrylamide is a neurotoxin in powder form--avoid inhaling.
The following abbreviations were usedz
TEMED
BIS

ml

(N, N, N', N'-Tetramethylethylenediamine);
(N, N'-Methylene-bisacrylamide).

ml
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TABLE III

WORKING SOLUTIONS

Separating Gel

Sample and Stacking Gel

(Small-pore gel)

(Large-pore gel)

Buffer Solution

Part

A

1 Part

B

TRIZMA-BASE 6.0

gm

2 Parts

C

2 Parts

D

Glycine

28.8

gm

4 Parts

E

1 Part

F

Water

1 Part

Water

4 Parts

Water

pH 8. 9

( 8. 8-9. 0)

pH 6.7

(6.6-6.8)

1

pH 8.J

to

1 liter

-86~ixative,
~

Fixative-Stain, and Destaining Solutions

Fixative solutions (Table IV ) and solutions for washing and destaining the polyacrylamide gels were prepared in advance and stored
indefinitely at room temperature.

The naphthol blue-black was added

to acetic acid or trichloroacetic acid and the mixture was stirred
and filtered through Whatman No 1 filter paper.
could be reused a number of times.

These solutions

The Coomassie Brilliant Blue

R-250 was prepared as an aqueous stock solution which was stirred
and filtered prior to use.

This stock solution was diluted 1:20

with trichloroacetic acid (TCA) just prior to staining the gels.
The fixative-stain solution was made up fresh from the stock soluti on each time.

The following procedure was utilized to resolve microsomal and
standard calcitonin preparations into their component protein fractions.
1)

Pyrex glass columns (6.5 cm long and having an inner diameter
of 0.5 cm) were acid cleaned and coated with a wetting agent
(1 part Kodak Photo-Flo or Canalco Column-Coat to 200 parts
water).

Base caps (vacutainer tops) were placed at one end

of the gel columns which were then placed into a loading rack
in which front-to-back vertical alignment of the gels could
be assured.

2)

Stock solutions A, C, and E were removed from the refrigera-

TABLE l.V

FIXATIVE, STAINING AND DESTAINING SOLUTIONS

Fixative Solutions

Acetic Acid

12%

TCA

10%

Fixative-Stain Solutions

0.5 gm

1) Naphthol Blue Black*

7% Acetic Acid

100

0.5

2) Naphthol Blue Black***
10% TCA

Destaining Solutions

100

ml
gm

ml

1) Acetic Acid**
Water

to

1

70 ml
liter

2) Acetic Acid****l20 ml

Water

to

1

liter

J) Coomassie Brilliant Blue

I
(X)

(Stock Solution)
Coomassie Brilliant Blue 1
Water
to
100
(Working Solutions)
20
12.5-20.0% TCA*****
Stock Solution
1

---J
I

gm

ml

ml
ml

* Fixative-stain solution commonly used for serum proteins.
** Destaining solution commonly used for serum proteins.
*** Fixative-stain solution used for staining calcitonin.
**** Destaining solution used for calcitonin preparations.
***** Fixative-stain solution used for staining calcitonin preparations. A further increase in sensitivity can be achieved by the use of a 20% TCA dye solvent.

-88tor and 2 ml of solution A, 8 ml of solution E, 4 ml of solution C, and 2 ml of deionized water were placed in separate
flasks and allowed to warm up to room temperature.

Sixteen

mls of separation gel solution is the volume required to run
twelve 6.5 cm long gels.

When at room temperature, the four

components were then added to a single flask and swirled gently to prevent air bubble formation and to provide thorough
mixing.

This was the separation gel solution.

Using a 1 ml

tuberculin syringe, to which 5 cm of tygon tubing was attached,
exactly

o.8

ml of the separating gel solution was dispensed

(without bubble formation) into each of the 12 vertical gel
columns.

3)

An Eppendorf or Oxford pipette was then used to carefully
layer 100 pl (2-3 mm) of water on top of the gel solution.
If the gel columns are not coated with a wetting agent prior
to their use, a bolus of water will form which will drop into
the gel solution and dilute it.

However, if the gel columns

are coated, water will layer evenly on top of the unpolymerized gel solutions.

The purpose of the water layering of gel

solutions is that it prevents a gel-air meniscus and produces
a flat gel surface which is essential for obtaining good protein band formation.

It also prevents oxygen, which retards

gel formation, from diffusing into the gels.

-89The separation gels remained undisturbed for one-half hour,
during which time complete chemical polymerization occurred.
one could determine if polymerization was complete by viewing
the gel columns from the side.

A distinct interface between

the gel and water layers was visible when polymerization had
occurred.

The gel columns were then removed from the loading rack and
the water layer was removed by giving the column a quick
flick of the wrist.

The lip of the gel column was then

touched to a piece of absorbant paper to remove the last
traces of water.

Two milliliters of solution B, 4 ml of solution D, 2 ml of
solution F, and 8 ml of water were put into another set of
small flasks.

These solutions were warmed to room tempera-

ture and gently mixed in a flask that was completely wrapped
in foil to protect this gel solution from premature photopolymerization.

This solution was to serve as the photopolymer-

izing stacking and sample gel.

A 1 ml syringe with tygon

tubing adapter was then used to add 0.2 ml of this solution
to each gel column.

This was to serve as the stacking gel.

Once again, 100 µl of water was layered over this gel solution as previously described.

The entire loading rack was

positioned approximately JO cm from a fluorescent light
source.

This resulted in stacking gels with a more uniform

pore size.

Fifteen minutes were allowed for photopolymeriza-

-90tion to begin as evidenced by the appearance of opalescence
in the stacking gel.

When photopolymerization had begun,

the light source was moved to within 5 cm of the columns and
another 15 minutes were allotted to insure total photopolymeriza tion.

The water layer was then removed as previously

described.

Sample Application
Generally 200 to 500 µg of solid sample can be resolved in a
single polyacrylamide gel.

However, samples that are rela-

tively homogeneous can be assayed in quantities as small as
50 to 100 µg range.

Samples whjch are heterogeneous can be

assayed at concentr.ation ranges of 500 to 2,000 µg.

Normally,

calcitonin standard and microsomal preparations were dissolved
in sufficient sample gel solution that JJJ µg of calcitonin
standard and 1,500 pg of microsomal calcitonin preparation
were present in 0.2 ml of sample gel solution.

The sample

gel solution (0.2 ml) was added on top of the stacking gel
and layered with 100 µl of water.

The sample gel solution

was allowed to photopolymerize for JO minutes while positioned

5 cm from a fluorescent light source.
Bromphenol blue {O.l to 0.2 ml), serving as a tracking dye,
was incorporated into the sample gel solution prior to its
addition to the gel column.

This dye migrates faster than

the fastest sample ion species.

-91The t,el columns were then removed from the loading rack and
inserted into the holes of the upper bath stoppers (sample
gel uppermost).

After all the gel columns were inserted in

this manner, buffer solution was added on top of the sample
gels making certain that no air bubbles were entrapped in the
remaining space of the upper gel column.

The entire upper

bath assembly containing the gel columns was then lifted out
and sufficient buffer solution was added to the separation
gels such that a hanging drop of buffer solution remained at
the bottom of all the gel columns.

The lower bath (containing the anode) of the Canalco Electrophoresis unit was then filled with 500 ml of buffer solution.
The upper bath assembly was then carefully placed into position making certain that no air bubbles had formed at either
end of the gel column.

Air bubbles result in uneven band for-

mation because a uniform current flow through the gels is prevented.

The upper buffer reservoir of the Canalco apparatus

was then filled with 250 ml of buffer solution.

The upper bath lid was then placed on the upper bath.
power supply was connected.

The

A current of 2.5 milliamps per

gel column provided for good resolution of protein bands.
Currents over 5 milliamps were avoided because they cause excessive ohmic heating within the gel, resulting in band distortion.

Electrophoresis was carried out until the now dis-

crete front of tracking dye band had migrated to within

t

-92inch of the separation gel end.

This required approximately

1 hour and 20 minutes at 2.5 ma per gel column.

At the completion of electrophoresis, the power supply was
turned off and the electrode jacks were disconnected.

Buffer

from the upper and lower baths was decanted into separate containers and was reused a number of times in the respective
buffer compartments as long as the upper buffer did not drop
below pH 8.2 or become contaminated with sample.

The gel columns were removed from the upper reservoir and were
placed in a wash tray containing ice-cold water.

The gels

remained immersed in the ice-cold water for 5 minutes which
was sufficient time for maximal gel contraction.

A ten milli-

liter syringe fitted with an 18 gauge needle was filled with
the ice-cold water.

The gel columns were kept submerged while

the tip of this needle (beveled edge towards the gel to avoid
scratching the gel) was inserted between the glass column and
the gel.

The needle was inserted slightly beyond the sample

gel of the gel column.

Keeping the gel columns submerged

and the needle flat against the glass surface, the entire gel
column was rotated with one hand while the position of the
needle was maintained.

This freed the entire circumference

of the sample gel from the glass column.

Ice-cold water was

continuously injected around the gel surface as the gel column
was rotated.

The water pressure freed the stacking and sep-

arating gels and in a few moments the intact gel was expelled

-93from the separating gel end of the glass column.

l4)

Microsomal and calcitonin standard preparations were fixed and
stained in fixative-stain No 2 (Table N ).

Ten per cent TCA

solution was found to be a good fixative for calcitonin preparations.

The gels were fixed and stained in this solution

for at least one hour.

Another method that was used in-

volved fixing the gels in 10% TCA or 12% acetic acid for one
hour.

The gels were then placed in fixative-stain solution

No 3 (Table IV) for a minimum of one hour or as long as 24
hours.

Chrambach et .§1_. (1967) demonstrated that Coomassie

Brilliant Blue, the stain in fixative-stain No

J, was approx-

imately five times as sensitive a stain for proteins and peptides when compared to the naphthol blue black stain.

Minute

protein bands were well detailed in 20% TCA-Coomassie Brilliant
Blue stain solutions.

Gels that were fixed and stained with

the No J fixative-stain solution destained themselves over a
period of several weeks.

Electrophoretic destaining of TCA-

fixed gels was more prolonged then those prepared in fixativestain solution No 1.

15)

Electrophoretic destaining of microsomal and standard calcitonin gels stained by fixative-stain No 2 (Table IV) was performed in the same apparatus.

The gels, sample gel uppermost,

were placed.in destaining tubes, which had been attached by
their wide ends to the upper buffer reservoir.

The gels were

wedged firmly against the constricted ends of the tubes.

-94The destaining tube was then carefully filled (using a
syringe to avoid bubble formation) with destaining solution
No 2.

Five-hundred milliliters of destaining solution No 2

were poured into the lower bath of the Canalco apparatus.
The upper reservoir was filled with 250 ml of destaining
solution No 2.
the upper

The electrodes were connected, the cathode to

reservo~r.

A constant current of

was set on the power supply.

4 ma per tube

On applying the current, the

unbound dye migrated down the gels into the lower reservoir.
At this milliamperage setting, it took 2 to J hours to destain the gels.

16)

When the section of gel containing no separated fractions
was completely clear of stain, the power supply was turned
off.

The destaining solution was decanted, and the gels were

transferred to small test tubes containing destaining solution No 2 for storage.

Alternatively, the gels were stored

in 10% TCA or in a solution comprised of equal parts of glycerol and deionized water.

This solution allows for storing

the gels up to two years without shrinkage.

iTANDARD PROCEDURE--CATIONIC GEL SYSTEM
In some instances, cationic gels were utilized to fractionate
calcitonin standard preparations.

-95stock Solutions

----

Stock solutions (Table V} were prepared and stored in the

same manner as anionic gel solutions.
Working Solutions
Working solutions (Table VI) were prepared fresh from the
stock solutions on the day they were to be used.
Fixative and Fixative-Stain Solutions
Cationic gels were fixed in 10% TCA.

Either fixative-stain

solution No 2 or No 3 (see Table IV) were utilized for staining
cationic gels.

However, Coomassie Brilliant Blue in 12.S to 20%

TCA was the most sensitive and therefore the most commonly employed fixative-stain solution for cationic gels.
Procedure
The experimental procedure for running cationic gels was
nearly identical to that described previously for anionic gels.
Any differences in procedure are listed below:
1)

Separation gels were allowed to stand undisturbed for one
hour while chemical polymerization was completed (see step
4, anionic gel system).

2)

Since electrical polarity had to be switched (see step 11,
anionic gel system), no tracking dye (see step 8, anionic gel
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TABLE V
CATIONIC GEL STOCK SOLUTIONS

Sample and Stacking Gels

Separation Gel

(A)*
1

J:! KOH

Acetic Acid

(B)*
ml

1 N KOH

53.2

ml

Acetic Acid

1.47

ml

ml

TEMED

0.1

ml

ml

Water

0.24

TEMED

100

Water to

24

12

to

(pH 2.9)

o.a

Water

100

to

ml

10

gm

(D)

JO

BIS

100
(pH 6.7)

(C)
Acrylamide

ml

gm

Acrylamide

gm

BIS

ml

Water

o.a
100

to

gm
ml

(F)

(E)

Ammonium Persulfate

0.12

gm

Ammonium Persulfate

0.06

gm

Riboflavin

0.002

gm

Riboflavin

0.001

gm

ml

Water

Water

*

to

100

to

pH adjusted by tit+ation with acetic acid.

100

ml

-97TABLE VI

WORKING SOLUTIONS
Sample and Stacking Gel

separating Gel

_ 2 parts
l-1

! Parts*

l Part***

(pH 2.9)

A

c
E

1 Part
, 1-2 Parts**
2 Parts

(pH 6.7)

Buff er Solutions

UPPER BUFFER

B
D

Glycine

F

Acetic Acid

3.05 ml

to

1 liter

Water

28.1

gm

(pH 4.0)
LOWER BUFFER

Acetic Acid
1 N KOH

Water

43

ml

120

ml

to

1 liter

--···-··-(pH 4.J)

* Separating gel concentration may be increased in some instances
to resolve protein samples into narrower bands (requires longer
running time).

'

I

** Sample gel contration may be increased for samples which retard
photopolymerization or those which are partially insoluble in
sample gel solution.
*** To insure stock solution stability, the catalyst, ammonium persulfate, may be deleted from stock solutions (E) and (F) until
the working solutions are being prepared. At that time, ammonium persulfate (6 mg/5 ml) of stock solution (E) and 3 mg/5 ml
of stock solution -(F) may be added to the proper ratios of stock
solutions for- the separation, stacking, and sample gels. pH of
the buffer solutions if titrated with acetic acid.

-98system) could be -utilized to gauge the distance of electrophoretic migration of the standard calcitonin preparations.
Therefore, one must experiment with different fractionation
times (at constant milliamperage) to determine the length of
electrophoresis that will result in optimal resolution of
protein bands.

3)

The lower bath {containing the cathode) was then filled with
500 ml of the 1 N KOH/acetic acid buffer (see Table VI) at

pH 4.3 and the upper bath was filled with 250 ml of glycine/
acetic acid buffer {see TableVI ) at pH 4,0,

DENSITO:vJETRY OF POJ.,YACRYLAMIDE GELS

Densitometry of gels was performed with a Densicord Model 542
densitometer {Photovolt Corporation, New York, N. Y.).

This densi-

tometer in conjunction with an automatic integrator attachment can
be utilized to give accurate quantitation of all electrophoretically
destained polyacrylamide gels.

The proper response setting was

chosen and the stained separation gels were scanned over their entire
length by the Densicord.

The automatic integrator attachment allows

one to determine the percentages of the various fractions from the
densitometer trace.

The number of integrator marks was in exact

proportion to the area under the curve at all

points.
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.PJiOTOGRAPHY OF POLYACRYLAMIDE

GEL~

A Polaroid camera with a close-up lens was the most convenient

method of photographing stained polyacrylamide gels.

-CHEMICALS

REQUTR~D

FOR POLYACRYLAMIDE GEL ELECTROPHORESIS

Acrylamide, Eastman Organic Chemicals, No. 5521.
Bromphenol Blue (Water Soluble), Hartman-Leddon Company, No. 859.

coomassie Brilliant Blue R250, Colab Laboratories, Inc., No. ll-152B.
Glycine (Ammonia-free), Eastman Organic Chemicals, No. 445.
N, N'-Methylene-bis acrylamide (BIS), Eastman Organic Chemicals,
No. P8J8J.
Naphthol Blue Black, Eastman Organic Chemicals, No. 9763.
Potassium Ferricyanide, Sargent-Welch Scientific Company, AR. 14180.
Riboflavin, Eastman Organic Chemicals, No. 5181.
N, N, N', N'-Tetramethyethylene diamine (TEMED), Eastman Organic
Chemicals, No. 8178.
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~CTRIC

FOCUSING

In recent years, the development of the highly sensitive isoeiectric focusing technique has become a powerful tool for the analytical or preparative separation of ampholytes, especially proteins,
and for the characterization of the ampholyte by determining its
isoelectric point (pI).

Isoelectric point determinations of re-

solved proteins can now be accomplished conveniently and with great
reproducibility in a single experiment.

The isoelectric focusing

technique permits essentially complete analytical resolution of
mixed protein components employing rather simply designed electrofocusing equipment and experimental protocol.

One can now conven-

iently resolve protein components in a mixture which have as small
a difference as 0.02 pH units separating their isoelectric points.
Isoelectric focusing of proteins is achieved when a direct
current potential is applied to a system of electrolytes in which
the pH steadily increases from the anode to the cathode.

Each pro-

tein species will be resolved in a stabilized pH gradient at the
zone in the gradient at which the pH of the gradient corresponds to
the pI of the species.

The focusing, or resolution of proteins, is

therefore attributable to the electric field they are in; hence, the
name, isoelectric focusing.

A necessary prerequisite is that the

electrolyte system is stabilized against uncontrolled convection and
against remixing of resolved proteins.

This is accomplished by

applying a linear sucrose gradient within the electrofocusing chamber of the column.·
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~
In isoelectric focusing of proteins, a pH gradient having the
iowest pH values at the anode and the highest pH values at the cathode is utilized.

When one adds a mixture of proteins with isoelec-

tric points occurring within the pH range of the pH-gradient, the
component protein molecules of the mixture will exhibit their characteristic charges.

The charge of each protein component will be

determined by the pl for that protein and the pH range of the gradient corresponding to the position in the electrofocusing column
where the protein is initially located.

When a constant current is

applied to such a system, each protein molecule of the mixture migrates towards the pH value in the column where its net charge is
zero.

Each protein of the mixture is therefore resolved at the

.

point in the electrofocusing column where the pH is equal to the pl.
This process is illustrated in Figure 11, which schematically
depicts the resolution of three proteins marked (pI 1 ), (pI 2 }, and
(pIJ) in an isoelectric focusing column.

The pH Gradient
In 1961, Svensson introduced the term "natural pH gradient."
Such a pH gradient was termed a natural one, since it is formed by
the electric current.

Prior to turning on the current, the pH is

constant throughout the solution.

A pH gradient in equilibrium

cannot be achieved until the current has transported each low-molecular weight ampholyte to its isoelectric point.

Since this pH

gradient is in equilibrium, it remains stable for long periods of
time, and· unlike an artificial pH gradient (obtained by arranging

Cathode(.-)

pH/pl

""

fi1
---lil
•

•

t

~-..~~~""111ncreas1ng

El ---8

pH
values

I
I-'

0
l\.)

I

tb ---8
-8---8

Pig -

Protein
1

Protein
2

l2J

El
Protein
3

Anode(+)

Figure 11. Three proteins marked Cpl 1), (pl 2 ), and (pl 3 ) are
schematically electrofocused in a column.
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buffer solutions of different pH in series so they can diffuse into
each o.ther), it will not migrate.

Therefore, the "natural pH gra-

dient" is an ideal medium for isoelectric fractionation of amphoiytes such as proteins.
Svensson°s theoretical considerations (1961) and fundamental
work (1962) defined the required properties of carrier ampholytes
which would comprise the natural pH gradient for isoelectric focusing of proteins.

The prerequisites of any carrier ampholytes used

for isoelectric fractionation are listed below:
1)

A carrier ampholyte should have good buffering capacity at
its isoelectric point, so that it is capable of well-defining
the pH at that point and of dominating the high-molecular ampholytes (proteins) which are to move in the zone where it
reigns.

2)

A good buffering capacity is accompanied by good conductivity
at the isoelectric point.

3)

The carrier ampholytes should have low molecular weights in
order to be separable by dialysis or column chromatography
from the high-molecular weight compounds which are to be
electrofocused.

4)

The carrier ampholytes should also have a chemical composition that is different from the substance to be separated
and analyzed, in order that conventional methods of identifi-

-104cation and analysis of these substances may be applied without disturbances from the carrier ampholytes.

5)

The carrier ampholytes should not react with or denature
the· substance to be fractionated.

Vesterberg and Svensson (1966) developed a method of synthesizing ampholytes having the characteristics which had been defined by Svensson (1961).

These synthetic ampholytes were ali-

phatic polyamino-polycarboxylic acids exhibiting many values of
pK for the same type of molecule and having great solubility in
water.

Vesterberg (1969) successfully accomplished the synthesis

of carrier ampholytes which were a mixture of many isomers and
homologues with different, closely spaced pK and pI values, covering the pH range from J to 10.

This was accomplished by reacting

a mixture of many different polyethylene-polyamines in aqueous
solution with acrylic acid.

The ampholytes with molecular weights

ranging from JOO to 1000 are focused and fractionated in a multicompartment electrolyzer, into groups with closely spaced pI values.
The carrier ampholytes, covering a multitude of pH ranges,
are now commercially available from LKB Instruments, Inc., Rockville, Maryland, under the trade name of Ampholine Carrier Ampholytes.

The carrier ampholytes may be characterized by the fol-

lowing general formulas
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---- CH 2 - N - (CH )x
I
2
(CH 2 )x
I

- N -

1

CH 2

----

R

NR2

wheres
and,

x

=2

or J

R = H or

At the beginning of an isoelectric focusing experiment, the pH
is constant throughout the electrofocusing column and is the average
value of all the carrier ampholytes in the solution.

Some of the

carrier ampholytes are positively charged and others are negatively
~charged.

When a current is applied to the electrofocusing compart-

ment, these ampholines start migrating towards their respective
electrodes.

While they are migrating, a pH gradient is successively

built up due to their buffering capacity.

Each carrier ampholyte

will establish a pH range corresponding to its isoelectric point.
The carrier ampholytes ct'ter a 24 to 72 hour period will be distributed in a pH gradient which they, themselves, have created in
order of their isoelectric points.
The mixed protein sample that is to be separated into its component fractions by the electrofocusing procedure is added to the
electrofocusing compartment together with the carrier ampholytes.
When the current is applied, the sample proteins will also start
migrating toward their respective isoelectric points because of the
PH gradient established by the carrier ampholytes.
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The pH range of the Ampholine Carrier Ampholytes should be
chosen as narrow as possible when electrofocusing to give the best
resolution for each protein.

The pH range should be just large

enough to include the pI values of the proteins of interest.

When

electrofocusing a mixture of proteins for the first time, it is
desirable to electrofocus a portion of the protein sample in the
broadest pH range (J-10) before the optimum range can be selected
for future electrofocusing experiments.

The Density Gradient
The carrier ampholytes and the protein sample in the electrofocusing column must be stabilized against convection in some way.
A suitable way to accomplish this is to use density gradient of
decreasing concentration 1 from bottom to top, of sucrose or other
non-ionic solutes (such as ethylene glycol) dissolved in the electrofocusing solution.

The linear sucrose gradient is arranged by

filling the electrofocusing column with fractions of decreasing density (carrier ampholytes, sucrose, and sample) or by utilizing an
LKB Gradient Mixer (LKB Instruments, Inc., Rockville, Maryland)
designed specifically for filling the electrofocusing column.
The gradient mixer gives a linear gradient of two solutions,
termed "light" and'tiense" (containing sucrose) solutions.

The

protein mixture is added to one or a few fractions if the density
gradient is made manually or in the "light" solution if the LKB
Gradient Mixer is utilized.
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The carrier ampholytes located near either electrode must be
protected from anodic oxidation and cathodic reduction.

This is

accomplished by surrounding the anode with a dilute acid solution
such as phosphoric acid or sulfuric acid and the cathode with a dilute alkaline solution such as sodium hydroxide or ethanolamine.
During the electrofocusing experiment, the dilute acid and base
solutions are drawn to the respective electrodes.

At the anode, the

dilute acid solution gives a net positive charge to any nearby carrier ampholytes, which are thus repelled from the anode and hence,
are protected from electrolytic decomposition.

Similarly, the dilute

base at the cathode results in the formation of negative ampholytes,
thereby causing them to be repelled from the cathode.

The Principle of a Practical Isoelectric Focusing Run
The highly sensitive resolving power of the isoelectric focusing technique can best be illustrated by an electrofocusing experiment in which a mixture of commercially available hemoglobin A,

s,

and C preparations (Travenol Laboratories, Inc., Costa Mesa, California) was resolved and the pI values determined.

A similar experi-

mental protocol was utilized to resolve microsomal and standard
calcitonin preparations and to determine their pl values.
Ampholine carrier ampholytes having a pH range of 7 to 9 were
utilized to resolve a 14 mg mixture of hemoglobin A,

s,

and C into

separated fractions whose characteristic pI values at 4° C was determined •

-108The entire electrofocusing column (LKB 8100 Arnpholine Column,

LKB Instruments Inc., Rockville, Maryland) is thermostated at 4° C
by utilizing a cryostat (Tamson Thermostatic Bath (TM-9) and circu-

iator (PBC-4, Neslab Instruments Inc., Portsmouth, New Hampshire),
which circulated coolant around both the inner and outer electrofocusing columns.

The coolant consisted of equal volumes of dis-

tilled water and ethylene glycol.
the open position.

The central electrode valve was in

The electrode solution for the central electrode,

10 ml of .0.1 N phosphoric acid, was filled with an LKB 12000-1 varioperpex pump (LKB Instruments Inc., Rockville, Maryland) into the central electrode compartment (containing a teflon rod around which a
platinum wire was wrapped).

This served as the anode during the iso-

electric focusing of the mixture of hemoglobins.
The mixed hemoglobin sample, Ampholine carrier ampholytes of

pH range 7 to 9, and sucrose were mixed together in the LKB Gradient
Mixer so that the solution (110 ml total) gave a linear density gradient when the electrofocusing compartment was filled with the peristaltic pump over a 1

h~ur

period.

The remaining space at the top

of the electrofocusing column was filled with 10 ml of 0.1 N NaOH so
that the upper platinum electrode was completely covered by electrode
solution.
ment.

This served as the cathode in the electrofocusing experi-

A constant voltage (400 volts) provided by an electrophoresis

power supply (Gelman Instrument Co., Ann Arbor, Michigan) was then
applied to the electrofocusing column via the plugs at the central
electrode terminal and upper electrode terminal and the isoelectric
focusing of the hemoglobin mixture was started.

In practice, the

best results are obtained by placing the cathode at the top of the
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electrofvcusing column for pH regions below pH 6, and the anode at
the to_p of the column for pH regions above pH 6.

If this practice

is not followed, protein precipitation may occur at the top of the
column and may disturb focused zones due to settling of the precipitate.
When the current (at a constant voltage of 500 volts) decreased
to a constant value of 2 ma all the carrier ampholytes in the electrofocusing column have migrated to their isoelectric points.

The

hemoglobin A, S, and C also have focused at their isoelectric points;
however, their contribution to the conductance was extremely low.
The electrofocusing run in which hemoglobin A,
required a 48 hour electrofocusing time.
~using

s,

and C were resolved,

In general, an electrofo-

run normally takes from 24 to 72 hours at a voltage of JOO to

500 volts, depending on the ampholine pH range used.

Generally

longer electrofocusing times are required for resolution of proteins

in narrower pH ranges of ampholines.
At the completion of the electrofocusing procedure, the voltage
was turned off and the central electrode valve was closed to prevent
the anode electrode solution from mixing with the effluent.
The outlet clamp for the electrofocusing column was then opened
and the column was emptied by means of an LKB peristaltic pump.
effluent was monitored with an LKB Absorptiometer at 280 nm.

The

Forty

drop fractions (circa J.6 ml) were collected in test tubes and the
PH of each fraction was measured at 4° C.
Figure 12 shows an LKB 8100 Ampholine Electrofocusing Column in
Which hemoglobin A, S, and C have been distinctly resolved.
number of unidentified minor bands are also shown.

A large

This indicates
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Electrode

• '- - Central Electrode

_,.,_Hb-A
,. ._••lll•-Hb-8
-Hb-C

Figure 12.

LKB 8100 Electrofocusing Column with com-

pleted separation of a mixture of hemoglobins A, S,
and C in a pH gradient of 7 to 9.
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the highly sensitive resolving power of the isoelectric focusing
technique and clearly demonstrates that commercially "pure" preparations of hemoglobin A, S, and C are, in reality, not at all in
the pure form.
Figure 13 depicts the absorption curve and superimposed pH
curve obtained by eluting the electrofocused A,

pin bands from the column.

s,

and C hemoglo-

The pH of the collected fraction at

the elution peaks corresponds to the pI of the various resolved
I

hemoglobin components.

pH B.O

Hb-A

pl 7.32
7.9

Hb-S

pl 7.18
7-B
7.7

Anode
Electrode
7.6 Solution
Hb-C

7.5

-

pl 7.12

7.4
I
I-'
I-'

7.3

N

I

7.2
7. 1

72 ml

54
7.0

30

27

23

22

20

18

15 cm

FIGURE 13. Separation of hemoglobin A, $, and .c mixture by the electrofocusing
apparatus shown in Figure
The curve with peaks shows the absorption in the
eluate at 280 nm. The steadily increasing curve is a plot of the pH gradient
superimposed. Isoelectric point values shown at the various peaks were read
from the pH gradient curve.

CHAPTER III
EXPERIMENTAL RESULTS
The experimental portion of this dissertation consists of
three parts.

The first part deals with the subcellular localiza-

tion of calcitonin and the influence of calcium concentration on
the biosynthesis of the hormone in subcellular fractions.

Ovine

thyroid gland slices were incubated in an in vitro biosynthetic
medium consisting of Krebs-Ringer bicarbonate buffer (pH 7.4) containing glucose, all the amino acids of ovine calcitonin, and in
many instances, glycine-C-14 (UL), which served as a tracer amino
acid.

The calcium concentration of the incubation medium was the

only parameter which was varied.

Low calcium concentration incu-

bation medium contained 4.8 mg of calcium/100 ml, the physiological, 11.5 mg of calcium/100 ml, and the high, 26.o mg of calcium/
100 ml.

After incubation, the slices were homogenized and mito-

chondrial, nuclear, and microsomal subcellular fractions were obtained by differential centrifugation.

Aliquots of these three

subcellular preparations obtained from incubation media containing
the varying calcium concentrations were injected into rats and
assayed for hypocalcemic activity.
The second part of this report concerns establishing the
identity of the hypocalcemic principle in the subcellular fraction
by comparison with a standard calcitonin preparation and deter-

mining the homogeneity of the hypocalcemic entity at each stage
-113-
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of hormone purification.

This was accomplished by electrophoretic

rractionation of the hypocalcemic preparations and of standard
calcitonin preparations of known potency, in polyacrylamide gels.
The hypocalcemic fraction was inspected for homogeneity in polyacrylamide· gels after passage through Sephadex G-100 and G-50
chromato~aphic

columns.

The:last part of the experimental work to be described deals
with the further characterization of the hypocalcemic subcellular
and standard calcitonin preparations by determining a significant
physical constant of this hypocalcemic principle, its isoelectric
point (pI) by means of isoelectric focusing.

Moreover, this tech-

nique permitted resolution of the hypocalcemic fraction into discrete protein bands which could be recovered in milligram quantities and assayed for hypocalcemic activity.

THE INFLUENCE OF INCREASING THE DOSE OF THE SUBCELLULAR FRACTION
ON HYPOCALCEMIC ACTIVITY

Protein synthesis occurs on the ribosomes and these subcellular organelles are prominent constituents of the heterogeneous
microsomal fraction obtained by differential centrifugation which
is composed of smooth and rough endoplasmic reticulum, dense granules, and free ribosomes.

Therefore, it seemed quite proper to

assay this subcellular fraction first for the hypocalcemic activity associated with this peptide hormone.

In order to establish

Whether or not this microsomal fraction would indeed exhibit
hypocalcemic activity, two grams of sheep thyroid slices were

-115placed in a series of 50 ml Erlenmeyer flasks which contained 10
ml of a physiological calcium concentration incubation medium, 11.5

mg Of calcium per 100 ml of Krebs-Ringer bicarbonate buffer. The
ovine thyroid slices were incubated for four hours at J7° C in a
constant temperature shaker water bath.

The incubation was ter-

minated by placing the flasks in an ice-bath.

The slices were im-

mediately homogenized and a microsomal subcellular fraction was
obtained by differential centrifugation.

The fresh microsomal

preparation was immediately lyophilized.

For hypocalcemic deter-

minations, various amounts of the microsomal material were dissolved in 250 pl of deionized water which served as the vehicle.
Microsomal material in concentrations of 250 µg, 1,000 µg and 2,000
pg per 250 pl of deionized water were assayed for hypocalcemic activity in lJO to 160 g Holtzman rats which were fasted for 18 hr
before their use for biological assay.

This was done first of all,

to establish whether or not this fraction was hypocalcemic, and
secondly, to determine the injection dose which would result in a
maximal hypocalcemic response.

The various concentrations of mi-

crosomal material were injected intravenously into rats and the
calcium concentration of the serum samples was determined before
and 50 minutes after injection.
The microsomal preparations were analyzed for protein content and the change in serum calcium was expressed as the change
in calcium in mg%/10 µg protein.

The influence on hypocalcemic

activity of increasing microsomal injection doses is presented in
Table VII.

It is apparent that intravenous injection of as little

as 250 µg of crude microsomal material evoked a hypocalcemic re-
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TABLE VII
HYPOCALCE'MIC ACTIVITY OF INCREASING DOSES OF MICROSOMAL
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING
PHYSIOLOGICAL CALCIUM CONCENTRATIONS
Dose

µg

,250

£g

l

2
3
4

5
6

Mean

.la 000

B,g

1
2
J
4

5
Mean

r
t~··

[
,.

[
I:

I

2,000

j!g

Ca

Animal
No.

to

10.40
10.10
l0.90

9.50
ll.J5
10.20

m~

t50

8.50
9.68
10.40
9.30
10.10
9.80

! s. D.
14.00
14.20
10.00
12.00
8.10

± s.

7.95
11.60
7.60
11.30
7.70

13.60

8.35

2

l0.75

J
4
5

11.40

6.90
8.35
7.70
8.80
9.40
11.60

6
7

Mean

± s.

D.

-1.90
-0.42

-0.50
-0.20
-1.25
-0.40

-0.173
-0.074
-0.069
-0.020
-0.011

-6.05
-2.60
-2.40
-0.70
-0.40

-0.069 ± 0.057

1

11.JO
11.00
13.JO

-0.101
-0.022
-0.027
-0.011
-0.066
-0.021

Net
Change

-0.041 :t 0.031

D.

l0.50

~ Ca mg:'/o/
10 µg Protein

-0.151
-0.110
-0.088
-0.080
-0.072
-0.046
-0.048
-0.085

-5.25
-3.85

-3.05
-2.80
-2.50
-1.60
-1.70

t 0.036

%

Change
-18.3
- 4.2
- 4.6
- 2.1
-11.0
- 3.9
- 7.4
-43.2
-18.3
-24.o

- 5.8
- 4.9
-19.2
-38.6
-35.8
-26.8
-26.7
-22.1
-14.5
-12.ts
-25.3

-117sponse, lowering the serum calcium by approximately

7% while in1

jection of 2,000 µg of this fraction resulted in a 25% decrease in
serum calcium of rats 50 minutes after injection.
increase in the specific activity term, mgs

A concomitant

% calcium change/10

pg protein, was also observed; the specific activity increased

from -0,041 for the 250 µg dose to-0.085 for the 2,000 µg preparation.

The 2,000 µg microsomal dose elicited a maximal hypocalcemic

response.

A number of attempts were made to assay a J,OOO µg dose

for hypocalcemic activity; however, this amount of microsomal material was quite insoluble in deionized water, often resulting in
the death of test rats, probably due to obstruction of the circulatory system by the suspension.

In the few surviving animals,

at this dosage, serum calcium was decreased by approximately the
same amount as with the 2 1 000 µg dose.
to utilize a 2,000

pg

It was therefore decided

dose of mitochondrial, nuclear, and microso-

mal preparations for hypocalcemic determinations in all subsequent
experiments.

THE INFLUENCE OF PHYSIOLOGICAL AND HIGH CALCIUM CONCENTRATIONS IN
THE INCUBATION MEDIUM ON THE HYPOCALCEMIC RESPONSE OF SUBCELLULA!i

.fRACTIONS ISOLATED FROM INCUBATED THYROID SLICES
Although the microsomal fraction exhibited hypocalcemic activity at all dose levels tested, a distinct possibility remained
that the mitochondrial and nuclear preparations might also exhibit
hypocalcemic activity.

Brown and Ulvedal (1960) had localized TSH

activity in the mitochondria and ACTH activity was found to be
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dispersed over several subcellular fractions; however, no hormonal
activity was found to be present in the nuclear fraction.

Yet, one

can not arbitrarily dismiss these fractions from any hypocalcemic
determinations.

Consequently, mitochondrial and nuclear fractions,

were obtained from incubation media containing either physiological
I'

or high levels of calcium, 11.5 mg/100 ml and 26.0 mg/100 ml, re'
spectively; and were assayed for hypocalcemic activity in rats at
a dose of 2,000 µg.

In these initial studies, no tracer amino

acid (glycine-C-14) was utilized in the incubation media.
A calcium concentration of 11.5 mg/100 ml of Krebs-Ringer
bicarbonate buffer incubation medium was selected as a physiological calcium concentration, since the normal serum calcium level
in most mammals ranges from 9.0 to 12.5% depending on the test
animal.

In rats, the normal serum calcium level ranges from 9 to

11.5%, therefore, the 11.5% calcium concentration was at the upper

end of the normal range.

The reason for selecting 26.0 mg/100 ml

of Krebs-Ringer bicarbonate buffer as a high calcium concentration
incubation medium was somewhat arbitrary.

It is known that in

mammals serum calcium levels seldom exceed 22 to 23 mg% even in
severe cases of hyperparathyroidism or experimentally induced hypercalcemia; consequently, tqe high calcium concentration used
here was slightly above the highest reported values for serum
calcium.
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The influence of a physiological calcium concentration of the
incubation medium on the hypocalcemic response in rats injected

with aliquots of mitochondrial and nuclear fractions isolated from
the incubated thyroid slices is shown in Table VIII. ·The hypocalcemic response of the microsomal preparation has already been noted
in Table VII.

Surprisingly, the nuclear preparation decreased the

serum calcium of rats by approximately 27%.

This was 2% more than

the 25% decrease in serum calcium of rats injected with micros9mal
material.

The mitochondrial preparation, however, elicited only

a slight hypocalcemic response.

Although the hypocalcemic response

of the nuclear and microsomal preparations were quite similar, injection of the nuclear preparation resulted in only a -0.038 mg%
change in serum calcium per 10 pg protein whereas the microsomal
preparation changed serum calcium by -0.085 mg% per 10 pg protein.
This indicated that the microsomal preparation exhibited over twice
the hypocalcemic response per 10 pg of protein, as did the nuclear
z

•1

fraction.

It appeared likely that the hypocalcemic response of

the nuclear fraction could be attributed to significant microsomal
contamination of this fraction.

This possibility was borne out in

further testing.
The influence of a high calcium concentration on the hypocalcemic response of the microsomal, mitochondrial, and nuclear subcellular fractions is shown in Table IX.

In this experiment, only

the microsomal preparation exhibited a hypocalcemic response,
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TABLE VIII
HYPOCALCEMIC ACTIVITY OF MITOCHONDRIAL AND NUCLEAR PREPARATIONS
AT A CONCENTRATION OF 2,000 µg OBTAINED FROM INCUBATION
MEDIA CONTAINING PHYSIOLOGICAL CALCIUM CONCENTRATIONS

Pre para ti on

--

Mitochondrial

Animal
No.

m~

t50

£,,.

10

Ca mg%/
Net
Protein Change

pg

%

Change

1

8.10

8.30

+0.002

+0.20

+ 2.5

2

7.80

8.50

+0.006

+0.70

+ 9.0

3

8.10

7.00

-0.010

-1.10

-13.6

4

7.40

7.60

+0.002

+0.20

+ 2.7

5

8.10

7.50

-0.005

-0.60

- 7.4

6

8.50

7.80

-0.006

-0.70

- 8.2

7

8.50

7.60

-0.008

-0.90

-10.6

Mean
Nuclear

Ca
to

-

± S. D.

-0.00J

± o.ooo

- J.7

1

12.40

7.90

-0.066

-4.50

-J6.)

2

9.50

6.50

-0.044

-3.00

-Jl.6

,.

)

10.40

6.oo

-0.064

-4.40

-42.)

t

/ 4

9.60

9.65

+o. 001

+0.05

o.o

5

9.80

7.55

-0.018

-2.25

-23.0

Mean :t

s.

~

J

D.

-0.038 :t 0.028

-26.6

-121-

TABLE IX

HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR
PREPARATIONS AT A CONCENTRATION OF 2,000 pg OBTAINED FROM
INCUBATION MEDIA CONTAINING HIGH CALCIUM CONCENTRATIONS
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10~ering

serum calcium of rats by approximately 19%.

The mitochon-

drial and nuclear preparations elicited a slight hypercalcemic response in rats, raising the serum calcium levels by 8.4 and 4.9%
respectively.

No hypocalcemic response was noted in rats injected

with the nuclear preparation obtained from incubation media containing a high calcium concentration.

This was in contrast to the

hypocalcemic response of the nuclear fraction obtained from an incubation medium containing a physiological calcium concentration
as was noted in Table VIII, probably indicative of significant microsomal contamination in this fraction.

Both the mitochondrial

and nuclear preparations raised the serum calcium by approximately

+ 0.015 mg% per 10 pg protein while the microsomal preparation decreased serum calcium by -0.047 mg% per 10

~g

protein, clearly in-

dicating that the microsomal preparation contained the subcellular
locus for the hypocalcemic hormone.
Tashjian and Warnock (1967) demonstrated that incubation of
0

crude porcine calcitonin in 0.03 N HCl at 110

C for 18 hours was

accompanied by gradual loss of hypocalcemic activity, whereas heating this preparation at 110° C for 2 hours in 0.1 N HCl resulted

'I·:.·1.·

in a more rapid inactivation of the molecule.

However, heating

the calcitonin preparation for 15 minutes at 110° C did little to
alter the hypercalcemic response, thereby indicating the extreme
thermostability of their crude CT preparation.

Therefore, an at-

tempt was made to test the microsomal preparation which had decreased

-123-

the serum calcium level of rats by 25% (Table VII) for its thermostability.

Heat treatment of this preparation at 100° C for 2

hours in 0.01 N HCl did not lead to inactivation.

The data for

the attempted heat-inactivation of this microsomal preparation
obtained from an incubation medium having a physiological calcium
concentration is presented in Table X.

When this heat-treated

preparation was assayed for hypocalcemic activity, a marked hypocalcemic response was noted.

Serum calcium levels of rats receiv-

ing this preparation decreased approximately 29%, indicating no
loss in hypocalcemic activity and the extreme thermostability of
the microsomal preparation.
Tashjian and Warnock (1967) had also shown that the timecourse of inactivation of -their crude porcine CT preparation by
numerous proteolytic enzymes was extremely rapid.

In order to

demonstrate a similar effect with the hypocalcemic microsomal
preparation, it was hydrolyzed for one hour at 37° C with pepsin
at pH 2.7.

The substrate:enzyme weight ratio was 10:1.

As can be

seen from Table XI, pepsin was extremely effective in destroying
the hypocalcemic activity of the microsomal preparation.

Now,

instead of lowering serum calcium by approximately 25% (Table VII),
injection of this pepsin-treated microsomal preparation resulted
in approximately a 4% increase in serum calcium, or a change in
calcium from -0.085 mg% per 10 pg protein to -0.001 mg% per 10 pg
protein.

This experiment indicated the protein nature of this
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TABLE X
HYPOCALCEMIC ACTIVITY OF HEAT-TREATED MICROSOMAL PREPARATION
AT A CONCENTRATION OF 2,000 pg OBTAINED FROM INCUBATION MEDIA
CONTAINING PHYSIOLOGICAL CALCIUM CONCENTRATIONS

Pre para ti on

Microsomal*

Animal
No.

Ca
to

m~

t50

6. Ca mg%/
10 µg Protein

Net
Change

%

Change

1

10.40

5.40

-0.148

-5.00

-48.l

2

10.10

9.25

-0.025

-0.85

- 8.4

3

7.90

6.oo

-0.056

-1.90

-24.l

4

11.20

6.55

-0.138

-4.65

-41.5

5

11.50

10.45

-0.031

-1.05

- 9.1

6

lJ.40

7.50

-0.175

-5.90

-44.o

Mean :!:

s.

D.

-0.096 :t 0.066

-29.2

*Microsomal preparation heated for 2 hours at 100° C in 0.01 N HCl.

r
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TABLE XI
HYPOCALCEMIC ACTIVITY OF PEPSIN-TREATED MICROSOMAL PREPARATION AT
A CONCENTRATION OF 2 1 000 pg OBTAINED FROM INCUBATION MEDIA
CONTAINING PHYSIOLOGICAL CALCIUM CONCENTRATIONS
Pre para ti on

Microsomal*

Animal
No.

Ca
to

m~

t50

6

Ca mg%/

Net

10 µg Protein Change

%

Change

1

9.30

10.00

+o. 0022

+0.70

+7.5

2

9.10

9.30

+0.0006

+0.20

+2.2

J

8.60

9.05

+0.0014

+0.45

+5.2

4

8.40

8.30

-0.0003

-0.10

-1.2

5

a.oo

8.75

+0.0024

+0.75

+9.4

6

8.10

8.30

-0.0006

+0.20

+2.5

Mean

± S. D.

-0.001

!

0.0000

+4.3

*Microsomal preparation hydrolyzed with pepsin for 1 hour at 37°
and pH 2. 7 at a substrateaenzyme weight ratio of 1011.

c

i:

-126p.reparation and the sensitivity of the microsomal fraction to inactivation by a proteolytic enzyme.
A statistical analysis employing the unpaired Student's "t"
Test was utilized to compare the hypocalcemic response of mitochondrial and nuclear preparations to that of the microsomal preparation.

The statistical comparison for the subcellular prepara-

tions obtained from incubation media containing physiological and
high calcium concentrations is presented in Table XII.

A compari-

son of the change in serum calcium mg% per 10 µg protein of heattreated microsomal preparation to that of untreated microsomal material from an incubation medium containing a physiological calcium
concentration indicated that there was no significant loss in hypocalcemic activity.

However, hydrolyzing this same microsomal prep-

aration with pepsin for one hour resulted in a highly significant
decline of hypocalcemic activity of this preparation when compared
to untreated microsomes.

Moreover, a significant difference in

·hypocalcemic activity was noted when the mitochondrial and the nuclear preparation were compared to the microsomal preparation obtained from an incubation medium containing a physiological calcium ion concentration.

Specific activity values (change in serum

calcium in mg%/10 pg protein)_ of the three subcellular fractions
Obtained from incubation media containing high calcium concentrations were also subjected to statistical analysis (Table XII).

Once

again, a significant difference in hypocalcemic activity was noted
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'!'ABLE XII
HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING HIGH
·AND PHYSIOLOGICAL CALCIUM CONCENTRATIONS

Preparation

t:i.

Ca mg%/

10 µg Protein

%

Change

P*

Physiological
Microsomal

-0.085

Microsomal**

-0.096

Microsomal***

+0.001

Mitochondrial

-0.003

Nuclear

-0.038

-+
-+
+
+

Microsomal

+

0.036

-25.3

0.059

-29.2

NS

o.ooo
o.ooo

+ 4.3

0.001

- J.7

0.001

-

0.028

-26.6

0.05

-0.046

+

-

0.010

-19.4

Mitochondrial

+0.015

o. 026

+ 8.4

0.001

Nuclear

+0.015

+
-

0.078

+ "-· 9

0.05

High

+

*

Probability of the significance of the difference of the means
as determined by the use of an unpaired Student's "t" Test.

**

Heat-treated microsomal preparation (2 hr, 100° C and 0.01 N
HCl).
·

***

Microsomal preparation hydrolyzed by pepsin for 1 hour at J7° C
and pH 2.7.

-128when the mitochondrial and the nuclear preparations were compared
to the hypocalcemic response of the microsomal preparation obtained
from a medium containing a high calcium concentration•

THE INFLUENCE OF VARYING CALCIUM CONCENTRATIONS IN THE INCUBATION
MEDIUM ON THE HYPOCALCEMIC RESPONSE OF SUBCELLULAR PREPARATIONS
ISOLATED FROM INCUBATED THYROID SLICES AND ON THE EXTENT OF
INCORPORATION OF GLYCINE-C-14 INTO THESE FRACTIONS
The first series of experiments described above dealt with
determining the subcellular locus of CT, defining the injection
dose which would elicit a maximal hypocalcemic response, evaluating the thermostability of the molecule, and establishing its protein nature.

These mitochondrial, microsomal and nuclear prepara-

tions were assayed for hypocalcemic activity without further purification.

I
J

·~

In this series of experiments, the incorporation of glycineC-14 (UL) into subcellular fractions obtained from incubation
media containing physiological, low, and high calcium concentrations was an additional parameter that was monitored.

In addition,

the subcellular preparations were subjected to a purification step.
This consisted in passing the fractions through a column of Sepha-

1

dex G-100 which eliminated a large portion of the membranous
macromolecular material associated with each subcellular fraction.

-129Sorgente (1969) had demonstrated that a very high calcium
concentration (45 mg/100 ml) in the incubation media was accompanied by an increase in both synthesis and release of CT from
ovine thyroid slices.

It was therefore a possibility that a tra-

cer amino acid, such as glycine-C-14 (one of the prominent amino
acids of ovine CT), could be incorporated preferentially into the
subcellular fraction exhibiting hypocalcemic activity.

It was

also possible that the concentration of calcium in the biosynthetic media could influence the extent of incorporation of label
into the hypocalcemic fraction.

Consequently, in vitro biosynthe-

tic media. were prepared as described previously; however, in this
instance, uniformly labeled glycine containing 2.5 µCi of carbon-14
was added to each biosynthetic medium.
Microsomal, mitochondrial, and nuclear preparations obtained
from incubation media containing physiological, low, and high calcium concentrations were assayed for hypocalcemic activity, protein
content and radioactivity.

The hypocalcemic response of purified

microsomal, mitochondrial, and nuclear preparations obtained from
an incubation medium containing a physiological calcium concentration is shown in Table XIII.

The microsomal preparation was the

only fraction which exhibited hypocalcemic activity, lowering serum
calcium levels of rats by 11.5%.

The mitochondrial and nuclear

preparations were slightly hypercalcemic, raising serum calcium
levels by 1.0% and 5.3% respectively.

The microsomal preparation

-130TABLE XIII
- HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING
PHYSIOLOGICAL CALCIUM CONCENTRATIONS AND
2.5 pCi OF GLYCINE-C-14 (UL)
J>repara ti on

-

Microsomal

Animal
No.
1
2
3
4
5
6
7
Mean !

Mitochondrial

1
2
3
4

5
6
7

Ca
to
11.10
10.40
9.90
8.80
10.15
10.30
10.05

s.

mg%

t50
10.00

a.oo
8.30
7.25
10.15
9.90

9.05
10.00
9.00
9.00
9.20
9.10
9.80
10.15

Mean ± S. D.
Nuclear

1
2
/ 3
4

5
6
7

9.95
9.45
9.30

a.50
9.95

9.80
9.90
8
10.30
10.45
9
Mean ± S. D.

Ca mg%/
10 pg Protein

Net
Change

-0.023
-0.050
-0.034
-0.033

-1.10
-2.40
-1.60
-1.55

o.ooo

o.oo

-0.008
-0.021

-0.40
-1.00

-0.024 ~ 0.017

D.

10.49
8.60
8.60
9.00
9.60
9.60
9.90

~

9.60
10.15
10.50
9.40
10.10
10.20
10.60
11.10
10.50

-0.037
+0.037
+0.037
+0.018
-0.046
+o. 018
+0.023

-0.40
+0.40
+0.40
+0.20
-0.50
+0.20
+0.25

%

Change
- 9.9
-23.1
-16.2
-17.6
o.o
- 3.9
-10.0
-113

+
+
+

3.8
4.7
4.7
2.2

- 5.2
+ 2.1
+ 2.5

+0.007 ! 0.005

+ 1.0

-0.031
-0.35
+0.063
+0.70
+0.107
+1.20
+0.080
+0.90
+0.013
+0.15
+0.40
+o. 036
+0.063
+0.70
+0.80
+0.071
+0.004
+0.05
+O. 045 t 0.042

- 3.5
+ 7~4
+12.9
+10.6
+ 1.5
+ 4.1
+ 7.1
+ 7.8
+ 0.5
+ 5.J!
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decreased serum calcium by -0.024 mg% per 10 µg of protein
while both the mitochondrial and nuclear preparations slight-

ly increased serum calcium levels by +0.007 and +0.045 per
10 pg protein, respectively. The microsomal preparation
which had been purified by passage through a Sephadex G-100
column actually exhibited less hypocalcemic activity per 10

pg of protein (-0.024) than the unpurified microsomal preparation (-0.085, Table VII).

It is likely that a large per-

centage of the stored CT in this fraction is intimately associated with membranous material that was unable to pass
through the chromatographic column.

This could account for

the smaller hypocalcemic response (11.5%), of purified microsomal preparation as indicated in Table XIII as compared
to a 25.3% decrease in serum calcium of unpurified microsomes
indicated in Table VII.
The elution pattern, protein content, and radioactivity
of a microsomal preparation obtained from an incubation medium
containing a physiological calcium concentration and passed
through a column of Sephadex G-100 is presented in Figure 14.
The six to seven fractions representing the elution peak were

pooled for the assay of hypocalcemic activity noted above.
In this instance, the protein and radioactive peaks corresPonded closely to the elution peak.

The radioactive peak

corresponded to approximately 2300 DPM / mg protein and the
microsomal protein peak contained approximately 250 µg
Protein / ml of eluent.

Figure

15

shows

the

elution
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-134pattern, protein content, and incorporation of glycine-C-14 into a
~itochondrial

preparation obtained from the same incubation medium

as the previously cited microsomal preparation.

The elution, pro-

tein, and radioactive peaks correspond rather closely.

However,

the protein peak of the mitochondrial preparation, 25 µg per ml
eluent, was about 10 times less than the 250 pg protein/ml eluent
of the microsomal preparation (Figure 14).

This was not an unex-

pected result since it has been well established that protein synthesis occurs on the ribosomes, which are constituents of the microsomal fraction.

However, the radioactive peak of this mito-

chondrial preparation representing 3300 DPM/mg protein was actually
somewhat higher than the radioactive peak of the microsomal preparation representing 2300 DPM/mg protein as indicated in Figure 14.
This seemed to rule out the possibility that glycine-C-14 was preferentially incorporated into the hypocalcemic microsomal fraction.
Similar data were observed with the nuclear preparation which was

l
I

I

obtained from an incubation medium containing a physiological calcium concentration as shown in Figure 16.

The elution, protein,

and radioactivity peaks overlapped quite closely.

The protein

peak, corresponding to approximately 20 µg of protein/ml eluent,
was much less than the protein peak of the microsomal preparation.
However, the peaks of radioactivity of the nuclear and microsomal

J

preparations were of similar magnitude, being approximately 2700

DPM per mg of protein for the nuclear preparation as compared to
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-136z300 DPM per mg protein for the microsomal preparation (Figure 14).

Sorgente (1969) demonstrated that a calcium concentration of
45 mg/100 ml, a concentration four times greater than a physiologi-

.

cal calcium level, enhanced the biosynthesis and release of CT

0

from thyroid slices in biosynthetic media.

~

·...·.·.·.··I.·

However, he did not

\'

.

determine the influence of a low calcium concentration on hormone
biosynthesis and release.

Therefore, microsomal, mitochondrial,

and nuclear preparations were obtained from an incubation medium
of Krebs-Ringer bicarbonate buffer containing a calcium concentration of 4.8 mg/100 ml.

'l
I

This low level of calcium in the incuba-

tion medium was selected due to its approximation to the physiological minimum to which serum calcium could decline as occurs in
parathyroidectomized animals or in animals on a severely restricted
calcium diet.

A change in the extent of tracer amino acid incor-

poration or an alteration in the hypocalcemic response of the
three subcellular fractions at this low calcium concentration

I
I

might give some indication of the degree of sensitivity of the
hormone biosynthetic process to short-term deprivation of calcium.
The influence of a low calcium concentration on hormone biosynthesis and incorporation of glycine-C-14 is presented in Table XIV.
The microsomal fraction decreased serum calcium by 12.4% and the
change in calcium in mg% was -0.034 per 10 pg protein.

These val-

ues are quite similar to those for the microsomal preparations
obtained from a physiological calcium-containing medium (Table XIII)

-1)8-

in which the decrease in serum calcium was 11.5% and serum calcium
was decreased by 0.024 mg%/10 pg protein.

Unlike the microsomal

preparation, injection of the_mitochondrial and nuclear prepara-

~.:-·

tions elicited less than a 2% hypocalcemic response in rats.

:1·

Microsomal preparations obtained from incubation media containing

(

r

either low or physiological calcium concentrations both lowered
serum calcium by approximately 12%.
•

Figure 17 shows the elution

pattern, protein content, and radioactivity of a microsomal preparation obtained from an incubation medium containing 4.8 mg Ca/
100 ml of Krebs-Ringer bicarbonate buffer.

The elution, protein,

and radioactivity peaks corresponded quite closely.

Once again,

the peak protein content of the microsomal fraction was quite high,
approximating 360 pg per ml of eluent.

The radioactive peak of

the purified microsomal preparation was approximately 5500 DPM/

mg protein.

Since the hypocalcemic response of this microsomal

preparation was almost identical to that of the microsomal preparation obtained from an incubation medium containing a physiological calcium concentration, it was apparent that glycine-C-14 was

I
I

being incorporated at an enhanced rate, into microsomal proteins
other than CT.

Actually, the high value can not be readily ex-

plained, since one would expect the same or lower levels of incorporation of tracer amino acid into a microsomal preparation
obtained from an incubation medium containing a low calcium concentration.
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-140The elution pattern, protein content, and radioactivity of a
mitochondrial preparation obtained from an incubation medium containing a low calcium

concent~ation

are exhibited in Figure 18.

The elution, protein and radioactivity peaks correspond quite
closely.

An incongruent feature is a rather large protein peak

of approximately 300

~g/ml

eluent compared to that observed for

the mitochondrial preparation obtained from an incubation medium
containing a physiological calcium concentration (Figure 15).
However, the peak of radioactivity of approximately 3,000 DPM per
mg protein is quite similar to that of mitochondrial and microsomal preparations obtained from incubation media containing low
or physiological calcium concentrations.
Figure 19 shows the elution pattern, protein content, and
radioactivity of purified nuclear preparation obtained from an
incubation medium containing a low calcium concentration.

I
j

I

Once

again, there is a close correspondence between the elution, protein, and radioactivity peaks.

The radioactivity peak corresponds

to approximately 5500 DPM per mg protein.

The high radioactivity

peaks of approximately 5500 DPM/mg protein of the nuclear (Figure
19) and microsomal preparations (Figure 17) do not indicate a
consistent trend of increased incorporation of radioactivity into
protein of subcellular fractions obtained from media containing
Since the mitochondrial preparation had a radioactivity peak of
only 3,000 DPM per mg protein (Figure 18).
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-14JThe hypocalcemic response of subcellular fractions incubated
in media containing a high calcium concentration is presented in
Table XV.

~nd

The mitochondrial

nuclear preparations were slightly

hypercalcemic, increasing serum calcium by 6.4 and 6.3%, respectively.

But the microsomal fraction was extremely hypocalcemic,

decreasing serum calcium by 22.5% and changing serum calcium by
-0.083 mg% per 10 µg protein.

This clearly indicated that a high

calcium concentration in the incubation medium had stimulated calcitonin biosynthesis in the microsomal fraction.

The 22.5% de-

crease in serum calcium was almost twice that observed with microsomal preparations obtained from incubation media containing physiological calcium concentration (11-.5%, Table XIII) and low ( 12 .4%,
Table XIV) calcium concentrations.
calcium of -0.085 mg per 10

Moreover, the change in serum

pg protein was over twice that observed

from microsomes obtained from an incubation medium containing a

I

physiological calcium concentration (which changed serum calcium
by -0.024 mg% per 10 pg protein) and those obtained from a medium
containing a low calcium concentration (which changed serum calcium by -0.034 mg% per 10 µg protein).

The elution pattern, pro-

tein content, and radioactivity of the microsomal preparation

I

obtained from an incubation medium containing a high calcium concentration is shown in Figure 20.
to 400 pg protein per ml eluent.

The protein peak corresponded
The peak of radioactivity was

900 DPM/mg protein and occurred several fractions beyond the

-144TABLE XV
HYPOCALCEMIC ACTIVITY OF MICROSOMAL, MITOCHONDRIAL, AND NUCLEAR
PREPARATIONS OBTAINED FROM INCUBATION MEDIA CONTAINING HIGH
CALCIUM CONCENTRATIONS AND 2.5 µCi OF GLYCINE-C-14 (UL)
pre para ti on
!1.!crosomal

Animal
No.

Ca
to

1

11.16
11.48
11.10
10.92
11.99
11.23
11.16
11.40
11.74
l0.93
10.51-

2

3
4

5
6
7

8
9
10
11
Mean ± S. D.
Mitochondrial

1
2
3
4

5

8.74
8.79
8.99

8.55
8.74
9.46

6
Mean '± S. D.
Nuclear

l

9.35

2

6

. 10. 06
9.10
8.74
9.25
9.71

Mean

± s. D.

3
4

5

m~

t50

l:l. Ca mg%/
10 µg Protein

-0.049

Net
Change

%

Change

-2.13
-2.40
-2.43
-1.89
-2.91
-2.86
-2.03
-2.99
-3.18
-2.70
-2.30
± 0.040

-19.1
-20.9
-21.9
-17.3
-24.3
-25.5
-18.2
-26.2
-27.1
-25.3
-21.9
-22.5

9.14
10.22
9.20
9.10
9.40
9.56

+0.40
+0.011
+1.43
+o. 039
+0.006
+0.21
+0.015
+0.55
+o. 018
+0.66
+0.10
+0.003
+0.015 ± 0.010

+ 4.6
+16.3
+ 2.3
+ 6.4
+ 7.6
+ 1.1
+ 6.4

10.00
8.99
10.57
9.25
10.86
9.89

+o. 023
-0.038
+o. 052
+0.018
+0.057
+0.006

+ 7.0
-10.6
+16.2
+ 5.8
+17.4
+ 1.9

9.03
9.08
8.67
9.03
9.08
8.37
9.13
8.41
8.56
8.17
8.21

-0.055
-0.056
-0.044
-0.067
-0.066
-0.047
-0.140
-0.149
-0.129
-0.107
-0.083

+o. 020

+0.65
-1.07
+l.47
+0.51
+1.61
+0.18

± 0.033

+ 6.3
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-146elution and protein peaks.

The relatively small amount of incor-

poration of glycine-C-14 into this fraction is not readily explained since one would expect increased

i~corporation

of the label into

a preparation undergoing increased protein biosynthesis.

This low

amount of radioactivity was not a consistent finding since Figure

21 shows that the mitochondrial preparation had 2500 DPM per mg
protein, The elution and protein peaks corresponded quite closely.
The elution pattern, protein content. and radioactivity of a
nuclear preparation which was obtained from an incubation medium
containing a high calcium concentration is shown in Figure 22.
Jn

this particular experiment. the protein peak occurred far be-

yond the elution and radioactive peaks.

The protein peak was

rather small. representing 50 µg of protein per ml eluent, and the
radioactivity peak was approximately

6.ooo

DPM/mg protein.

The

foregoing study which monitored the incorporation of glycine-C-14
into subcellulRr fractions did not demonstrate a preferential incorporation of the tracer amino acid
somal fraction.

in~o

the hypocalcemic, micro-

Moreover, the extent of incorporation 0£ the

label into subcellular preparations was not influenced by the calcium concentration of the biosynthetic media, since no consistent
,patterns in glycine-C-14 incorporation were evident.

However. it

was apparent that glycine-C-14 was being incorporated into all of

the proteins of the microsomal. mitochondrial. and nuclear preparations without any preferential incorporation into CT of the microsomal preparation.
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-149A statistical analysis was utilized to compare the hypocalcemic response of Sephadex G-100-purified and labeled mitochondrial,
and nuclear preparations to that of the consistently hypocalcemic
microsomal preparations.

The analysis, employing an unpaired

student's "T" Test, is presented in Table XVI.

A significant dif-

ference in hypocalcemic activity was evidenced when the mitochondrial and nuclear preparations obtained from incubation media containing a physiological calcium concentration were compared to the
hypocalcemic response of the microsomal preparation which was obtained from the same type of biosynthetic media.

I

'
I
I

t

I

While the micro-

somal preparation decreased serum calcium by 0.024 mg% per 10 µg
protein, the mitochondrial preparation and nuclear

preparation

actually increased serum calcium by 0.007 and 0.045 mg%/10
protein, respectively.

pg

Similarly, the mitochondrial and nuclear

preparations, obtained from incubation medium containing a low
calcium concentration, were significantly different in their hypocalcernic responses from that of the microsomal preparation obtained
from this biosynthetic medium.
serum calcium by 0.034 mg%/10

The microsomal fraction decreased

pg protein while the mitochondrial

fraction decreased serum calcium by only 0.005 mg%/10 µg protein

'

'

'

and the nuclear preparation by 0.007 mg%/10 ug proteino

Moreover,

a highly significant difference in hypocalcemic activity was noted
when the hypocalcemic response of the microsomal preparation obtained from a medium containing high calcium concentration was
compared to

th~~t

of mitochondrial and m.lclear preparations ob-

tained from the same incubation medium.
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TABLE XVI
HYPOCALGEMIC ACTIVITY OF PURIFIED MICROSOMAL, !UTOCHONDRIAL, AND
NUCLEA.-q PREPAHATIONS OBTAINED FROM INCUBA'I'ION MEDIA CONTAINING

LOW, PHYSIOLOGICAL, AND HIGH CALCIUM CONCENTRATIONS

A

Preparation

fLl_Y.S i

I

%
Change

019.EJ.~1

Microsomal
Mitochondrial
Nuclear

I

Ca mg%/

10 µg Protein

-0.024
+0.007

+o. 045

+
+
+

-

0.042

-11.5
+ l.. 0
+ 5.3

0.024

. -12.4

0.017
0.005

0.001
0 .. 001

~

't

'I
'I

Nuc.;lear

-0.007

Microsomu.l
Mitochondrial
Nuclear

-

I

-0.005

-0.0)4

+
+

-

0.026

-

+

0.040

+

+

0.010

-22 .. 5
+ 6.4

0.001

-

0.033

+ 6.J

0.001

+

0.014

- 1.8

0.01

1.5

0.05

High

I

4

Microoomal
Mitochondrial

==-

..

-:::=r~.:;-···----- ~---

-0.08J
+o. 015

+o. 020

-

~----

*Probability of the significance of the difference of the means as
determined by the use of an unpaired Student's "t" Test.
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The influence of varying calcium concentrations on the hypocalcemic response of microsomal preparations is shovm in· Table
XVII.

In this instance, the hypocalcemic response of Sephadex

G-100 purified microsomal preparations obtained from incubation

·I

'I
'I
II
I

media of low and high calcium concentrations was compared to that
of a microsomal preparation obtained from an incubation medium
containing a physiological calcium concentration.

parent that lowering the calcium concentration of the biosynthetic
media (4.8 mg/100 ml) does not significantly alter the hypocalcemic response of the microsomal preparation when compared to that
of a microsomal preparation obtained from a medium containing a
physiological calcium concentration.

However, increasing the cal-

cium concentration of the biosynthetic medium to 26 mg per 100 ml
buffer results in a very significant increase in the hypocalcemic
response of the microsomal preparation.

1

It is quite ap-

This clearly demonstrates

that a high calcium concentration in the incubation medium enhances CT biosynthesis at the subcellular level, even though in-

t

corporation of glycine-C-14 into the microsomal preparation is not

'

enhanced by this calcium concentration.

'

QJ:LARAQTERIZATION OF MICROSOMAL AND

J

I

STAND~RD

CAJ.,CITON1.1LPREPA!{.ATIONS

BY POLYACRYLAMIDE GEL ELECTROPHORESIS

.. The second part of this investigation dealt with establishing
the identity

o~

the hypocalcemic micros0mal fraction by comparison

with a standard calcitonin preparation of known potency.

To ac-

complish this, microsomal and standard calcitonin preparations of

-152-

TABLE XVII
THE INFLUENCE OF VARYING CALCIUM CONCENTRATIONS ON THE
HYPOCALCEMIC

--Preparation

RESPONSE

___ ___

OF MICROSOMAL PREF.A,-qATIONS

,,,,..

-~-·-·-"'

Ca mg%/
10 pg Protein
Ll,.

·--± 0.017

%

P*

Change

---..-----

Physiological

-0.024

Low

-O.OJ4 +

0.024

-12.4

NS

High

-0.0BJ ± o. 040

-22.5

0.005

-11~5

====---*Probability of the significance of the difference of the means as
determined by the use of an unpaired Student's "t" Test.
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)Cnown potency were electrophoretically fractionated in polya.crylamide gels.

Microsomal fractions were then assayed for

homog::?n~-

i tY in polyacrylamide gels after purifjcation through Sephadex
G-100 and G-50.

Initial experiments consisted in the electrophoretic resolution in polyacrylamide gels of a standard calcitonin preparation
having a potency of 88 MRC units/mg.
gel system was used.

A cationic polyacrylamide

It was determined that 200 µg of this stan-

dard CT preparation per 200 µl of sample gsl solution W\Scre sufficient for resolving this calcitonin preparation into its component
peptide fractions after an electrophoretic running time of one
hour and twenty minutes with a current of

2i

ma per gel column.

The densitometer trace of this cationic standard gel is presented
in Figure 23.

Readily apparent from the densitometer trace are

two well-defined protein oands in these gels.

The resolved band

nearest the end of the separation gel was the largest and most
intensely stained.

Virtually all of the standard CT sample had

electrophoretically migrated from the sample gel into the separation gel.
A number of attempts were then made to resolve the Sephadex
G-100 purified microsomal preparation in this cationic polyacrylamide gel system as was achieved with the standard preparation.
'

l

IrJ.i tial attempts to resolve this preparation were performed at

200 µg of microsomal sample per gel.

Electrophoresis was carried

out for the same length of time and milliamperage per gel as had
proved successful in resolving the standard calcitonin preparation.
However, none of the sample material electrophoretically migrated

-154-
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Figure 23. Densitometer trace of a stained polyacrylamide gel.
88

~RC

Two hundred micrograms of an

unit calcitonin standard were resolved in

a cationic gel system.

-15.5-·
into the separation gel.

In repetitive attempts to resolve this

microsomal preparation, the sample concentration was incr·eased to
'
"I

i

I
I

'

i,500 pg per gel.

These rather high sample concentrations were

utilized since it was apparent that a large portion of the microsomal preparation was not dissolved in the sample gel solution.
This insoluble material was probably the remnants of the membra··
nous macromolecular material of the microsomal fraction which was
impossible to solubilize in the sample gel.

Once again, all at-

I.

tempts to resolve the microsomal preparation in a cationic gel

I

proved to be unsuccessful.

Since the microsomal preparation could

not be resolved in cationic gels as was the standard CT prepara-

f

tion, this cationic gel system could not be utilized to establish

I

the identity of the hypocalcemic microsomal material by comparison
with a standard CT preparation.

Therefore, attempts were made to

electrophoretically resolve the standard calcitonin and microsomal
preparations into their component protein fractions in an anionic
gel system.

A standard CT preparation at a concentration of JJJ

µg per gel column was electrophoretically fractionated in an anionic gel at a current of
minutes.

2~

ma per column for one hour and forty

Bromphenol blue served as the tracking dye in this an-

ionic gel system.

The trial run proved to be successful.

The

standard calcitonin preparation could be resolved into its component protein bands in both cationic and anionic polyacrylamide
gel systems.

This indicated the amphoteric nature of the standard

CT preparation.

However, not all of the standard CT preparation

was resolved iu the anionic gel system as evidenced by the substantial amount of sample remaining unresolved in the sample.

-156A densitometer trace of a resolved JJJ
pre para ti on is shown in Figure 24.

)lg

calcitonin standard

An unusual finding was that in

the anionic gel system, three major resolved protein bands (bands

i, 2 and J) were evident as compared to the two bands observed in
the cationic gels (Figure 2J).

There was also a minor, rather in-

distinct band at the beginning of the separation gel and a diffuse
band a. short distance beyond this minor band.

It was possible

that the major band (band 1) and the band adjoining it (band J),
•, ·

which were observed at the end of the separation gel, represented
a better resolution of the single broad band which was observed at
the end of the cationic standard CT gel {Figure 2J).
Initial electrophoretic separations of Sep.had.ex G-J.00 micro-

somal preparations at sample concentrations varying from 200 to
i,500

)lg

at a constant current of 2t ma per gel column and one

hour and forty minutes electrophoretic separation time indicated
that the microsomal preparation could, indeed, be resolved in -'i:;his

I
I
I

I

I

anionic gel system.

Good resolution of protein bands was achieved

at a sample concentration of 1,500 )lg•

Thus, this concentr·ation

was routinely used for electrophoretic resolution.

A densitometer

trace of the Se:phadex G-100 microsomal preparation is shown in

Figure 24.

The three protein bands at the end of the separation

gel consisting of two prominent bands (band 1 and 2) and one band
{band 3) next to the dense bottom band were in identical positions
to those cf the JJJ ug CT standard.

An additional small band was

evident a shcrt distance from the end of the stacking gel which
corre~'3p1:mded

standard.

to the minor band in the densitometer trace of the CT

A densely stained band occurred at the interface of the

-
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Figure 2~

r.1inor
Band

Densitometer traces of electrophoretically resolved hormone

preparations in anionic polyacrylamide gels.

A, an 88 N~C unit calci-

tonin standard at a concentration of JJJ µgJ B, Sephadex G-100 microsomal preparation at a concentration of 1,500 µg1 C, Sephadex G-50 microsomal preparation at a concentration of 1,500 µg.
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separation and stacking gels c-.1 though it is not shown in the den··
sitometer trace.
111

This band may be attributable to macromolecular

aterial such as the remnants of the membranous portion of the

1111crosomal

fraction.

Such densely stained bands at the stacking

gel/separation gel interface are routinely observed when serum
proteins are fractionated in polyacrylamide gels.
A Sephadex G-50 purified microsomal preparation was run at
the same sample concentration and milliamperage per gel as that
for the Sephadex G·-100 purified preparation.
of this preparation is presented in Figure 24.

A densitometer trace

'1.1he two dense

bands (band 1 and 2) at the end of the separation gel still remained and were identical in position to the standard calcitonin
preparation.

However, the protein band (band J) seen next to the

dense band in the densitometer trace of the Sephadex G-100 gel and
the anioni.c standard CT preparation was no longer evident.

There

was a very minor protein band a short distance from the end of the
stacking gel.

I

Once again, a dense band remained at the separation

gel/stacking gel interface but is not shovm on the densitometer
trace.

An electrophoretic separation was performed with the CT standard, the

Sep~adex

G-100, and the Sephadex G-50 microsomal prepara-

tions in the same electrophoretic unit, thereby subjecting these
three preparations to identical conditions of milliamperage per
gel, electrophoretic separation time, and gel concentration.

This

was done to verify that the two major protein bands observed with
these preparations were indeed attributable to the same peptide
fraction in the CT standard, the Sephadex G-100, and the Sephadex

-159G-50 preparations.

In all instances, the two major resolved pro-

tein bands of the standard CT and microsomal preparations corresponded well as seen in Figure 25.

'
I

It is also apparent that the

5ephadex G-50 purification step of the microsomal preparation had
removed a peptide band (band J) which was evident in the

sta~dard

i

CT preparation and the Sephadex G-100 preparation (Figure 24 and

'

25).

I
l

'

CHARACTF~IZATION

OF MICROSOMAL AND STANDARD CALCITONIN

fR~:AT.191:!~

BY ISOELECTRIC POCUSING

I
T

Further characterization of the standard calci tonin prepara··
tion and microsomal calcitonin preparations was accomplished by
isoelectric focusing.

This highly sensitive, resolving technique

was utilized to determine ·a physical constant, the isoelectric
point, of both standard and microsomal calcitonin preparations.
Seven milligrams of a standard CT preparation having a potency of 88

~1RC

units were electrofocused in an LKB 8100 Electrofocus-

ing Column in a pH gradien·t extending from pH J to 6.

Electro-

phoretic resolution of the standard CT preparation was completed
after 48 hours.

The electrofocusi.ng column was then slowly emp-

tied starting from the anode electrode solution and the elution
pattern at 280 nm was monitored.

Fractions o:f :forty drops each

were collected and the pH of these fractions was determined at

4°

C~

This permitted the drawing of a pH curve for the entire

electrofocusing column.

The elution pattern and the pH curve for

the standard CT preparation are shown in Figure 26.

The standard
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Fig;Jre 25.

Polyacryla<nide gels

re~

resenti,;1g el ectro-

phoretically resolved standard and microsomal calcitonin preparations.

The calcitcnin standard at a con-

centrati on of JJJ µg and the Sephadex G-100 and G-50
purified microsomal preparations were fractionated in
anionic gels under identical conditions.

The standard

calcitonin preparation at a concentration of 200 ?g
was resolved in an anionic gel system and is shown
for comparison.
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Separation of 7 mg, of a standard calcl tonin preps.ration
having a potency of 88 MRC uni ts by the I.1.KB 8100 Elcctrofocusi.ng column in a pH gradient extending from pH 3 to :60 The curve with two
peaks shows the absorption of eluate at 280 nmo The steadily incre?..t~
ing curve is a plot of the pH gradient supe1·imp1.)sed.

-162C'..f' prepe.ra.tion was resolved into two :protein bands.

The pl val-

ues of these two resolved protein bands were determined from the
plot of the steadily increasing pH curve.

Th~

resolved protein

band, repri-::sented by the elution peak nearest the anode electrode
solution had a. pI of ). 70 w.hile the pI of the second resolved prot~in

band was J.94.
A similar type o:f determination was carried out with a Sepha-

t

. f.

dex G-50 pu.rifi.ea microsomal preparation which was obtB.ined from

an' incubation medium containing a physiological calcium concentra-

l

t
1

tion.

However, ln this instance, the microsomal material was re-

solved in a pH g"!'adient extending from pH J . . 0 to 5. o..

'I'he narrower

pH gradient was utilized since a preliminary electrophoretic resolution of microsomal material in a broad pH gradient extending fron
pH 3.0 to 10.0 indicated that the pI of the protein(s) of the mi··
crcsomal ma:terial was approximately 4 .. o.

Figure 27 shoitiS -che

electrophoretic resolution of 14 mg of microsomal material in the
LKB 8100 EJ.ectrofocusing Column.

for t-}8 tours.

Electrofocus.i...ng was carried out

The elution pattern was monitored at 280 r...."n and 40

drop fractions were collected.

A pH curve for the entire electro·

focusing column was determined at 4°
ti.or•

l'•:lS

c.

The microsomc>.l prepara-

rZ;3olved into two distinct protein

band~:;

having pI values

of J .. 4·9 and J.,8i+; these were determined from the plot of the

curve.

ste::>.d~

These pI values for the microsomal CT

preparation we:.-e quite similar to the pI values of J. 70 and J. 94·

obtained

fc:..~

,.LOH
Prepar.::. ·t~

th~'

twci resolved protein bands of the standard CT

/n•.
" / ) ,.
, r 1.gure .::.c.

It is possible that the pl values of

the two preparations woulc have been more nearly the same had the
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Figure 27. Separation of 14mg of Sephadex G-50 purified microsomal
preparation by the LKB 8100 Electrofocusing Column in a pH gradient
extending from pH J to 5. The curve with the two peaks shows the absorption of eluate at 280 nm. The steadily increasing curve is a
plot of the pH gradient superimposed,

-164standard CT preparation been resolved in the same narrower pH
gradient {pH J.O to 5.0) in which the microsomal CT preparations
had been electrophoretically resolved.

The isoelectric focusing

procedure did establish the pl values of the protein components of
both the standard and microsomal CT preparations, and the identity
of the microsomal CT preparation with that of the standard CT preparation •. It is also possible that the slight differences in pl
values between the two resolved protein bands of the standard and
microsomal CT preparations could be attributed to species differ-

1
I

ences in amino acid composition of the CT molecule.

The standard

porcine CT molecule is known to differ from ovine CT molecule at
four positions, at amino acid residue number 14, 15, 19, and 22
(Figure 2), thereby resulting in slightly different pI values between the two molecules.

I

Most of the amino acid differences be-

tween porcine and ovine CT are conservative.

The phenylalanine

residues at position 19 and 2 of the porcine molecule are replaced
by tyrosine in the ovine CT molecule and the basic arginine resi-

due at position 14 of the porcine molecule is replaced by lysine,
another basic amino acid, in the ovine CT molecule.

The only sig-

nificant change in replacement of an amino acid residue is noted
'--at position 15 where the amino acid, amide asparagine, in the porcine molecule, is replaced by an aspartic acid residue in the ovine
CT molecule.

This change in amino acid at position 15 could ac-

count for the slight differences in the observed pI values.
Three forty-drop fractions corresponding to each of the two
elution peaks in the resolved microsomal material were then passed
through a column of Sephadex G-50 to remove most of the contamina-

-165ting ampholytes from the resolved microsomal proteins.
~ately

Approxi-

2 mg of purified microsomal material was obtained from each

of the elution peaks.

The radioactivity of 200 pg of microsomal

I

material from the elution peaks having pl values of 3.49 and 3.84
(Figure 27) was determined.

It was not possible to determine the

specific activity in terms of DPM/mg protein.

There was still.a

slight amount of ampholyte contamination with each of the resolved
microsomal preparation and it interfered with the determination of
protein by the Lowry method.

Therefore, radioactivity was expressed

f

as counts per minute ( CPl\'1) per 200 pg of sample.

I

fraction exhibited enhanced incorporation of labeled glycine.

Neither resolved
The

fraction having a pI of 3.49 had 238 CPM per 200 pg of sample,
w~ile

that of the fraction having a pI of 3.84 had a value of 215

CPM per 200 µg sample.
t

Once again, this demonstrated that no pre-

ferential incorporation of glycine-C-14 into microsomal proteins
was occurring.
The two electrophoretically resolved microsomal fractions were
then assayed for hypocalcemic activity.

In order to have sufficient

quantities of resolved microsomal material for biological assay determinations, three isoelectric focusing runs were required.
These were carried out as previously described.

In the three in-

stances, the microsomal material was electrophoretically resolved
into two protein bands and the pI values of each band did not differ by more than !O.l pH unit.

Bioassays were performed as pre-

viously described: however, in this instance. the injection dose
was 1,000 µg of electrophoreticallyresolved and Sephadex G-50
Purified microsomal CT preparation.

The hypocalcemic activity of

'I

I

-166these preparations are shown in Table XVIII.

The microsomal CT

•aterial having a pI value of approximately 3.5 decreased serum
calcium by 9.6% while the change in serum calcium was O.OJl mg%

I

per 10

t

pl value of approximately J.8 resulted in a similar hypocalcemic

pg

response~

1
f

protein.

Injection of microsomal CT material having a

since the serum calcium was decreased by 8.8% and the

change in serum calcium was 0.027 mg% per 10 pg of protein.
The hypocalcemic responses of the two electrophoretically resolved microsomal CT fractions having pI values of 3.49 and J.84

t

't

't

were compared to that of the unresolved microsomal CT preparation
obtained from an incubation medium containing a physiological calcium concentration.

The statistical evaluation of the hypocalcemic

responses is shown in Table XIX.

The resolved microsomal protein

bands with isoelectric points of J.49 and J.84 were not statistically different in their hypocalcemic response from that of unresolved microsomal material.

-167TABLE XVIII

HYPOCALCEMIC ACTIVITY OF ELECTROPHORETICALLY RESOLVED MICROSOMAL*

'

PREPARATIONS OBTAINED FROM AN INCUBATION MEDIUM CONTAINING

A PHYSIOLOGICAL CALCIUM CONCENTRATION

I

AND 2.5 pCi OF GLYCINE-C-14 (UL)

t

~ Ca mg%/
10 µg Protein

Net
Change

%

Animal
No.

Ca
to

Microsomal

1

11.50

10.45

-0.031

-1.05

- 9.1

pl ::: 3.49

2

11.35

10.10

-0.037

-1.25

-11.0

3

io.51

9.94

-0.017

-0.57

- 5.4

4

11.41

10.17

-0.037

-1.24

-10.9

5

l0.52

9.34

-0.035

-1.18

-11.2

J>reparation

't. ''

Mean t

s.

m£:%
t50

-0.031

D.

t 0.010

Change

- 9.5

Microsomal

1

10.10

9.25

-o. 025

-0.85

- 8.4

pl = 3. 84

2

l0.93

10.40

-0.016

-0.53

- 4.8

3

9.60

9.10

-0.015

-0.50

- 5.2

4

10.06

8.99

-0.0)2-

-1.07

-10.6

5

11.00

9.40

-0.047

-1.60

-14.5

Meant S. D.

-0.027

± u.010

- 8.7

*Fourteen milligrams of Sephadex G-50 purified microsomal material
was electrophoretically fractionated into two protein peaks in an
LKB 8100 Electrofocusing Column in a pH gradient extending from
PH 3 to 5. The first resolved protein band had a pl of 3.49 and
the second had a pl of J.84.
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TABLE XIX

THE HYPOCALCEMIC RESPONSE OF ELECTROPHORETICALLY
RESOLVED MICROSOMAL PREPARATIONS*

A

Preparation

Ca mg%/
10 pg Protein

%
Change

P**

' Microsomal

-0.024

+

0.017

-11.5

Microsomal
pI=J.49

-0.031

+

-

0.010

- 9.5

NS

Microsomal
pI=J.84

-0.027

+

0.010

- 8.7

NS

-

, *

The microsomal preparations having pI values of 3.49 and J.84
were resolved in an LKB 8100 Electrofocusing Column in a pH
gradient extending from pH J to 5.

, **

Probability of the significance of the difference of the means
as determined by the use of an unpaired Student's ttt" Test.

CHAPTER IV

'
f

•

'

DISCUSSION
Since Ithe postulated existence of calcitonin by Copp et al •
'

(1962) and its discovery and isolation from the thyroid gland by

t
,I

Hirsch et al. (1963), a large body of information has accumulated

l
'

factors involved in the mechanism of action, metabolism, duration

'

l

concerning the cell of origin, chemistry, and sites of action of
this hypocalcemic hormone.

However, full clarification of the

of action, control of secretion, and physiological role of this
hormone in the maintenance of mammalian mineral homeostasis have
not been elucidated.
This study was concerned with further clarification of one of
these areas of investigation, the control of calcitonin secretion;
hence, its localization in thyroid glands and factors involved in
its biosynthesis.

More specifically, this study dealt with the

subcellular localization of this hypocalcemic hormone in ovine

I
I

thyroid glands, determining the influence of varying calcium ion
concentration on hormone biosynthesis at the subcellular level, and
establishing the identity of the hypocalcemic species with a ref-

.J

erence standard calcitonin preparation by polyacrylamide gel electrophoresis and by isoelectric focusing.

In addition, this inves-

tigation has provided for the first time, in so far as is known,
information on the isoelectric point(s) of standard porcine and
microsomal ovine calcitonin preparations.

-170Calcitonin is secreted by the thyroid gland into the general
circulation when a naturally occurring stimulus of hypercalcemia
occurs.

Its action is to markedly retard bone resorption as evi-

denced by the rapid decrease in blood calcium levels.

When calci-

tonin is administered to rats, it produces a hypocalcemia which is
manifest~d shortly after hormone administration and reaches a peak

approximately one hour after the hormone injection (Hirsch et al.,

1964; Kumar et al., 1965) and it is effective even in parathyroidectomized rats (Gudmundsson

e~

al., 1966).

Considerable evidence

has been presented which indicates that CT inhibits the PTH-induced resorptive process both in vivo and in vitro.

In vivo ex-

periments of Milhaud and Moukhtar (1966), Johnston and Diess (1966),
Klein _g1

~·

(1967) have consistently demonstrated that CT is ef-

fective in blocking PTH-induced bone resorption and may play a
role in preventing bone matrix degradation as evidenced by the
dramatically decreased excretion of hydroxyproline in intact rats
(Martin et al., 1966, and Rasmussen et al., 1967),

These experi-

ments provided evidence for the concept that CT administration retarded all phases of bone resorption and that its action was not
by direct inhibition of PTH.
The characteristic hypocalcemic response and the retardation
of PTH-induced mineral resorption by CT has been demonstrated in

in

vitro experiments utilizing bone cultures (Friedman and Raisz,

-

1965; Friedman -et -al., 1968; Aliapoulios et -al., 1966; Raisz and
---~

Nieman, 1967; Reynolds and Dingle, 1968; and Brand and Raisz, 1972),
and isolated and perfused limbs (Macintyre et.§;!., 1967).

These

experiments have clearly demonstrated that the hormone is bio-

-17110 gically active in in vitro systems and that its action in these
systems may provide valuable information about its normal physiological role in mammals.
The problems associated with the control of CT secretion
have been studied extensively.

The mechanism(s) that controls the

level of circulating hormone is akin to that controlling PTH.

It

is well-established that PTH secretion is controlled directly by
blood calcium concentration, hypocalcemia enhancing secretion and
I

hypercalcemia abolishing secretion.

Calcitonin secretion has also

been shown to be dependent upon blood calcium concentration.

The

level of this hormone in the peripheral circulation is in direct
proportion to increases in calcium concentration above normal
levels.

The observations of Copp et al. (1962), Kumar et al. (1963),

Care (1965), and

Care~

al. (1968) provided ample evidence that

the extent of CT secretion from the thyroid is directly dependent
upon the calcium concentration of the blood flowing through the
thyroid gland, rising as the calcium level increases and falling
as it decreases.

The 'C' cells of the thyroid release CT only in

response to the actual calcium concentration of the blood flowing
through the thyroid and the secretion rate is not dependent on the
rate, degree, or direction of calcium flux in the blood.

These

observations correlated well with the evidence presented by Foster
~

al. (1964) and Matsuzawa and Kurosumi (1967) who demonstrated

that hypercalcemic stimulation resulted in a gradual decrease of
densely staining secretory granules of the 'C' cells.

The highly

sensitive radioimmunoassay technique of Deftos et al. (1968), Lee
~ ~·

(1969) and Cooper et al. (1971) confirmed that CT is being

l

-172continuously secreted, even at physiological concentrations of
blood calcium and that a rapid increase in CT secretion resulted
when hypercalcemia was induced followed by a rapid decline in
l

hormone when normocalcemia'was
restored.
...
----~ "'-----~

The feasibility of utilizing in vitro biosynthetic media for
studying the biosynthesis and release of hormones has been wellestablished.

In vitro biosynthetic media containing either slices

or homogenates of such endocrine tissues as the hypothalamus
(Takabatake and Sachs, 1964), anterior pituitary (Adiga et al.,
1965), parathyroid glands (Hamilton and Cohn, 1969 and Hamilton

!! al., 1971), and thyroid glands (Sorgente, 1969 and Radde et al.,
1970) have been utilized to monitor the biosynthesis and release
of hormones.

These endocrine tissues exhibited the physiological

regulatory mechanism in in vitro biosynthetic media which is typical of the gland in vivo, thereby providing a valuable insight
into the factors involved in the physiological regulation of hormone synthesis and release.
Pertinent to this investigation, Sorgente (1969) utilized
an in vitro biosynthetic medium containing thyroid gland slices
in an effort to establish the role of calcium and magnesium ion
at the tissue level on the synthesis and release of CT.

Sorgente's

biosynthetic media contained ovine thyroid slices which were incubated (4 hr, 37° C) with glycine-C-14 in Krebs-Ringer bicarbonate buffer containing glucose (320 mg/100 ml) and all the amino
acids of calcitonin (20 mg/l).

The calcitonin, which was isolated

by salt precipitation from incubated thyroid slices, was assayed
for hypocalcemic activity in rats.

Sorgente's experiments indi-

-173cated that a high calcium concentration (45.6 mg%) in the biosynthetic medium stimulated both synthesis and release of CT
since there was a 50% increase in the hypocalcemic response above
physiological levels.

However, varying the magnesium ion concen-

tration was without effect in the CT regulatory mechanism.

Later,

Radde et al. (1970) presented evidence that a high calcium concentration in the biosynthetic medium was directly responsible for
enhanced CT release into biosynthetic media.
In this investigation, Sorgente's in vitro biosynthetic medium was utilized for the incubation of ovine thyroid slices.
Further, his experimental findings were confirmed in this study
and provided a working model to allow for extrapolation to xhe
subcellular level.

Thns, in this study, three distinct subcellu-

lar fractions, the microsomes, the mitochondria, and the nuclei
were obtained from incubated thyroid slices by differential centrifugation and were assayed for hypocalcemic activity in rats to
determine the subcellular locus of CT.

The influence of a vary-

ing calcium ion concentration on biosynthesis at the subcellular
level was investigated by utilizing incubation media containing
low (4.8 mg%), physiological (11.5 mg%), and high (26.0 mg%) calcium concentrations.

The incorporation of glycine-C-14 into these

subcellular fractions was monitored in an attempt to determine
whether the hypocalcemic fraction could be shown to reflect an
enhanced incorporation of labeled amino acid, a further evidence
of calcitonin biosynthesis.

In addition, this approach would

determine whether the alterations in the calcium ion concentration
could effect the extent of incorporation of labeled amino acid into

r
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the hypocalcemic fraction.
Assaying subcellular fractions for hormonal activity is not
an unprecedented investigative procedure since Brown and Ulvedal
(1960) localized hormonal activity in a number of anterior pituitary fractions.

Similarly, Hamilton and Cohn (1969) demonstrated

that the 105,000 x g particulate fraction of parathyroid glands
exhibited hypercalcemic activity which is characteristic of PTH.
Moreover, Bauer and Tietelbaum (1966) and Cooper and Tashjian
(1966) provided evidence that the 100,000 x g particulate fraction of pigs and rats exhibited hypocalcemic activity.
In the work reported here, the microsomal subcellular preparation was the only fraction which consistently exhibited hypocalcemic activity and a maximal hypocalcemic response occurred at
a dose of 2,000 pg.

Microsomal preparations obtained from bio-

synthetic media containing physiological and high calcium concentrations were demonstrated to have significant differences in
hypocalcemic activity when compared to mitochondria and nuclei
from these biosynthetic media.

These experiments with unpurified

subcellular preparations clearly demonstrated that the microsomes
were the subcellular locus of this hypocalcemic principle.
The microsomal CT preparation was not inactivated by heat,
thereby indicating its thermostability.

The ability of this

preparation to withstand high temperature might be attributed
to the protective influence of non-specific protein macromolecular material associated with these crude subcellular preparations.
However, the microsomal preparation was readily inactivated by
the proteolytic enzyme, pepsin.

These characteristics of the
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unpurified hypocalcemic principle in the microsomal fraction are
in accordance with the findings of Tashjian and Warnock (1967) in
their studies with crude extracts of porcine CT.
The experiments of Hamilton and Cohn (1969) and Hamilton
et al.
--

(1971) demonstrated that a labeled amino acid which was a

constituent of bovine PTH could be preferentially incorporated
into a 100,000 x g particulate fraction which elicited a hyper-

calcemic response when injected into rats.

Moreover, the extent

of incorporation of the labeled amino acid into the hypercalcemic
fraction was dependent upon the calcium concentration of the biosynthetic medium.

Incorporation of the labeled amino acid into

the hypercalcemic fraction was inversely proportional to the
calcium concentration of the biosynthetic medium, being decreased
at high calcium concentrations and increased at low calcium concentrations.

These in vitro observations correlated well with

the normal physiological response of PTH to hypocalcemia.
A distinct possibility therefore existed that a tracer amino
acid, such as glycine-C-14 (a prominent constituent of ovine CT),
could be incorporated preferentially into the hypocalcemic microsomal fraction and that varying the calcium concentration of the
biosynthetic media might influence the extent of incorporation of
the labeled amino acid.

However, this investigation revealed

that no such preferential incorporation occurred.

Similarly, the

extent of incorporation of the labeled amino acid into the various
subcellular fractions was not influenced by the calcium concentration of the biosynthetic medium, since no consistent trend in
glycine-C-14 incorporation occurred among subcellular fractions

r
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obtained from incubation media containing low, physiological, and
high calcium concentrations.

However, it was apparent that gly-

cine-C-14 was being incorporated non-specifically into all of the
proteins associated with the microsomal, mitochondrial, and nuclear
preparations and not specifically into the hypocalcemic microsomal fraction.
Although no consistent patterns of incorporation of label
into subcellular preparations could be discerned, it was readily
observed from the closely corresponding radioactivity, protein and
elution peaks, that each of these subcellular fractions was rather
homogeneous in its protein composition.

For, unlike Sorgente's

observation of multiple radioactivity and protein peaks at the
tissue level, only a single elution, protein, and radioactivity
peak was observed for each of these subcellular preparations.
This clearly indicated that a single subcellular fractionation
step resulted in more purified protein preparations, especially
the hypocalcemic microsomal preparation, than had the harsher
multi-step isolation scheme utilized by Sorgente.

This study

confirmed the feasibility of isolating CT by a completely different procedure than the commonly employed extraction method from
whole thyroid glands.
Although no consistent patterns in radioactive label incorporation were observed, the influence of calcium concentration at
the subcellular level was very prominent.

A high calcium con-

centration (26.o mg%) in the biosynthetic media resulted in a
highly significant increase in the hypocalcemic response of
Sephadex G-100 purified microsomal preparations resulting in
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almost a 2-fold increase in hypocalcemic activity as compared to
the hypocalcemic response of microsomes obtained from incubation
media containing physiological and low calcium concentrations
which decreased serum calcium by approximately 12%.

This sub-

stantiated the concept that the effect of calcium ion was a direct
one at the subcellular level as well as at the whole tissue level.
No alteration in the hypocalcemic response was detected in
microsomes obtained from an incubation medium containing a low
·calcium concentration when the response was compared to that of
microsomes derived from incubation media containing physiological
levels of calcium.

This indicated, possibly, that a four hour

period of incubation of thyroid slices at a low calcium concentration (4.8 mg%) was not adequate time to alter the biosynthetic
process of the 'C' cells or that a sufficient amount of CT was
present in the 'C' cells which could
hours.

not be depleted in four

A third possibility was that CT biosynthetic mechanism(s)

was only sensitive to increasing calcium ion concentration in the
'C' cells and not to calcium levels below physiological levels.
It was also likely that the 'C' cells of the thyroid continued
normal CT synthesis from residual unlabeled amino acids in the
cells during short term (4 hr) calcium deprivation.

Since CT bio-

synthesis is significantly enhanced in the microsomal preparations
obtained from incubation media containing a high calcium concentration, it is possible that calcium ion may exert its effect on
hormone biosynthesis in a number of ways.

High calcium ion con-

centration could possibly enhance the activity of one or more of
the enzymes involved in the synthesis of the calcitonin molecule.

-179-

The CT standard could be resolved in both cationic and
~

anionic polyacrylamide gels.

It is possible that two differently

charged species of the standard porcine CT molecule were present,
perhaps due to the method of extracting this hormone preparation
from whole porcine thyroid glands.

A more satisfactory explana-

tion is not presently available since the porcine CT extraction

l

procedure, utilized by Dr. Robert Schleuter of Armour Pharmaceuticals, Kankakee, Illinois, is now being patented and is therefore
not available for inspection.
The microsomal material could be electrophoretically fractionated only in anionic polyacrylamide gels.

It is likely that

the native ovine molecule was therefore predominantly negatively
charged since migration of the microsomal material proceeded
towards tha anode.

A slight difference between the porcine and

ovine CT molecule is that the ovine has an aspartate residue at
position 15 whereas the porcine molecule has an asparagine residue and this may account for the ability of the ovine molecule to
be resolved only in anionic gels.
The homogeneity of microsomal preparations was monitored
after passage of the microsomal material through Sephadex G-100
and G-50 chromatographic columns.

The Sephadex G-50 purification

step had removed one of the protein bands seen in the Sephadex
G-100 preparations.

It was also apparent that a large portion

of the hypocalcemic microsomal fraction was probably macromolecular material which was either uncharged or too large to be resolved in the small pore separation gel.

Hence, the large quan-

tities of sample required (1,500 pg) to electrophoretically
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resolve the Sephadex G-100 and G-50 microsomal preparations as
compared to the standard CT preparation

(JJJ

~g).

This does not

present a serious disadvantage since it is likely that the isolation procedure for the standard porcine CT preparation required
much

lar~er
,

quantities of porcine thyroid glands than did the sub-

cellular fractionation procedure utilized in this study to obtain microsomal fractions.
The microsomal and standard CT preparations were further
·characterized by isoelectric focusing.

This procedure allowed

the first determination yet reported of the isoelectric points of
these two molecules.

The microsomal preparation was electrophor-

etically resolved into two protein bands having isoelectric points
of

J.49 and J.84 in a pH gradient extending from J to 5.

The

standard porcine CT preparation was also resolved into two protein
bands having quite similar isoelectric points of 3.70 and
a pH gradient of 3 to 6.

J.94 in

The closeness of the isoelectric points

of the electrophoretically resolved bands of the ovine and porcine
CT preparations further established the identity of the hypocalcemic principle of the microsomal preparation with a standard CT
preparation.

The slight discrepancy in the pI values of the

resolved band between the two CT preparations may be attributed to
either the use of a broader pH gradient (pH 3 to 6) utilized for
resolving the standard CT

pr~paration

or more likely, to the spe-

cies differences already alluded to in amino acid composition of
the CT molecule.

This may result in a slightly different elec-

trophoretic resolution of the porcine molecule in the electrofocusing column as compared to the ovine microsomal preparation.

t
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Each of the two electrophoretically resolved microsomal protein bands were found to contain hypocalcemic activity.

It was

--

therefore likely that the highly sensitive resolving power of the
isoelectric focusing technique had separated two slightly different charged species of the same ovine CT molecule.

The biological

assay of electrophoretically resolved microsomal preparations was
hampered by ampholyte contamination of the protein bands and therefore allowed for poor recovery of this purified material.

This is

attributable to the closeness of the molecular weights of the
largest ampholyte species (M. W. to 1800) as compared to the CT
molecule having a molecular weight of J600.
The fact that CT was localized in the microsomal fraction,
that its biosynthesis is enhanced by high calcium concentrations in
in vitro biosynthetic media, and that the microsomal hormone preparation was characterized by polyacrylamide gel electrophoresis
and isoelectric focusing, lays the groundwork for further studies.
The subcellular fractionation technique may be utilized as an
alternative large scale hormone isolation procedure for CT and
possibly for other hormones such as insulin and glucagon of the
pancreas, should they be associated with a particular subcellular
fraction.

It is an isolation and purification procedure which

does not involve harsh extraction methods which tend to denature
or alter the composition of biologically active species.

The

technique would be especially amenable to isolation of highly
purified CT preparations from ultimobranchial tissues of fish or
sharks which Copp and his associates have shown to have extremely

r
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potent CT preparations.

This is possible since there is no con-

tamination of the 'C' cells in this tissue with large amounts of
thyroglobulin, thyroid hormones, and parathyroid tissue as occurs
with the thyroid 'C' cells in most mammalian species.

Moreover,

the monitoring of labeled amino acid incorporation into a hypocalcemic subcellular preparation in an in vitro biosynthetic
medium such as the one utilized in this study might be more advantageously studied in a system utilizing homogenates of ultimobranchial tissue.

There would be two advantages to such a system

since in a gland homogenate of ultimobranchial tissue, there would
be fewer membranes present to hinder transport of a labeled amino
acid and incorporation- of label should proceed more rapidly.
Secondly, one would not be hindered with the possibility of incorporation of tracer amino acid into as many non-specific proteins.

r
CHAPTER V

SUMMARY AND CONCLUSIONS
From the information provided by the studies of Hamilton
and Cohn (1969), Hamilton et al. (1971), and Sorgente (1969) on

--

the il'! yj.._!;ro biosynthesis of parathyroid hormone and calcitonin
and the experiments of Brown and Ulvedal (1960) which localized
hormonal activity of anterior pituitary within several subcellular fractions, it appeared likely that the subcellular locus of
ovine CT could be determined as well as the influence of calcium
ion on hormone biosynthesis at the subcellular level.

Conse-

quently, ovine thyroid gland slices were incubated in in

y..i:tr.£

biosynthet.ic medieo_ containing low (4.8 mg%), 'physiological (11.5
mg%), and high (26.o mg%) calcium concentrations and 2.5 pCi of
glycine-C-14, which served as a tracer amino acid.

After incuba-

tion, the slices were homogenized and mitochondrial, nuclear, and
microsomal subcellular fractions were obtained by differential centrifugation.
Microsomal, mitochondrial, and nuclear preparations were
assayed for hypocalcemic activity at a dose of 2,000

pg.

It was

determined that the microsomes were the subcellular locus of calcitonin.

A hypocalcemic microsomal preparation which had de-

creased serum calcium level of rats by 25% could not be inactivated
by heating at 100° C for 2 hours in 0.01 N HCl.

However, this

same preparation was readily inactivated by incubation for 1 hour
-183-
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at J7° C with the proteolytic enzyme, pepsin, at a substratea
enzyme weight ratio of 10 to 1.

These findings are known charac-

teristics of unpurified calcit-0nin preparations.
Microsom~l,

mitochondrial, and

n~clear

preparations purified

by passage through a column of Sephadex G-100 were assayed for
hypocalcemic activity, protein content, and radioactivity.

Once

again, hypocalcemic activity was consistently demonstrated in the
microsomal preparation.

Microsomal preparations obtained from

the low and physiological calcium concentration incubation media
reduced serum calcium levels of rats by approximately 12%.

How-

ever, a microsomal preparation obtained from a high calcium concentration incubation medium decreased serum calcium levels of
rats by 22.5%, a highly significant increase in hypocalcemic activity.

These findings indicated that a high calcium concentra-

tion in the in vitro biosynthetic media had stimulated calcitonin
biosynthesis in the microsomes.

The elution, protein, and radio-

activity peaks of the mitochondrial, microsomal, and nuclear preparations corresponded closely.

This indicated that the subcellu-

lar fractionation procedure could be effectively utilized as an
alternative isolation procedure to the whole gland extraction
methods for calcitonin.

However, no preferential incorporation

of glycine-C-14 into the hypocalcemic microsomal preparation was
observed.

The labeled amino acid was being incorporated non-

specifically into all three of these subcellular preparations.
Standard porcine and ovine microsomal calcitonin preparations
were fractionated into their component protein bands by polyacrylamide gel electrophoresis.

The microsomal fraction was inspected

r

for homogeneity in polyacrylamide gels after passage through
Sephadex G-100 and G-50 chromatographic columns.
the electrophoretic

resolutio~

A comparison of

of these preparations in anionic

gels under identical conditions of milllamperage per gel, electrophoretic resolution time, and acrylamide gel concentration, established the identity of the hypocalcemic principle in the microsomal preparation with a standard porcine calcitonin preparation
of known potency.
The isoelectric points of a microsomal and a standard calcitonin preparation of known potency (88 MRC Units per mg) were determined by isoelectric focusing.

Fourteen milligrams of Sephadex

G-50 purified microsomal preparation were electrophoretically resolved in a pH gradient extending from pH J to 5 into two protein
bands having isoelectric points of 3.49 and J.84.

Seven milli-

grams of the standard porcine calcitonin preparation were also resolved into two protein bands having quite similar isoelectric
points of 3.70 and 3.94 in a pH gradient extending from pH J to 6.
The highly sensitive resolving power of this technique was employed to obtain milligram quantities of each of the two electrophoretically resolved protein bands of the microsomal preparation.
These two protein fractions were both found to possess hypocalcemic activity when injected into rats.
This investigation indicated that the microsomal fraction is
the locus of ovine calcitonin and that high calcium concentration
enhances hormone biosynthesis of this fraction.

In addition, the

first deterrninationsof the isoelectric points of standard porcine
and microsomal ovine calcitonin preparations were established.
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ABSTRACT
Abstract of the dissertation entitled "CALCITONIN ACTIVITY
OF PARTICULATE FRACTIONS OF THE OVINE THYROID GLAND" submitted by
Peter Rudolf Oeltgen in partial fulfillment of the requirements
for the degree of Doctor of Philosophy, February, 1973.
Oyine thyroid gland slices were incubated (4 hr, J7° C) in
an in vitro biosynthetic medium consisting of a Krebs-Ringer bicarbonate buffer (pH 7.4), glucose (320 mg/100 ml), all the amino
acids of ovine calcitonin (20 mg/l) and glycine-C-14.

The incu-

bations were carried out in media containing low (4.8 mg%), physiological (11.5 mg%}, and high {26.o mg%) calcium concentrations.
After incubation, the slices were homogenized and mitochondrial,
nuclear, and microsomal subcellular fractions were obtained by
differential centrifugation.

After

purifica~ion

by passage through

a column of Sephadex G-100, these fractions were assayed for hypocalcemic activity, protein content, and radioactivity.
Hypocalcemic activity was consistently demonstrated in the
microsomal preparation.

The microsomal fraction was found not to

be inactivated by heat, but was readily inactivated by incubation
with the proteolytic enzyme, pepsin, thereby exhibiting known
characteristics of the molecule.

Purified microsomal preparations

derived from the low and physiological calcium concentration incubation media reduced serum calcium levels of rats by approximately
12%.

However, a microsomal preparation obtained from a high cal-

cium concentration incubation medium decreased serum calcium levels
of rats by 22.5%, a highly significant increase.

The elution,

r
protein, and radioactivity peaks corresponded closely.
Standard and microsomal calcitonin preparations were fractionated into their protein components by polyacrylamide gel
electrophoresis.

The microsomal fraction was inspected fer homo-

geneity in polyacrylamide gels after passage through Sephadex
G-100 and G-50 chromatographic columns.

A comparison of the elec-

trophoretic resolution established the identity of the hypocalcemic principle in the microsomal preparation with a standard
calcitonin preparation of known potency.
Isoelectric points of the microsomal and standard
preparations were determined by isoelectric focusing.

calci~onin

The micro-

somal preparation was electrophoretically resolved in a pH gradient extending from 3 to 5 into two protein bands having isoelectric points of 3.5 and 3;8.

The standard

ca~citonin

preparation

was also resolved into two protein bands having quite similar isoelectric points of 3.7 and 3.9 in a pH gradient of 3 to 6.
The results of this investigation indicated that the microsomal preparation was the only particulate fraction of ovine
thyroid tissue that exhibited calcitonin activity and that high
calcium concentration enhanced hormone biosynthesis in this fraction.

Determination of the isoelectric points of ovine and por-

cine calcitonin was achieved by isoelectric focusing.
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